2023/2075(INI) Non-communicable diseases
Lead committee dossier:
Progress: Procedure completed
| Role | Committee | Rapporteur | Shadows |
|---|---|---|---|
| Lead | ENVI |
POULSEN Erik ( Renew)
|
SKYTTEDAL Sara ( EPP),
UJHELYI István ( S&D),
RIVASI Michèle ( Verts/ALE),
KARSKI Karol ( ECR),
KONEČNÁ Kateřina ( GUE/NGL)
|
| Committee Opinion | DEVE |
LUCKE Karsten ( S&D)
|
Charles GOERENS ( RE),
Michèle RIVASI ( Verts/ALE),
Miguel URBÁN CRESPO ( GUE/NGL),
Beata KEMPA ( ECR),
Marlene MORTLER ( PPE),
Antoni COMÍN I OLIVERES ( NA)
|
Lead committee dossier:
Legal Basis:
RoP 54
Legal Basis:
RoP 54Subjects
Events
2023/12/13
EP - Text adopted by Parliament, single reading
Documents
2023/12/13
EP - Decision by Parliament
Documents
2023/11/17
EP - Committee report tabled for plenary
Details
The Committee on the Environment, Public Health and Food Safety adopted the own-initiative report by Erik POULSEN (Renew, DK) on non-communicable diseases (NCDs).
The report noted that non-communicable diseases (NCDs) are diseases that are not passed from person to person. They cause 90 % of all deaths in the EU, account for 80 % of the health burden in EU countries and their prevalence continues to grow across the EU.
Moreover, premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe.
Improved health promotion and disease prevention can reduce the prevalence of NCDs by as much as 70%.
NCD prevention
Members stressed that it is important to prevent and reduce the prevalence of NCDs through early diagnosis and screening , better access to public healthcare, and through better disease management and treatment.
Member States are also encouraged to develop, implement and monitor national NCD plans and strategies, in particular for the most prevalent diseases with high mortality and morbidity rates.
Highlighting that 60 % of children are exposed to second-hand smoke at home which can lead to sudden infant death syndrome, lower respiratory infections, ear infections and more severe asthma, the EU and the Member States are called on to ensure greater protection of non-smokers from second-hand smoke and to develop campaigns in order to create a smoke-free environment and to raise the first tobacco-free EU generation by 2040.
Members also called on the Commission and the Member States to:
- promote smoking cessation and implement measures to help tobacco users quit and follow up on the scientific research and evaluations by public health authorities on the health risks related to electronic cigarettes, particularly taking into consideration the threat posed to non-smokers, children and youth;
- protect minors from commercial communications on alcohol consumption ;
- encourage and help consumers to make informed and healthy choices about food products, empowering them to follow healthy, varied and balanced diets;
- propose a new, comprehensive and integrated EU action plan for obesity with benchmarks, indicators and mechanisms to monitor and guarantee results;
- promote physical activity and the practice of sports in urban planning as an accessible and widely available means of reducing the risk factors for NCDs;
Identification of high-risk populations and early diagnosis of NCDs
The report pointed out that many people living with NCDs in Europe are undiagnosed and unaware of their illness, and, thus, fail to get proper, timely treatment. The Commission should collect examples of best practices regarding screening for and early detection of NCDs. NCD prevention and management can help lighten the burden of NCDs on healthcare systems and strengthen their resilience in the face of health crises.
Member States are encouraged to introduce targeted health checks for high-risk individuals and promote self-sampling to address the main shared metabolic risk factors such as high blood pressure, high blood glucose, high BMI and high LDL cholesterol.
Improving NCD healthcare
Stressing that healthcare professionals, patient organisations and the third sector at large play a significant role in referring patients for early diagnostic tests and treating NCDs, the report encouraged Member States to ensure continued patient access to primary and secondary care, and to offer inter-professional training to healthcare professionals in order to better recognise at-risk individuals and to better prevent, identify and treat NCDs.
The report also stressed the importance of accessible and cost-effective healthcare, so that limited resources are put to the best use and provided to the patients in most need.
The valuable role of community pharmacies is stressed in continuously providing essential services to support the treatment of NCDs and to keep the general public informed.
Members called for the adoption of an EU strategy to anticipate and monitor the impacts of serious health threats on people affected by communicable diseases and NCDs, and other diseases or conditions. They proposed exploring the possibility of creating an emergency reserve of European NCD specialists, composed of voluntary NCD experts trained and ready to be deployed to provide care to people living with NCDs in any Member State or neighbouring country in times of crisis.
Patient empowerment and health literacy are also crucial in preventing NCDs.
Lastly, digital health solutions are strongly welcomed which can enable better access to healthcare in rural areas and protect immunosuppressed NCD patients from exposure to infectious diseases.
Documents
2023/11/07
EP - Vote in committee
2023/10/27
EP - Committee draft report
Documents
2023/10/06
EP - Committee opinion
Documents
2023/09/08
EP - Amendments tabled in committee
Documents
2023/09/08
EP - Amendments tabled in committee
Documents
2023/09/08
EP - Amendments tabled in committee
Documents
2023/06/15
EP - Committee referral announced in Parliament
2023/06/13
EP - LUCKE Karsten (S&D) appointed as rapporteur in DEVE
2023/04/20
EP - POULSEN Erik (Renew) appointed as rapporteur in ENVI
Documents
- Text adopted by Parliament, single reading: T9-0467/2023
- Decision by Parliament: T9-0467/2023
- Committee report tabled for plenary: A9-0366/2023
- Committee draft report: PE751.761
- Committee opinion: PE750.007
- Amendments tabled in committee: PE752.881
- Amendments tabled in committee: PE752.914
- Amendments tabled in committee: PE752.915
- Amendments tabled in committee: PE752.881
- Amendments tabled in committee: PE752.914
- Amendments tabled in committee: PE752.915
- Committee opinion: PE750.007
- Committee draft report: PE751.761
- Text adopted by Parliament, single reading: T9-0467/2023
Votes
Non-communicable diseases – A9-0366/2023 – Erik Poulsen – Motion for a resolution #
2023/12/13 Outcome: +: 578, -: 39, 0: 15
The Left
ID| Amendments | Dossier |
| 935 |
2023/2075(INI)
2023/07/24
DEVE
91 amendments...
Amendment 1 #
Draft opinion Recital -A (new) -A. having regard to Article 208 of the Treaty on the Functioning of the European Union (TFEU), which states, in part, that the Union must take account of the objectives of development cooperation in the policies that it implements which are likely to affect developing countries,
Amendment 10 #
Draft opinion Recital -A i (new) -Ai. having regard to the Opinion of the Committee on Development on the proposal for a regulation of the European Parliament and of the Council on the sustainable use of plant protection products and amending Regulation (EU) 2023/2115,
Amendment 11 #
Draft opinion Recital -A j (new) -Aj. having regard to the Opinion of the Committee on Development on the objective of ensuring food security and the long-term resilience of EU agriculture (2022/2183 (INI)),
Amendment 12 #
Draft opinion Recital -A k (new) -Ak. having regard to the proposal for a regulation of 22 June 2022 on the sustainable use of plant protection products and amending Regulation (EU) 2021/2115 (COM(2022)0305),
Amendment 13 #
Draft opinion Recital -A l (new) -Al. having regard to the Commission Communication of 30 November 2022 entitled ‘EU Global Health Strategy, Better Health for All in a Changing World’ (COM(2022)675),
Amendment 14 #
Draft opinion Recital -A m (new) -Am. having regard to the Commission communication of 20 May 2020 entitled ‘A Farm to Fork Strategy for a fair, healthy and environmentally-friendly food system’ (COM(2020)0381),
Amendment 15 #
Draft opinion Recital -A n (new) -An. having regard to the Commission communication of 11 December 2019 entitled ‘The European Green Deal’ (COM(2019)0640),
Amendment 16 #
Draft opinion Recital -A o (new) -Ao. having regard to the UN resolution "Outcome document of the high-level meeting of the General Assembly on the comprehensive review and assessment of the progress achieved in the prevention and control of non-communicable diseases" (A/RES/68/300), 17 July 2014,
Amendment 17 #
Draft opinion Recital -A p (new) -Ap. having regard to the WHO Global Action Plan 2013-2020 that has been extended to 2030 (resolution WHA66.10), 27 May 2013,
Amendment 18 #
Draft opinion Recital -A q (new) -Aq. having regard to the UN Political Declaration on the Prevention and Control of Non-communicable Diseases (NCDs) (A/RES/66/2), 24 January 2012,
Amendment 19 #
Draft opinion Recital -A r (new) -Ar. having regard to the 2023 WHO report “A clinical case definition of post COVID-19 conditions in children and adolescents by expert consensus”, 16 February 2023,
Amendment 2 #
Draft opinion Recital -A a (new) -Aa. having regard to the joint statement by the Council and the representatives of the governments of the Member States meeting within the Council, the European Parliament and the European Commission of 30 June 2017 on ‘The new European consensus on development’,
Amendment 20 #
Draft opinion Recital -A s (new) -As. having regard to the 2021 WHO report “A clinical case definition of post COVID-19 conditions by a Delphi consensus”, 6 October 2021,
Amendment 21 #
Draft opinion Recital -A t (new) -At. having regard to the UN Report of the Special Rapporteur on the right to food, Michael Fakhri, of 30 December 2021 entitled ‘Seeds, right to life and farmers’ rights’ (A/HRC/49/43)
Amendment 22 #
Draft opinion Recital -A u (new) -Au. having regard to the UN Report of the Special Rapporteur on the right to food, Michael Fakhri, of 24 December 2020 entitled ‘Right to food’ (A/HRC/46/33),
Amendment 23 #
Draft opinion Recital -A v (new) -Av. having regard to the UN resolution of 28 September 2018 on the Rights of Peasants and Other People Working in Rural Areas (A/HRC/RES/39/12),
Amendment 24 #
Draft opinion Recital -A w (new) -Aw. having regard to the UN resolution of 2 October 2007 on the Rights of Indigenous Peoples (A/RES/61/295),
Amendment 25 #
Draft opinion Recital A A. whereas non-communicable diseases, or chronic diseases, are the cause of death of 41 million people every year and account for 74 % of all deaths globally; whereas people in the Global South are disproportionally affected, and according to World Health Organization estimates, 77 % of all premature deaths from non-communicable diseases occur in low- and middle-income countries; whereas NCDs are often linked to chronic illness-related disability;
Amendment 26 #
Draft opinion Recital A a (new) Aa. whereas the EU development cooperation policy should emphasize a comprehensive and integrated approach that addresses the multiple risk factors and determinants of NCDs in partner countries, while also considering social, economic and environmental factors that are relevant to each specific context; whereas universal health coverage is an important factor in preventing and treating NCDs;
Amendment 27 #
Draft opinion Recital A a (new) Aa. whereas Latin America and the Caribbean experienced in 2022 the largest sustained decline in childhood vaccination in the last 15 years, where 2.4 million children have not received the complete vaccination schedule against diptheria, tetanus and whooping cough, 400 thousand more than in 2019;
Amendment 28 #
Draft opinion Recital A a (new) Aa. whereas the right to enjoy the highest attainable standard of physical and mental health is a fundamental human right which is in line with the provisions of Article 25 of the Universal Declaration of Human Rights; whereas this right is being denied to over a fifth of the world's population;
Amendment 29 #
Draft opinion Recital A a (new) Aa. whereas SDG target 3.4 on non- communicable diseases and mental health seeks to reduce by 2030 by one third the premature mortality rate from non- communicable diseases through prevention and treatment and to promote mental health and well-being;
Amendment 3 #
Draft opinion Recital -A b (new) -Ab. having regard to the United Nations 2030 Agenda for Sustainable Development and the Sustainable Development Goals (SDGs),
Amendment 30 #
Draft opinion Recital A a (new) Aa. whereas according to the World Health Organisation, climate change, air pollution and non-communicable diseases represent some of the most serious threats to global health;
Amendment 31 #
Draft opinion Recital A a (new) Aa. whereas the COVID-19 pandemic placed an increasing strain on mental health, especially among young people and those already suffering from mental illness;
Amendment 32 #
Aa. whereas developing countries face serious constraints in the financing of healthcare, particularly with regard to non-communicable diseases;
Amendment 33 #
Draft opinion Recital A b (new) Ab. whereas non-communicable diseases are linked to poverty, as they impede poverty reduction initiatives by increasing the share of household costs for health care; whereas treatments of non-communicable diseases tend to involve long-term treatment that can be hard to access to and have a significant impact on household economy;
Amendment 34 #
Draft opinion Recital A b (new) Amendment 35 #
Draft opinion Recital A b (new) Ab. whereas Article 35 of the Charter of Fundamental Rights of the European Union calls for a high level of human health protection in the definition and implementation of all Union policies and activities;
Amendment 36 #
Draft opinion Recital A b (new) Ab. whereas the COVID-19 pandemic has exposed insufficient investment in the Health Care Workforce and shown how unprepared health systems were to respond to a global health crisis;
Amendment 37 #
Draft opinion Recital A b (new) Ab. whereas food security and education have a significant impact on health in the area of non-communicable diseases;
Amendment 38 #
Draft opinion Recital A b (new) Ab. whereas there is a need to enhance access to the diagnosis, treatment, and care of noncommunicable diseases in developing countries;
Amendment 39 #
Draft opinion Recital A c (new) Amendment 4 #
Draft opinion Recital -A c (new) -Ac. having regard to the report of the Committee on Development and of the Committee on the Environment, Public Health and Food Safety on the implementation and delivery of the Sustainable Development Goals (2023/2010 (INI)),
Amendment 40 #
Draft opinion Recital A c (new) Ac. whereas low- and middle-income countries’ health systems focus on acute illness because of their weaknesses; whereas, as a result, the patient's journey is often characterised by gaps, whether at the diagnostic phase, treatment or lack of adherence to therapy; whereas prevention aspects are often missing in those systems;
Amendment 41 #
Draft opinion Recital A c (new) Ac. whereas the Global Goals for Sustainable Development comprise combatting poverty, including the access to basic human needs of health, zero hunger, including establishing sustainable food production and good health and wellbeing, including better and more accessible health systems to increase life-expectancy;
Amendment 42 #
Draft opinion Recital A d (new) Ad. whereas non-communicable disease-related health misinformation is a growing concern as more and more individuals obtain their health information from new media such as search engines or social media platforms; whereas, while increased access to information on health issues can be seen as generally positive, the spread of inaccurate medical information is problematic and can lead to harmful lifestyle or dietary choices, self- medication, the abandonment of medical treatment and incorrect diagnoses;
Amendment 43 #
Draft opinion Recital A d (new) Ad. whereas the Agreement on Trade Related Investment Measures (TRIMS) and other investment rules, which are part of the Free Trade Agreements (FTAs), also compromise the efforts of many developing countries to achieve self- sufficiency in manufacturing of medical products by making the application of many local production stimulation tools like local content rule, export obligation, etc. as illegal;
Amendment 44 #
Draft opinion Recital A d (new) Ad. whereas SDG 3 calls for ensuring healthy lives and promoting well-being for all at all ages; whereas target 3.4, which is interlinked with SDGs beyond SDG 3, aims for a 30% reduction in premature mortality from the four major NCDs clusters: cardiovascular disease, cancer, chronic respiratory disease and diabetes;
Amendment 45 #
Draft opinion Recital A e (new) Ae. whereas NCDs are not only linked to excess mortality, but also to suffering from morbidity, chronic illness-related disability and increased socio-economic burdens on individuals and families, including poverty from long-term treatment and care costs, loss of productivity that considerably threatens household income and impairs national economies, making non-communicable diseases a contributing factor to poverty and hunger;
Amendment 46 #
Draft opinion Recital A f (new) Amendment 47 #
Draft opinion Recital A g (new) Amendment 48 #
Draft opinion Recital A h (new) Amendment 49 #
Draft opinion Recital A i (new) Ai. whereas therefore in the age of pandemics, global health security does not only has to take the immediate threat of infectious disease into account, but also to deal with chronic long-term suffering as a consequence thereof, in particular PAIS, whereas interactions between communicable and non-communicable diseases (NCDs) are complex and often mediated by shared risk factors; whereas the co-existence of NCDs and communicable diseases lead to increased morbidity, in particular in lower- and middle income countries;
Amendment 5 #
Draft opinion Recital -A d (new) -Ad. having regard to the report of the Special Committee on the COVID-19 pandemic on the COVID-19 pandemic: lessons learned and recommendation for the future (2022/2076 (INI)),
Amendment 50 #
Draft opinion Recital A j (new) Aj. whereas although upcoming pandemics are likely to be followed by PAIS, the EU Global Health Strategy of 2022 neither addresses Long Covid nor PAIS in general; whereas PAIS cannot count for “rare diseases” due to their overall prevalence of ME/CFS alone and certainly not since the high prevalence of Long Covid;
Amendment 51 #
Draft opinion Recital A k (new) Ak. whereas in general, next to infections and behavioural risk factors interlinked with socio-economic factors, such as unhealthy diet, physical inactivity, harmful use of alcohol and tobacco use, environmental risks also contribute to developing NCDs; whereas the One Health approach recognises that health, environment, climate protection, biodiversity, food security and nutrition are closely interlinked; whereas One Health needs to become a central determinant in the prevention of health risks and in combatting them;
Amendment 52 #
Draft opinion Paragraph -1 (new) -1. Is deeply concerned about the high prevalence of non-communicable diseases (NCDs) as cause for excess mortality and morbidity; underlines that NCDs do not get adequate attention globally and lead to particular dire consequence in low- and middle-income countries; underlines that health in general and global health security need more political attention and financial support with a special focus on NCDs, certainly as more pandemics with post-infectious chronic illnesses can be expected;
Amendment 53 #
Draft opinion Paragraph 1 1.
Amendment 54 #
Draft opinion Paragraph 1 1. Notes the surge in post-acute infection syndromes (PAIS) following COVID-19 infections; recalls that PAIS also occur following other bacterial, viral and parasitic infections, including mononucleosis, Lyme disease, Ebola, polio and influenza; recalls that the pathogenesis of PAIS is linked to chronic fatigue syndrome (ME/CFS), in the context of 65 million people suffering from long COVID to date, as well as reinfection pressure and upcoming pandemics; is concerned that the global health strategy addresses neither the post-acute sequelae of SARS-CoV-2 nor PAIS in general; recalls that many countries, especially those on the African continent, are still having major difficulties in accessing the health technologies used to fight not only the coronavirus but also other diseases; emphasises that the universal access to health depends among others on the ability of developing countries to build up their own production capacities and develop local know-how; in this respect, stresses that Intellectual Property Rights undoubtedly constitute a barrier to access to vaccines; urges the EU to support developing countries, in particular LDCs, in the effective implementation of flexibilities for the protection of public health provided for in TRIPs agreements, notably compulsory licencing and parallel import; calls for the EU, with a view to lessons learned from the pandemic, to make PAIS a priority and to develop an EU strategy for PAIS, comparable to Europe’s beating cancer plan and the EU strategy on mental health, and to extend the PAIS strategy to global health security, including in the implementation of the global health strategy;
Amendment 55 #
Draft opinion Paragraph 1 1. Notes the surge in post-acute infection syndromes (PAIS) following COVID-19 infections; recalls that PAIS also occur following other bacterial, viral and parasitic infections, including mononucleosis, Lyme disease, Ebola, polio and influenza; recalls that the pathogenesis of PAIS is linked to chronic fatigue syndrome (ME/CFS), in the context of 65 million people suffering from long COVID to date, as well as reinfection pressure and upcoming pandemics; is concerned that the global health strategy addresses neither the post-acute sequelae of SARS-CoV-2 nor PAIS in general; calls for the EU, with a view to lessons learned from the pandemic, to make PAIS a priority and to develop an EU strategy for PAIS, comparable to Europe’s beating cancer plan and the EU strategy on mental health, and to extend the PAIS strategy to global health security, including in the implementation of the global health strategy; urges the EU to establish programs to address chronic and severe noncommunicable diseases by ensuring that essential medicines, technologies, and diagnostics are both available and accessible at district hospitals;
Amendment 56 #
Draft opinion Paragraph 1 a (new) 1a. Stresses the need to strengthen healthcare systems in partner countries and provide support for the integration of NCD programs into national health systems, including by investing in capacity building programs to strengthen the skills and knowledge of healthcare professionals, researchers, and policymakers in addressing NCDs;
Amendment 57 #
Draft opinion Paragraph 1 a (new) 1a. calls on the WHO to provide more funding for the research and development of vaccines and medicines for non- communicable diseases and to ensure easier access to affordable essential pharmaceuticals;
Amendment 58 #
Draft opinion Paragraph 1 b (new) 1b. calls on the WHO to promote further awareness and information in the fight against non-communicable diseases such as cancer or diabetes, as well as further prevention of substance abuse;
Amendment 59 #
Draft opinion Paragraph 1 c (new) 1c. underlines that, in particular, the education and training of healthcare professionals in developing countries and particularly in least developed countries can play a role in improving health outcomes;
Amendment 6 #
Draft opinion Recital -A e (new) -Ae. having regard to the report of the Committee on Development on Policy Coherence for Development (2021/2164(INI)),
Amendment 60 #
Draft opinion Paragraph 2 2. Notes that guiding principle 2 of the global health strategy aims to ensure that innovative vaccines, treatments and diagnostics for new, prevalent or neglected infectious and non-communicable diseases are developed and used, including through funding from Horizon Europe and the EU- Africa Global Health European and Developing Countries Clinical Trials Partnership (EDCTP3) for research, capacity building and strengthening the regulatory environment in sub-Saharan Africa; calls for Team Europe to implement this approach, with a focus on non-communicable diseases.
Amendment 61 #
Draft opinion Paragraph 2 2. Notes that guiding principle 2 of the global health strategy aims to ensure that innovative vaccines, treatments and diagnostics for new, prevalent or neglected infectious and non-communicable diseases are developed and used, including through funding from Horizon Europe and the EU- Africa Global Health European and Developing Countries Clinical Trials Partnership (EDCTP3) for research, capacity building and strengthening the regulatory environment in sub-Saharan Africa; calls for Team Europe to implement this approach, with a focus on non-communicable diseases
Amendment 62 #
Draft opinion Paragraph 2 a (new) 2a. Recalls the high prevalence of PAIS in countries of the Global South; calls for supporting cooperation partnerships on pharmaceutical research and innovation and the creation of networks to exchange data and research results on PAIS and for supporting the development of medication for all PAIS; welcomes long-term partnerships such as between the Institut Pasteur de Dakar in Senegal and the Coalition for Epidemic Preparedness Innovation (CEPI) and calls for Team Europe to enable these partnerships also for NCDs and in particular PAIS through Global Gateway initiatives;
Amendment 63 #
Draft opinion Paragraph 2 a (new) 2a. Recalls that health is a prerequisite for human development, which implies mobilizing additional public funds to guarantee Universal Health Coverage; stresses that the delivering of “horizontal health” through an holistic and rights-based approach entails i.a. to fully address the multidimensional nature of health (with close links to gender, food security and nutrition, water and sanitation, education and poverty), along the line of “One Health” approach;
Amendment 64 #
Draft opinion Paragraph 2 a (new) 2a. Underlines the urgency of strengthening public and universal health systems in developing countries, to improve preventive actions and infrastructures; stresses the need of tackling restrictions on access to medicines; calls for the waiving of IPRs on essential medicines and treatments against NCDs for developing countries and to facilitate their access to technology;
Amendment 65 #
Draft opinion Paragraph 2 a (new) 2a. (new) reminds that the priority 2 of the European Global Health Strategy is to "strengthen health systems and advance universal health coverage"; insists that particular attention should therefore be put on prevention, diagnostic and community-centred approaches that can facilitate those aspects;
Amendment 66 #
Draft opinion Paragraph 2 a (new) 2a. Notes the importance of the EU- LAC partnership on local manufacturing of vaccines and medicines and the use of Global Gateway flagship projects to respond to the regression in the past decade regarding the vaccination of young children in the region of Latin- America and the Caribbean;
Amendment 67 #
Draft opinion Paragraph 2 a (new) 2a. Stresses the need to support developing countries in educating communities about the risk factors and prevention strategies for NCDs by disseminating information through various channels such as mass media, community outreach programs and digital platforms;
Amendment 68 #
Draft opinion Paragraph 2 a (new) 2a. stresses that the human and financial costs of non-communicable diseases are expected to rise, owing to the fact that those who suffer from non- communicable diseases are also more likely to be affected by other diseases;
Amendment 69 #
Draft opinion Paragraph 2 a (new) 2a. Calls for developing countries to be supported in their efforts to prevent non-communicable diseases via the modernisation of their public health systems and the provision of universal access to healthcare;
Amendment 7 #
Draft opinion Recital -A f (new) -Af. having regard to the report of the Committee on Development on the role of development policy in the response to biodiversity loss in developing countries, in the context of the achievement of the 2030 Agenda (2020/2274 (INI)),
Amendment 70 #
Draft opinion Paragraph 2 b (new) Amendment 71 #
Draft opinion Paragraph 2 b (new) 2b. Notes with deep concern that pollutants in the environment have a massive impact on global health, especially for low- and middle-income countries (LMICs); calls on the EU to assist developing countries, notably the LMICs and LDCs, to prioritize disease prevention, through investment in the management of pollution, including through strategies on access to clean energies, clean and efficient transport, control of industrial emissions, the sound use of chemicals, as it is a highly cost- effective strategy for enhancing population health, reducing the burden on limited health resources and advancing national development;
Amendment 72 #
Draft opinion Paragraph 2 b (new) 2b. (new) highlights that the fight against stigma is also an important component of the fight against non- communicable diseases, which is particularly critical for mental health issues, which are part of non- communicable diseases; reminds that stigmas lead to non disclosure or concealment of conditions, which are often related to a concern related to reduced work, employment opportunities but also social isolation;
Amendment 73 #
Draft opinion Paragraph 2 b (new) 2b. Calls on the EU and its Member States to support developing countries in research and data collection efforts to better understand the prevalence, risk factors, and impact of NCDs in different populations, in view of enabling evidence- based decision-making and designing targeted interventions; underlines the need to design and scale up solutions for high risk, resource-limited, and marginalized populations;
Amendment 74 #
Draft opinion Paragraph 2 b (new) 2b. notes that a unified and integrated approach is needed to reduce the burden of non-communicable diseases; underlines that the prevalence of non- communicable diseases can be reduced by as much as 70% through healthcare and disease prevention alone;
Amendment 75 #
Draft opinion Paragraph 2 b (new) 2b. Emphasises the need for technological and organisational innovation, as well as lasting, coordinated multilateral cooperation;
Amendment 76 #
Draft opinion Paragraph 2 b (new) 2b. Calls on the EU to support local and public pharmaceutical production capacity in developing countries;
Amendment 77 #
Draft opinion Paragraph 2 c (new) 2c. calls on the Commission to continue supporting Member States in their efforts to achieve the nine voluntary UN and WHO targets by 2025 as well as sustainable development target 3.4, which aims to reduce premature mortality from non-communicable diseases by one third by 2030 and to promote mental health and well-being;
Amendment 78 #
Draft opinion Paragraph 2 c (new) 2c. Welcomes the Commission’s 2022 Global Health Strategy “Better Health for all in a Changing World”, highlighting in particular Guiding Principle 2 that addresses a comprehensive approach, including equitable access to health services, disease prevention, affordable quality treatment and rehabilitation and palliative care to fight communicable and non-communicable diseases;
Amendment 79 #
Draft opinion Paragraph 2 c (new) 2c. (new) reminds the scale of the problem of health misinformation and the potential danger to human lives that has become apparent with the COVID-19 pandemic; calls on the Commission to support projects, tools and policies that seeks to fight the health misinformation topic;
Amendment 8 #
Draft opinion Recital -A g (new) -Ag. having regard to the report of the Committee on Development on the Ebola crisis: the long-term lessons and how to strengthen health systems in developing countries to prevent future crises (2014/2204 (INI)),
Amendment 80 #
Draft opinion Paragraph 2 c (new) 2c. Emphasises that innovative business models provide the opportunity to create incentives for patients and service providers to complete prevention programmes; calls for cooperation with developing countries in this area;
Amendment 81 #
Draft opinion Paragraph 2 d (new) 2d. Highlights that the Global Health Strategy follows a human-rights based approach with attention to the needs and rights of women, children and young people, persons with disabilities in line with the UN Convention on the Rights of Persons with Disabilities, as well as to access to health by other vulnerable groups such as LGBTIQ people, older people, migrants, refugees and internally displaced people, also in the context of natural or man-made disasters and the impacts of climate change; calls for implementing this human-rights based approach including addressing NCDs and the so far neglected post-infectious syndromes;
Amendment 82 #
Draft opinion Paragraph 2 d (new) 2d. calls for easier access to essential health services and for global health policy to be strengthened in the areas of early warning, prevention and awareness, in line with the Global Health Strategy and with the aim to achieve the Sustainable Development Goals relating to health;
Amendment 83 #
Draft opinion Paragraph 2 d (new) 2d. Draws attention to the need for knowledge-sharing and data collection, screening and early detection of diseases, and management of diagnosis and treatment;
Amendment 84 #
Draft opinion Paragraph 2 e (new) 2e. Considers strengthening health systems and advancing universal health coverage in an equitable way that ensures financial risk protection and access to quality essential healthcare services and safe, effective, quality and affordable essential medicines and vaccines, as outlined in the Global Health Strategy, of utmost importance; is concerned about development banks investing in for-profit hospitals in the Global South and calls on Team Europe to develop safeguards that ensures equitable access to healthcare in cases where EU development funds are involved; underlines that support to primary healthcare in order to ensure the management of non-communicable diseases is not sufficient, but given the high prevalence of NCDs, more awareness, training of medical personal, and a greater share of development assistance has to be dedicated to NCDs;
Amendment 85 #
Draft opinion Paragraph 2 e (new) 2e. recalls that 'One Health' lies at the interface between ecological, animal and human health; calls on the EU to commit to a feasible design and implementation of the 'One Health' approach at European and international level through the WHO, regional organisations and States, in particular in negotiations relating to the planned Pandemic Treaty and the Global Health Strategy;
Amendment 86 #
Draft opinion Paragraph 2 e (new) 2e. Emphasises the important role of and the need for interdisciplinary points of care;
Amendment 87 #
Draft opinion Paragraph 2 f (new) Amendment 88 #
Draft opinion Paragraph 2 f (new) 2f. calls on the EU to actively work together with the WHO and other relevant international organisations and to become active at international level in this regard, in order to guarantee an appropriate and coordinated approach; recalls that NDICI resources can also be used in the area of healthcare;
Amendment 89 #
Draft opinion Paragraph 2 g (new) 2g. Underlines the impact of the living environment on health and on the prevention of non-communicable diseases; urges Team Europe to take the One Health approach in health programming and action into account, including in intersectional fields such as biodiversity, agriculture and a healthy living environment;
Amendment 9 #
Draft opinion Recital -A h (new) -Ah. having regard to the Motion for a Resolution of the Committee on Development on accelerating progress and tackling inequalities towards ending AIDS as a public health threat by 2030 (2021/2604(RSP)),
Amendment 90 #
Draft opinion Paragraph 2 h (new) 2h. With view to preventing NCDs, such as malnutrition, obesity, metabolic syndrome, cancers, immunological conditions, parkinson diease, fetal malformation and others, highlights the basic requirement of food security and a healthy nutrition variety on the one hand, linked to the right to food and to the right of small-scale farmers to access land and the right to seeds as pointed out in the light of UN Report A/HRC/49/43, and reminds in this regard of the value of agroecology and the decrease of the overall use of chemical pesticides for a healthy living environment, including water and soil on the other; underlines furthermore, that biodiversity and intact ecosystems are the best prevention of zoonoses; condems in this regard EU’s double standards on pesticides, which enable the export from the EU of hazardous substances which are themselves banned in the EU and calls on the Commission to ensure reciprocity in international trade agreements, particularly in relation to agriculture and agricultural products, and to lead by example by ensuring that hazardous pesticides banned in the EU are not exported to partner countries, preventing residues of banned pesticides from being tolerated in food on the EU market and strengthening the enforcement mechanism of the TSD chapters;
Amendment 91 #
Draft opinion Paragraph 2 i (new) 2i. Recalls in this regard the principle of policy coherence for development (PCD) enshrined in Article 208 TFEU, according to which ‘the Union shall take account of the objectives of development cooperation in the policies that it implements which are likely to affect developing countries’, and the importance of ensuring coherence between all EU policies in order to guarantee the effectiveness of development cooperation for the benefit of developing countries and to increase the effectiveness of the EU’s commitment to food autonomy and to a healthy living environment with intact ecosystems, also under the aspect of preventing non-communicable diseases;
source: 751.578
2023/09/08
ENVI
836 amendments...
Amendment 1 #
Motion for a resolution Citation 9 a (new) – having regard to Regulation (EU) 2022/123 of the European Parliament and of the Council of 25 January 2022 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices,
Amendment 10 #
Motion for a resolution Citation 6 – having regard to its resolution of 16 February 2022 on strengthening Europe in the fight against cancer – towards a comprehensive and coordinated strategy and the Commission communication of 3 February 2021 entitled ‘Europe’s Beating Cancer Plan’ (COM(2021)0044),
Amendment 100 #
Motion for a resolution Recital D a (new) Amendment 101 #
Motion for a resolution Recital D a (new) Da. whereas a much stronger focus on prevention is needed, which requires a holistic approach based on the One Health approach;
Amendment 102 #
Motion for a resolution Recital D b (new) Amendment 103 #
Motion for a resolution Recital D b (new) Db. whereas the economic effects of NCDs manifest themselves in the loss of potential years of productive life; whereas this has an impact on part of the economy of the Member States;
Amendment 104 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by four main preventable risk factors: tobacco use, unhealthy diet, lack of physical activity and harmful use of alcohol; whereas behavioural risk factors lead to biological risk factors, the most common being overweight and obesity, high blood pressure, high blood glucose and high blood cholesterol6 ; whereas these risk factors often overlap, giving rise to severe complications and increased risk of developing other NCDs _________________ 6 World Health Organization, ‘Monitoring
Amendment 105 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by
Amendment 106 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by four preventable risk factors
Amendment 107 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by
Amendment 108 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by
Amendment 109 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by f
Amendment 11 #
Motion for a resolution Citation 6 a (new) Amendment 110 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by four preventable risk factors: tobacco use, unhealthy diet, lack of physical activity and harmful use of alcohol; whereas behavioural risk factors lead to biological risk factors, the most common
Amendment 111 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by four preventable risk factors: tobacco use, unhealthy diet, lack of physical activity and harmful use of alcohol; whereas behavioural risk factors lead to biological risk factors, the most common being overweight and obesity, high blood pressure, high blood glucose
Amendment 112 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by four preventable risk factors: tobacco
Amendment 113 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by four preventable risk factors: combustion tobacco use, unhealthy diet, lack of physical activity and harmful use of alcohol; whereas behavioural risk factors lead to biological risk factors, the most common being overweight and obesity, high blood pressure, high blood glucose and high blood cholesterol6 ; _________________ 6 World Health Organization, ‘Monitoring
Amendment 114 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by f
Amendment 115 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by four preventable risk factors: tobacco use, unhealthy diet, lack of physical activity and
Amendment 116 #
Motion for a resolution Recital E E. whereas most NCDs are impacted by four preventable risk factors: tobacco use, unhealthy diet, lack of physical activity and
Amendment 117 #
Motion for a resolution Recital E a (new) Amendment 118 #
Motion for a resolution Recital E a (new) Ea. whereas the World Health Organization’s best buys and other recommended interventions for the prevention and control of NCDs include policies such as: front-of-pack nutrition labelling, reformulation of food products and policies to protect children from the harmful impact of unhealthy food marketing on diet;
Amendment 119 #
Motion for a resolution Recital E a (new) Ea. whereas the development of NCDs and resulting health outcomes are linked to commercial and social determinants of health, which correspond to substantial health inequities within and across EU countries;
Amendment 12 #
Motion for a resolution Citation 6 a (new) – having regard to its resolution on strengthening Europe in the fight against cancer – towards a comprehensive and coordinated strategy (2020/2267(INI)) adopted on 16-02-2022,
Amendment 120 #
Motion for a resolution Recital E a (new) Ea. whereas unhealthy diets, high in salt, sugar, fat and animal protein are a leading risk factor for disease and mortality in Europe;
Amendment 121 #
Motion for a resolution Recital E a (new) Ea. whereas smoking increases the risk of being hospitalised with a mental illness by 250 per cent; 1a _________________ 1a https://tech.au.dk/en/about-the- faculty/news/show/artikel/smoking- significantly-increases-the-risk-of- depression
Amendment 122 #
Motion for a resolution Recital E b (new) Eb. whereas there is no safe amount of alcohol that does not affect health and ere is no threshold for safe drinking; all levels bring some added risk of cancer or NCDs when it comes to alcohol consumption; whereas alcohol consumption has been linked to a large number of diseases and disorders, including CVD, cancers, diabetes, digestive diseases and mental health disorders; whereas all types of alcoholic beverages, including beer, wine and spirits, can cause cancer and the risk starts at low levels and increases substantially the more alcohol is consumed;
Amendment 123 #
Motion for a resolution Recital E b (new) Eb. whereas a diet rich in plant-based foods and with fewer animal source foods confers both to improved health and environmental benefits, and transformation to healthy diets by 2050 will require substantial dietary shifts; whereas global consumption of fruits, vegetables, nuts and legumes will have to double, and consumption of foods such as red meat and sugar will have to be reduced by more than 50% in order to achieve dietary shifts;
Amendment 124 #
Motion for a resolution Recital E b (new) Amendment 125 #
Motion for a resolution Recital E c (new) Ec. whereas the EFSA panel could not set “a safe level of intake” of free and added sugars because: “the risk of adverse health effects (responses) increased across the whole range of observed intake levels (doses) in a constant (linear) manner, i.e. the higher the intake, the greater the risk of adverse effects.”; whereas the World Health Organization's Cancer Research Agency (IARC) has classified the sweetener aspartame as "possibly carcinogenic to humans."; whereas a systematic review by the WHO suggests that non-sugar sweeteners could be linked to an increased risk of type 2 diabetes, cardiovascular disease, all-cause mortality, and increased body weight
Amendment 126 #
Motion for a resolution Recital E c (new) Ec. whereas front-of-pack nutritional labeling supports citizens in making healthier food choices and thereby preventing unhealthy consumption of food high in salt, fat and sugar;
Amendment 127 #
Motion for a resolution Recital F F. whereas most NCDs are impacted by environmental risk factors such as
Amendment 128 #
Motion for a resolution Recital F F. whereas most NCDs are impacted by environmental risk factors such as air pollution or exposure to hazardous chemicals in the environment, food or objects; whereas a good quality environment, plenty of green spaces in cities and spending time outdoors have been shown to reduce health risks and improve the physical and mental well- being of healthy and sick people;
Amendment 129 #
Motion for a resolution Recital F F. whereas
Amendment 13 #
Motion for a resolution Citation 9 a (new) – having regard to its resolution of 16 January 2019 on the Union’s authorisation procedure for pesticides1a _________________ 1a Texts adopted, P8_TA(2019)0023.
Amendment 130 #
Motion for a resolution Recital F F. whereas most NCDs are impacted by environmental risk factors such as air pollution, water, soil pollution, chemicals exposure, indoor fuel combustion, radiation, noise pollution, land use patterns, work environment, and climate change ;
Amendment 131 #
Motion for a resolution Recital F F. whereas most NCDs are impacted by environmental risk factors such as
Amendment 132 #
Motion for a resolution Recital F F. whereas most NCDs are impacted by environmental risk factors such as
Amendment 133 #
Motion for a resolution Recital F F. whereas most NCDs are impacted by environmental risk factors such as
Amendment 134 #
Motion for a resolution Recital F F. whereas most NCDs are impacted by environmental risk factors, such as
Amendment 135 #
Motion for a resolution Recital F F. whereas most NCDs are impacted by environmental risk factors such as
Amendment 136 #
Motion for a resolution Recital F F. whereas most NCDs are impacted by environmental risk factors such as
Amendment 137 #
Motion for a resolution Recital F F. whereas most NCDs are heavily impacted by environmental risk factors such as air pollution and therefore a stronger One Health approach should be applied when preventing NCDs;
Amendment 138 #
Motion for a resolution Recital F F. whereas most NCDs are impacted by environmental risk factors
Amendment 139 #
Motion for a resolution Recital F a (new) Fa. whereas, according to WHO environmental burden of disease estimations, annually, 13% of deaths (630 000) in the WHO Europe region are attributable to environmental stressors1c; whereas an EEA report concluded that, 90% of deaths attributable to the environment result from non- communicable diseases, including cancers, cardiovascular diseases, stroke, chronic obstructive pulmonary disease, mental, behavioural and neurological disorders, diabetes, kidney, liver disease and asthma; whereas according to Report No21/2019 of the European Environment Agency (EEA), cancer is the top non- communicable disease attributable to the environment, with more than 250.000 cancer deaths attributable to the environment in 32 European high-income countries in 2016; _________________ 1c Source of the text is EEA report 'Healthy environment, healthy lives: how the environment influences health and well-being in Europe' 2019- Data is from the World Health Organization (WHO) 2012 -
Amendment 14 #
Motion for a resolution Citation 12 a (new) – having regard to its resolution of 16 February 2022 on strengthening Europe in the fight against cancer – towards a comprehensive and coordinated strategy (2020/2267(INI);
Amendment 140 #
Motion for a resolution Recital F a (new) Fa. whereas the development of NCDs and resulting health outcomes are linked to commercial and social determinants of health, which underlying factors correspond to substantial health inequities within and across EU countries;
Amendment 141 #
Motion for a resolution Recital F a (new) Fa. whereas most NCDs are impacted by socioeconomic factors and inequalities, notably disadvantaged socioeconomic status having significantly negative impact on mortality and morbidity caused by NCD;
Amendment 142 #
Motion for a resolution Recital F a (new) Fa. whereas there is a firmly scientifically established link between certain communicable diseases and NCDs, and especially types of cancer, caused by either viral or bacterial infections;
Amendment 143 #
Motion for a resolution Recital F a (new) Fa. whereas chronic inflammation plays a role in contributing to the development and progression of NCDs, including CVDs, RMDs, diabetes, cancer, and neurodegenerative disorders among others;
Amendment 144 #
Motion for a resolution Recital F a (new) Fa. whereas most NCDs are impacted by socioeconomic inequalities, notably low socioeconomic status having significant consistent impact on mortality and morbidity caused by NCDs;
Amendment 145 #
Motion for a resolution Recital F a (new) Fa. whereas most NCDs are impacted by socioeconomic inequalities, notably low socioeconomic status having significant consistent impact on mortality and morbidity caused by NCDs;
Amendment 146 #
Motion for a resolution Recital F a (new) Fa. whereas the development of NCDs and resulting health outcomes are significantly related to the socio-economic determinants of health;
Amendment 147 #
Motion for a resolution Recital F b (new) Fb. whereas in 2020, air pollution led to a significant number of premature deaths in the 27 EU Member States; whereas about 300 000 premature deaths per year and a significant number of non- communicable diseases such as asthma, cardiovascular problems and lung cancer are attributed to air pollution;
Amendment 148 #
Motion for a resolution Recital F b (new) Fb. whereas such interconnections between communicable diseases and NCDs might exist in many other cases and much still has to be learned about the effect of communicable diseases on non- communicable diseases, including severe post-viral conditions such as post- COVID-19 conditions;
Amendment 149 #
Motion for a resolution Recital F b (new) Fb. whereas air pollution is a main driver of morbidity and mortality of NCDs, from a wide range of sources including energy, transport, agriculture and industry, contributing to 400.000 premature deaths annualy, including from lung cancer, heart disease and strokes;
Amendment 15 #
Motion for a resolution Citation 12 a (new) – having regard to the European Parliament resolution of 12 July 2023 on the COVID-19 pandemic entitled 'Lessons learned and recommendations for the future' (2022/2076(INI)),
Amendment 150 #
Motion for a resolution Recital F c (new) Amendment 151 #
Motion for a resolution Recital F c (new) Fc. whereas NCDs are impacted by pervasive chemical exposure from endocrine disruptors which are abundantly present in packaging materials, foods, clothing, cosmetics and other consumer products, and are linked to a myriad of NCDs such as obesity, type 2 diabetes, thyroid disorders, neurodevelopmental disease, hormone- dependant carcinoma and reproductive disorders;
Amendment 152 #
Motion for a resolution Recital F c (new) Fc. whereas the COVID-19 pandemic shed light on the serious phenomenon of comorbidity and comortality when communicable diseases reach patients with NCDs;
Amendment 153 #
Motion for a resolution Recital F d (new) Fd. whereas noise from transport continues to harm health, with little progress made towards reducing noise levels in EU; whereas long-term noise pollution is more than just a nuisance, it can cause serious health effects, such as ischaemic heart disease, obesity and diabetes, amongst others; whereas it is estimated that long-term exposure to noise causes 41,000 new cases of heart disease and 11,000 premature deaths every year in Europe; whereas 5 million people are highly sleep disturbed because of long- term exposure to noise. 1e _________________ 1e https://www.eea.europa.eu/en/newsroom/e ditorial/are-you-noticing-the-harmful- noise
Amendment 154 #
Motion for a resolution Recital F d (new) Fd. whereas the interconnections between communicable diseases and NCDs have been poorly studied in the recent decades, mainly due to insufficient funding for research and lack of systematized epidemiological, statistical and other scientific data;
Amendment 155 #
Motion for a resolution Recital F e (new) Fe. whereas REGULATION (EU) 2022/2370 of 23 November 2022 amending Regulation (EC) No 851/2004 establishing a European centre for disease prevention and control explicitly obliges the Commission to address the impact of cross-border threats to health on non-communicable diseases through an independent external evaluation;
Amendment 156 #
Motion for a resolution Recital F e (new) Fe. whereas the International Agency for Research on Cancer (IARC) classified radiofrequency (RF) EMF as 'possibly carcinogenic to humans' (Group 2B) in 2011, and that extremely low frequency (ELF) magnetic fields were also evaluated as ‘possibly carcinogenic to humans’(2B) in 2002 by IARC;
Amendment 157 #
Motion for a resolution Recital G G. whereas improved evidence-based health promotion and disease prevention can reduce the prevalence of NCDs by as much as 70 %7 ; whereas digital and literal literacy discrepancies can create barriers that hinder individuals' ability to access, comprehend, and utilize health- related information, resulting in suboptimal engagement in NCD prevention measures; whereas all efforts to increase both health and digital literacy should take into account people with learning disabilities, as well as ensure that the necessary information is available in common non-EU languages in order to reach migrants, new arrivals and other minority communities; whereas the improvement of levels of digital literacy for both the general population and all actors of the healthcare system is essential to enable the effective implementation of health strategies to combat NCDs; _________________ 7 European Commission, ‘Healthier
Amendment 158 #
Motion for a resolution Recital G G. whereas improved evidence-based health promotion and disease prevention can reduce the prevalence of NCDs by as much as 70 %
Amendment 159 #
Motion for a resolution Recital G G. whereas improved evidence-based health promotion and disease prevention can reduce the prevalence of NCDs by as much as 70 %7, and consequently also the degree and prevalence of disability; _________________ 7 European Commission, ‘Healthier
Amendment 16 #
Motion for a resolution Citation 12 a (new) – having regard to the European Parliament resolution of 12 July 2023 on the COVID-19 pandemic: lessons learned and recommendations for the future’ (2022/2076(INI))
Amendment 160 #
Motion for a resolution Recital G G. whereas improved evidence-based health promotion and
Amendment 161 #
Motion for a resolution Recital G G. whereas improved evidence-based health promotion, harm reduction policies and disease prevention can reduce the prevalence of NCDs by as much as 70 %7 ; _________________ 7 European Commission, ‘Healthier
Amendment 162 #
Motion for a resolution Recital G a (new) Ga. whereas people living with one or more NCDs were one of the most severely affected population groups during the COVID-19 pandemic1a; whereas investment in NCD prevention and management remains limited, despite access to care, essential complications screening and diagnosis being severely disrupted during the COVID-19 pandemic, potentially leading to severe complications over the longer term; _________________ 1a https://www.who.int/publications/i/item/97 89240057661
Amendment 163 #
Motion for a resolution Recital G a (new) Ga. whereas people living with one or more NCDs were one of the most severely affected population groups during the COVID-19 pandemic; whereas investment in NCD prevention and management remains limited, despite access to care, essential complications screening and diagnosis being severely disrupted during the COVID-19 pandemic, potentially leading to severe complications over the longer term;
Amendment 164 #
Motion for a resolution Recital G a (new) Ga. whereas people with one or more NCDs were one of the most severly affected population groups during the COVID-19 pandemic; whereas investment in NCD prevention and management remains limited, despite disrupted access to care, essential complication-screening and diagnosis during the COVID-19 pandemic, potentially leading to severe complications over the long term;
Amendment 165 #
Motion for a resolution Recital G a (new) Ga. whereas the development and impact of NCDs are also shaped by commercial determinants, including inaccurate health and nutritional claims, aggressive marketing of unhealthy products, and social determinants, such as income disparities or education levels, and play a pivotal role in influencing health behaviours and outcomes;
Amendment 166 #
Motion for a resolution Recital G a (new) Ga. whereas antimicrobial resistance (AMR) is a challenge for medical procedures such as surgeries and cancer treatments; whereas AMR leads to increased disease incidence, hospitalisations, mortality rates and healthcare expenses; 1a _________________ 1a https://www.thelancet.com/journals/lancet /article/PIIS0140-6736(21)02724- 0/fulltext
Amendment 167 #
Motion for a resolution Recital G a (new) Ga. whereas NCDs such as cardiovascular disease, diabetes and obesity are highly complex and interconnected conditions with a multitude of expressions and causes, exacerbating their respective morbidity and mortality;
Amendment 168 #
Motion for a resolution Recital G a (new) Ga. whereas new studies of the interconnection of communicable and non-communicable diseases will greatly improve both prevention and diagnosis of NCDs;
Amendment 169 #
Motion for a resolution Recital G b (new) Gb. whereas not all NCDs can be prevented as some factors are not modifiable such as age, family history, genetics, gender, auto-immunity (e.g. type 1 diabetes) and/or not known such as some neurological disorders;
Amendment 17 #
Motion for a resolution Citation 12 a (new) – having regard to the report of the Special Committee on the Covid-19 pandemic: lessons learned and recommendations for the future (2022/2076 (INI)),
Amendment 170 #
Motion for a resolution Recital G b (new) Gb. whereas NCDs, such as obesity and diabetes, also increasingly affect children1, which requires a dedicated approach to prevention and management;
Amendment 171 #
Motion for a resolution Recital G b (new) Gb. whereas health inequalities within Europe are impacting access to care, preventive measures, overall well-being and health outcome of citizens impacted by NCDs.
Amendment 172 #
Motion for a resolution Recital G c (new) Gc. whereas refugees and migrants face circumstances that put them at a higher risk of falling ill during transitions or stays in receiving countries; whereas the challenges they encounter, such as poor living conditions and lifestyle adjustments, can contribute to increased susceptibility to non-communicable diseases (NCDs); whereas the prevalence of non-communicable diseases (NCDs) among refugees and migrants in EU is concerning, often diagnosed at advanced stages leading to worse health outcomes than those of the host population; whereas mental health issues such as depression and anxiety tend to impact refugees and migrants more than the host populations;
Amendment 173 #
Motion for a resolution Recital G c (new) Gc. whereas not all NCD cases can be prevented, as some factors are not modifiable, such as age, family history, gender, ethnicity, genetics, auto-immunity (e.g., type 1 diabetes) and/or not known (e.g., some neurological disorders, such as Parkinson’s disease);
Amendment 174 #
Motion for a resolution Recital G d (new) Gd. whereas people living with one or more NCDs were one of the most severely affected population groups during the COVID-19 pandemic;
Amendment 175 #
Motion for a resolution Recital G e (new) Amendment 176 #
Motion for a resolution Recital H H. whereas i
Amendment 177 #
Motion for a resolution Recital H H. whereas innovation with regard to development of technologies, medicines and healthcare practises is crucial to ensure the elimination or reduction of harm caused by preventable risk factors, early detection, integration of care, improved diseases management and therapeutic adherence, and new and better treatments for NCDs;
Amendment 178 #
Motion for a resolution Recital H H. whereas innovation with regard to development of technologies, medicines and healthcare practi
Amendment 179 #
Motion for a resolution Recital H H. whereas innovation with regard to development of technologies, medicines and healthcare practises is crucial to ensure the elimination or reduction of harm caused by preventable risk factors, early detection, integration of care, improved disease management, and new and better treatments for NCDs;
Amendment 18 #
Motion for a resolution Citation 12 b (new) – having regard to its resolution of 12 July 2023 on the COVID-19 pandemic: lessons learned and recommendations for the future (2022/2076(INI)),
Amendment 180 #
Motion for a resolution Recital H H. whereas innovation with regard to development of technologies, medicines and healthcare practises is crucial to ensure the elimination or reduction of harm caused by preventable risk factors, early detection, improved disease management, integration of care and new and better treatments for NCDs;
Amendment 181 #
Motion for a resolution Recital H H. whereas innovation with regard to development of technologies, medicines and healthcare practises is crucial to ensure the elimination or reduction of harm caused by preventable risk factors, early detection, integration of care, improved disease management and new and better treatments for NCDs;
Amendment 182 #
Motion for a resolution Recital H H. whereas innovation with regard to development of technologies, medicines and healthcare practises is crucial to ensure the elimination or reduction of harm caused by preventable risk factors, early detection, integration of care, improved disease management and new and better treatments for NCDs;
Amendment 183 #
Motion for a resolution Recital H H. whereas innovation with regard to development of technologies, medicines and healthcare practises, and harm reduction policies is crucial to ensure the elimination or reduction of harm caused by preventable risk factors and new and better treatments for NCDs;
Amendment 184 #
Motion for a resolution Recital H H. whereas
Amendment 185 #
Motion for a resolution Recital H a (new) Ha. whereas the development of NCDs and resulting health outcomes are significantly based on commercial and social determinants of health, including racism; whereas these underlying factors correspond to substantial and transversal health inequities within and across EU countries, which include prevention and access to care; whereas these inequities are beyond individual control and can accumulate along one’s life-course, affecting their health behaviours and choices;
Amendment 186 #
Motion for a resolution Recital H a (new) Amendment 187 #
Motion for a resolution Recital H a (new) Ha. whereas approximately half of people living with diabetes are not achieving or maintaining optimal blood glucose targets1a, leading to an increased risk of diabetesrelated complications resulting in deterioration of well-being and other consequences including productivity loss and costs for society; _________________ 1a Blonde L, Aschner P, Bailey C, et al. Gaps and barriers in the control of blood glucose in people with type 2 diabetes. Diabetes and Vascular Disease Research. 2017;14(3):172-183. doi:10.1177/1479164116679775
Amendment 188 #
Motion for a resolution Recital H a (new) Ha. whereas thanks to research knowledge about the biology of many types of non-communicable diseases, such as neurodegenerative ones, has grown exponentially, but has not yet been translated into decisive therapeutic interventions, and is still limited to purely symptomatic interventions;
Amendment 189 #
Motion for a resolution Recital H a (new) Ha. whereas people suffering from NCDs run a higher risk of being affected by communicable diseases such as COVID-19; whereas data shows that people suffering from NCD’s run a higher risk of complications and dying from COVID-19; 1a _________________ 1a https://health.ec.europa.eu/system/files/20 22-06/eu-ncd- initiative_publication_en_0.pdf page 57
Amendment 19 #
Motion for a resolution Citation 12 b (new) – having regard to its resolution of 20 October 2021 on the Farm to Fork Strategy for a fair, healthy and environmentally-friendly food system (2010/2260(INI)),
Amendment 190 #
Motion for a resolution Recital H a (new) Ha. whereas the EU and its Member States should mobilise their forces and provide adequate incentives and sustainable budgets so as to prevent, treat and reduce the burden of non communicational diseases as well as mitigate and reduce preventable risks;
Amendment 191 #
Motion for a resolution Recital H a (new) Ha. whereas the development of NCDs and resulting health outcomes are linked to commercial and social determinants of health. These underlying factors correspond to substantial health inequities within and across EU countries;
Amendment 192 #
Motion for a resolution Recital H a (new) Ha. whereas the development of NCDs and resulting health outcomes are linked to commercial and social determinants of health. These underlying factors correspond to substantial health inequities within and across EU countries;
Amendment 193 #
Motion for a resolution Recital H a (new) Ha. whereas people with one or more NCDs were one of the population cohorts most severely affected during the COVID- 19 pandemic;
Amendment 194 #
Motion for a resolution Recital H a (new) Ha. whereas people living with one or more NCDs were one of the most severely affected population groups during the COVID-19 pandemic;
Amendment 195 #
Motion for a resolution Recital H b (new) Hb. whereas recognising the critical impact of conflict of interest between public health objectives and the interests of industries producing alcohol, tobacco, and poorly nutritious and ultra-processed foods. The undue influence of these industries on health policies and strategies can hinder effective NCD prevention efforts. Just as transparency is vital in maintaining the integrity of public health, it is equally essential to implement stringent measures to mitigate conflicts of interest;
Amendment 196 #
Motion for a resolution Recital H b (new) Hb. whereas antimicrobial resistance (AMR) significantly disrupts medical procedures such as surgical procedures, dental implants, cancer treatments and organ transplants ; whereas AMR also makes it more difficult to manage prevalent NCDs, including cardiovascular disease, dementia and tumours;
Amendment 197 #
Motion for a resolution Recital H b (new) Hb. whereas people living with one or more NCDs were one of the most severely affected population groups during the COVID-19 pandemic; whereas investment in NCD prevention and management remains limited, despite disrupted access to care, essential complications screening and diagnosis during the COVID-19 pandemic, potentially leading to severe complications over the longer term;
Amendment 198 #
Motion for a resolution Recital H b (new) Hb. whereas the European Parliaments’ resolution on prevention, management and better care of diabetes calls on Member States to develop, implement and monitor national diabetes plans and strategies with comparable milestones and targets, including a risk- reduction and screening/early action component;
Amendment 199 #
Motion for a resolution Recital H b (new) Hb. whereas WHO has set a goal to reduce premature deaths from NCDs by 25% by 2025 and world leaders reaffirmed their commitment at the G20 Health Ministers meeting to achieving the UN’s Sustainable Development Goal (UNSDG) 3.4: to reduce premature deaths from NCDs by one-third by 2030; 1a _________________ 1a https://www.who.int/teams/noncommunic able-diseases/on-the-road-to-2025
Amendment 2 #
Motion for a resolution Citation 9 b (new) – having regard to Regulation (EU) 2022/2371 of the European Parliament and of the Council of 23 November 2022 on serious cross-border threats to health and repealing Decision No 1082/2013/EU,
Amendment 20 #
Motion for a resolution Citation 12 e (new) – having regard to its resolution of 12 July 2023 on the COVID-19 pandemic: lessons learned and recommendations for the future (2022/2076(INI)),
Amendment 200 #
Motion for a resolution Recital H b (new) Hb. whereas suboptimal therapeutic adherence and therapeutic inertia can lead to worse health outcomes and irreversible complications, increased mortality and higher costs;
Amendment 201 #
Motion for a resolution Recital H c (new) Amendment 202 #
Motion for a resolution Recital H c (new) Hc. whereas antimicrobial resistance (AMR) significantly disrupts medical procedures like surgeries, dental implants, cancer treatments, and organ transplants; AMR also complicates the management of prevalent NCDs, including cardiovascular diseases, dementias, and tumours; whereas the repercussions of AMR on disease incidence, mortality rates, hospital stays, and healthcare expenses;
Amendment 203 #
Motion for a resolution Recital H c (new) Hc. whereas one cargo ship produces as much fine particle pollution as all of the cars in France and there are thousands of them sailing around the world as a result of unfettered free trade; whereas this widespread pollution harms air and water quality, and ultimately Europe's citizens;
Amendment 204 #
Motion for a resolution Recital H c (new) Hc. whereas the Commissions Healthier together – EU non- communicable diseases (NCD) initiative emphasises the need for a more coordinated, integrated and transversal action on NCDs, through ambitious targets at EU level in order to provide a stronger response to the increasing burden of NCDs;
Amendment 205 #
Motion for a resolution Recital H a (new) Ha. whereas diabetes is one of the most common non-communicable diseases; whereas there are more than 33 million people in the EU living with diabetes; whereas the number of people living with diabetes in the EU is predicted to rise to 38 million by 2030;
Amendment 206 #
Motion for a resolution Paragraph 1 Amendment 207 #
Motion for a resolution Paragraph 1 1. Highlights that NCDs account for 90 % of all deaths in the EU8 , most of which are preventable and which leads to high levels of productivity loss and makes NCDs account for the largest share of countries’ healthcare expenditures; stresses that it is important to reduce the prevalence of NCDs
Amendment 208 #
Motion for a resolution Paragraph 1 1. Highlights that
Amendment 209 #
Motion for a resolution Paragraph 1 1. Highlights that NCDs account for 90 % of all deaths in the EU8 ,
Amendment 21 #
Motion for a resolution Citation 8 c (new) – having regard to the conclusions and recommendations of the European Parliament's Science and Technology Options Assessment (STOA) Panel's study of July 2021 on ‘The health impact of 5G’,
Amendment 210 #
Motion for a resolution Paragraph 1 1. Highlights that NCDs account for 90 % of all deaths in the EU8, which leads to high levels of productivity loss and makes NCDs account for the largest share of countries’ healthcare expenditures; stresses that it is important to reduce the
Amendment 211 #
Motion for a resolution Paragraph 1 1. Highlights that NCDs account for 90 % of all deaths in the EU8
Amendment 212 #
Motion for a resolution Paragraph 1 1. Highlights that NCDs account for 90 % of all deaths in the EU8 , which leads to high levels of productivity loss and makes NCDs account for the largest share of countries’ healthcare expenditures; stresses that it is important to reduce the prevalence of NCDs and believes that enhanced health promotion and disease prevention can reduce the prevalence of NCDs by 70 %9 in conjunction with investment in
Amendment 213 #
Motion for a resolution Paragraph 1 1. Highlights that NCDs account for 90 % of all deaths in the EU8
Amendment 214 #
Motion for a resolution Paragraph 1 1. Highlights that NCDs account for 90 % of all deaths in the EU8, which
Amendment 215 #
Motion for a resolution Paragraph 1 1. Highlights that NCDs account for 90 % of all deaths in the EU8 , which leads to high levels of productivity loss and makes NCDs account for the largest share of countries’ healthcare expenditures; stresses that it is important to reduce the prevalence of NCDs and believes that enhanced health promotion and disease prevention can reduce the prevalence of NCDs by 70 %9 in conjunction with investment in health innovation and technologies, early diagnosis and screening, and better disease management; _________________ 8 European Commission, ‘Non-
Amendment 216 #
Motion for a resolution Paragraph 1 1. Highlights that NCDs account for 90 % of all deaths in the EU8 , which leads
Amendment 217 #
Motion for a resolution Paragraph 1 a (new) 1a. Recalls the need to consider, together with the health challenges, also the socioeconomic impact of NCD's, which affects the workforce and the overall productivity; recalls that NCDs account for the largest share of countries’ healthcare expenditures and this burden is projected to rise in the near future due to the ageing population, among other factors;
Amendment 218 #
Motion for a resolution Paragraph 1 a (new) 1a. Reiterates, that financing for new research and studies and ensuring the systematization and study of comprehensive epidemiological, statistical and other scientific data on NCDs and their interconnection with communicable diseases can shed new light on the causes of various NCDs, including defining new behavioural and environmental risks;
Amendment 219 #
Motion for a resolution Paragraph 1 a (new) 1a. Highlights that beyond mortality, NCDs represent a major burden on the quality of life of citizens living with NCDs, as well as their families and carers;
Amendment 22 #
Motion for a resolution Citation 12 d (new) – having regard to the conclusions and recommendations of the study prepared for its Panel for the Future of Science and Technology (STOA) in December 2021 entitled "European pharmaceutical research and development - Could public infrastructure overcome market failures?";
Amendment 220 #
Motion for a resolution Paragraph 1 a (new) Amendment 221 #
Motion for a resolution Paragraph 2 2. Welcomes the ‘Healthier together – EU non-communicable diseases (NCD)’ initiative, Europe’s Beating Cancer Plan, the EU4Health work programme and the Commission
Amendment 222 #
Motion for a resolution Paragraph 2 2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A comprehensive approach to mental health’; calls on the Commission to strengthen the ‘Healthier together – EU NCD’ initiative by introducing a holistic EU strategy on NCDs complemented by tailored action plans for specific NCDs
Amendment 223 #
Motion for a resolution Paragraph 2 2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A
Amendment 224 #
Motion for a resolution Paragraph 2 2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A comprehensive approach to mental health’; calls on the Commission to strengthen the ‘Healthier together – EU NCD’ initiative by introducing a holistic EU strategy on NCDs complemented by action plans for specific NCDs; welcomes national plans and actions already taken against NCDs by Member States, and calls on the European Commission to facilitate knowledge sharing and the scale up of good practices introduced by existing national plans across other Member States;
Amendment 225 #
Motion for a resolution Paragraph 2 2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A comprehensive approach to mental health’; calls on the Commission to strengthen the ‘Healthier together – EU NCD’ initiative by introducing a holistic EU strategy on NCDs complemented by action plans for specific NCDs; welcomes national plans and actions already taken against NCDs by Member States; believes however that a special cardiovascular strategy is needed in the light of cardiovascular disease being the number one cause of death in the Union;
Amendment 226 #
Motion for a resolution Paragraph 2 2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A comprehensive approach to mental health’; calls on the Commission to strengthen the ‘Healthier together – EU NCD’ initiative by introducing a holistic and comprehensive EU strategy on NCDs complemented by action plans for specific NCDs with clear targets, benchmarks, indicators and mechanisms to monitor progress; welcomes national plans and actions already taken against NCDs by Member States;
Amendment 227 #
Motion for a resolution Paragraph 2 2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A comprehensive approach to mental health’; calls on the Commission to strengthen the ‘Healthier together – EU NCD’ initiative by introducing a holistic EU strategy on NCDs complemented by action plans for specific NCDs, including obesity; welcomes national plans and actions already taken against NCDs by Member States and calls in this regard for sharing of best practice between Member States;
Amendment 228 #
Motion for a resolution Paragraph 2 2. Welcomes the ‘Healthier together – EU non-communicable diseases (NCD)’ initiative, Europe’s Beating Cancer Plan, the EU4Health work programme and the Commission
Amendment 229 #
Motion for a resolution Paragraph 2 2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A comprehensive approach to mental health’; calls on the Commission to strengthen the ‘Healthier together – EU NCD’ initiative by introducing a holistic and integrated EU strategy on NCDs complemented by action plans for specific NCDs with clear targets, benchmarks indicators and mechanisms to monitor progress; welcomes national plans and actions already taken against NCDs by Member States;
Amendment 23 #
Motion for a resolution Citation 12 a (new) – having regard to its resolution of 16 February 2022 on strengthening Europe in the fight against cancer – towards a comprehensive and coordinated strategy (2020/2267(INI)).
Amendment 230 #
Motion for a resolution Paragraph 2 2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A comprehensive approach to mental health’; calls on the Commission to strengthen the ‘Healthier together – EU NCD’ initiative by including other NCDs such as chronic kidney diseases, by introducing a holistic EU strategy on NCDs complemented by action plans for specific NCDs; welcomes national plans and actions already taken against NCDs by Member States;
Amendment 231 #
Motion for a resolution Paragraph 2 2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme
Amendment 232 #
Motion for a resolution Paragraph 2 2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A comprehensive approach to mental health’; calls on the Commission to strengthen the ‘Healthier together – EU NCD’ initiative by introducing a holistic EU strategy, in line with Article 168 TFEU, on NCDs complemented by action plans for specific NCDs; welcomes national plans and actions already taken against NCDs by Member States;
Amendment 233 #
Motion for a resolution Paragraph 2 a (new) 2a. Calls on the Member States to develop, implement and monitor national NCD plans and strategies, in particular for the most prevalent diseases with high mortality and morbidity rates, with comparable milestones and targets, including a risk-reduction and screening/early action component to target, among other things, the socio- economic determinants of health, the promotion of health-enabling environments and health and digital literacy, education and awareness rising aimed at both the population at large and at-risk groups in particular, and which is designed to reduce inequalities and optimise healthcare resources; Stresses that the national NCD plans should not only aim at reverting the rising number of people living with NCDs, but also at improving the quality of life and well- being of people affected by NCDs;
Amendment 234 #
Motion for a resolution Paragraph 2 a (new) 2a. Recognises the adverse impact of conflict of interest between public health objectives and the interests of industries producing alcohol, tobacco, poorly nutritious and ultra-processed foods, and meat from animals treated with antibiotics and/or fungicides; emphasises the undue influence of these industries on health policies and strategies which hinder effective NCD prevention efforts, and underlines that transparancy is vital in maintaining the integrity of public health and that it is essential to implement stringent measures to mitigate conflicts of interest;
Amendment 235 #
Motion for a resolution Paragraph 2 a (new) 2a. Acknowledges that social, economic, cultural, and commercial determinants of health, and health inequities increase the risk of NCDs and underlines the need to create favourable conditions that address these factors; emphasizes the importance of a more robust implementation of the Health in All Policies principle, in dialogue with the public health community, and with thorough consideration of the health impacts of sectoral policies;
Amendment 236 #
Motion for a resolution Paragraph 2 a (new) 2a. Calls on every Member State to develop national NCD plans to complement the ‘Healthier together – EU non-communicable diseases (NCD)’ initiative; asks Member States to include in their national plans ambitious measures to address all stages of NCDs, from early detection to disease management, and to tailor these national plans to specific NCDs;
Amendment 237 #
Motion for a resolution Paragraph 2 a (new) 2a. Highlights that the COVID-19 pandemic had serious consequences for the health of patients with NCDs owing to delays and disruptions in diagnostics and treatments; stresses the decreased survival chances, complications and further deterioration of quality of life for patients resulting from delayed access to care;
Amendment 238 #
Motion for a resolution Paragraph 2 a (new) 2a. Acknowledges that socio-economic factors and health inequities increase the risk of NCDs and underlines the need to create favourable conditions that address socio-economic and environmental determinants, with policies and actions beyond health.
Amendment 239 #
Motion for a resolution Paragraph 2 a (new) 2a. Considers that the ‘Health in All Policies’ and ‘One Health’ approaches should be promoted further, and efforts to fight NCDs should be integrated into all EU policies;
Amendment 24 #
Motion for a resolution Citation 9 g (new) – having regard to the Council Recommendation of 13 June 2023 on stepping up EU actions to combat antimicrobial resistance in a One Health approach (AMR),
Amendment 240 #
Motion for a resolution Paragraph 2 b (new) 2b. Underlines the critical impact of conflicts of interest between public health objectives and the interests of industries producing alcohol, tobacco, and poorly nutritious and unhealthy foods on the effective prevention and management of NCDs; Stresses the importance of transparency in all stages of policy development, implementation, and evaluation related to NCD prevention, and encourages member states to ensure that all relevant stakeholders, including industry representatives, public health experts, and civil society organizations, are involved in a transparent and inclusive manner; urges Member States to establish mechanisms for regular disclosure of financial relationships between policymakers, public health officials, and representatives of industries, especially the ones producing alcohol and tobacco and calls for the creation of a centralized public database to facilitate access to this information;
Amendment 241 #
Motion for a resolution Paragraph 2 b (new) 2b. Stresses that antimicrobial resistance (AMR) significantly disrupts medical treatments and procedures such as surgeries, organ transplants and cancer treatment, and that AMR also complicates the management of prevalent NCDs, including cardiovascular diseases, dementia and tumours; emphasises that AMR has far-reaching repercussions on disease incidence, mortality rates, hospital stays and healthcare expenses;
Amendment 242 #
Motion for a resolution Paragraph 2 b (new) 2b. Acknowledges the efforts of the European Commission to support Member States in reducing the burden of NCDs with the launch of the ‘Healthier together – EU non-communicable diseases initiative (NCD)’ in December 2021; but calls for more ambitious action at EU level not only to revert the rising number of people living with NCDs but also to improve quality of life and well- being of people affected by NCDs;
Amendment 243 #
Motion for a resolution Paragraph 2 b (new) 2b. Calls on the Commission to facilitate the sharing and scale-up of best practices between Member States with regard to national plans and other actions already taken against NCDs at the Member State level; invites Member States to implement clear and comparable targets, benchmarks and indicators in their NCD national plans to monitor and compare progress;
Amendment 244 #
Motion for a resolution Paragraph 2 c (new) 2c. Building on the experiences of the Knowledge Centre on Cancer, calls on the Commission to create a Knowledge Centre on Obesity to gather data, share best practices and prepare the way for implementation of an NCD framework for obesity along the life course;
Amendment 246 #
Motion for a resolution Paragraph 3 a (new) 3a. Strongly believes that comprehensive preventive actions against non-communicable diseases, through measures supporting the elimination or reduction of harm caused by modifiable risk factors, should be implemented across all relevant European policies and funding programmes; calls on the Commission and the Member States to integrate public awareness-raising campaigns about non-communicable diseases prevention into all relevant policies; strongly believes that preventive actions should be evidence-based; therefore, calls on the Commission and Member States to increase the funding for scientific research into the causes of non- communicable diseases and the efficiency and implementation of preventive measures;
Amendment 247 #
Motion for a resolution Paragraph 2 c (new) 2c. Deplores the significant health inequalities in the EU as regards non communicational diseases prevention and screening; insists on the need to pay special attention to vulnerable and marginalised populations to minimise exposure to risk factors, to ensure their access to NCDs prevention services and involve them in organised screening programmes;
Amendment 248 #
Motion for a resolution Paragraph 3 b (new) 3b. Calls on the Commission and Member States to design and implement effective prevention measures at national and EU level, which are based on independent scientific expertise, best practices and lessons learned, and clinical guidance;
Amendment 249 #
Motion for a resolution Paragraph 3 c (new) 3c. Deplores the significant health inequalities and inequities in the EU in non-communicable diseases prevention; insists on the need to identify, as well as to pay special attention to, vulnerable, marginalised, socially excluded populations and people living in remote areas (such as in rural, isolated or outermost regions far from medical centres), in order to ensure their access to prevention services; considers in this regard that prevention measures also need to be framed in the context of social justice, entailing the need for systemic changes through population-wide public policies beyond changes in individual behaviour;
Amendment 25 #
Motion for a resolution Citation 4 a (new) – having regard to the Commission communication of 12 May 2021 entitled ‘Pathway to a Healthy Planet for All-EU Action Plan: ‘Towards Zero Pollution for Air, Water and Soil’’ (COM(2021)0400),
Amendment 250 #
Motion for a resolution Paragraph 3 d (new) 3d. Stresses the importance of viewing NCDs from a position that acknowledges that human, animal and environmental health are intrinsically linked and that therefore all actions to combat NCDs should be firmly rooted in the One Health approach;
Amendment 251 #
Motion for a resolution Paragraph 3 3. Acknowledges that tobacco use, physical inactivity,
Amendment 252 #
Motion for a resolution Paragraph 3 3. Acknowledges that tobacco use and smoking, physical inactivity,
Amendment 253 #
Motion for a resolution Paragraph 3 3. Acknowledges that tobacco use, physical inactivity, the harmful use of alcohol, unhealthy diets and environmental factors such as air, food, water and soil pollution and chemical exposure, and socio-economic determinants of health increase the risk of NCDs10 ;
Amendment 254 #
Motion for a resolution Paragraph 3 3. 3. Acknowledges that tobacco use, physical inactivity, the harmful use of alcohol, unhealthy diets
Amendment 255 #
3. Acknowledges that combustion tobacco use, physical inactivity, the harmful use of alcohol, unhealthy diets and environmental factors such as air, food, water and soil pollution and chemical exposure increase the risk of NCDs10 ; _________________ 10
Amendment 256 #
Motion for a resolution Paragraph 3 3. Acknowledges that tobacco use, physical inactivity, the harmful use of alcohol and drugs, unhealthy diets and environmental factors such as air, food, water and soil pollution and chemical exposure increase the risk of NCDs10 ; _________________ 10
Amendment 257 #
Motion for a resolution Paragraph 3 3. Acknowledges that tobacco use, physical inactivity,
Amendment 258 #
Motion for a resolution Paragraph 3 3. Acknowledges that tobacco use, physical inactivity, the
Amendment 259 #
Motion for a resolution Paragraph 3 3. Acknowledges that tobacco use, physical inactivity, the harmful use of alcohol, unhealthy diets and environmental factors such as air, food, water and soil pollution and chemical exposure increase the risk of NCDs10 ; _________________ 10
Amendment 26 #
Motion for a resolution Citation 7 a (new) – having regard to the EU Action Plan on Childhood Obesity 2014-2020,
Amendment 260 #
Motion for a resolution Paragraph 3 3. Acknowledges that tobacco use,
Amendment 261 #
Motion for a resolution Paragraph 3 3. Acknowledges that tobacco use, physical inactivity,
Amendment 262 #
Motion for a resolution Paragraph 3 a (new) 3a. Acknowledges that social, economic, cultural, and environmental determinants of health, and health inequities increase the risk of NCDs and underlines the need to create favourable conditions that address these factors; emphasizes the importance of a more robust implementation of the Health in All Policies principle, in dialogue with the public health community, and with thorough consideration of the health impacts of sectoral policies;
Amendment 263 #
Motion for a resolution Paragraph 3 a (new) 3a. Acknowledges that social, economic, cultural, and commercial determinants of health, and health inequities increase the risk of NCDs and underlines the need to create favourable conditions that address these factors; emphasizes the importance of a more robust implementation of the Health in All Policies principle, in dialogue with the public health community, and with thorough consideration of the health impacts of sectoral policies;
Amendment 264 #
Motion for a resolution Paragraph 3 a (new) 3a. Notes that many NCD patients suffer from a weakend immune system and acknowledges that the COVID-19 pandemic had a severe impact on them; Calls on the European Commission and Member States to develop specific policy actions to protect immunocompromised patients in times of pandemic;
Amendment 265 #
Motion for a resolution Paragraph 3 a (new) 3a. Acknowledges the complex and multifactorial causes of NCDs and that NCDs cannot always be prevented, and that even among preventable NCDs, there are many cases that cannot be explained by preventable risk factors and that many NCDs display a high degree of hereditary risk;
Amendment 266 #
Motion for a resolution Paragraph 3 a (new) Amendment 267 #
Motion for a resolution Paragraph 3 a (new) 3a. Highlights the environmental risks that increase the risk of NCDs and calls for a stronger One Health approach to be applied when preventing NCDs;
Amendment 268 #
Motion for a resolution Paragraph 3 a (new) 3a. Stresses that prevention is key in combating NCDs and urges the Commission and Member States to step up their efforts in this regard;
Amendment 269 #
Motion for a resolution Paragraph 3 b (new) 3b. Recognises that over 150,000 new cases of melanoma every year, accounting for 4% of all new cancer diagnoses in EU-27 countries in 2020, making it the sixth most frequently occurring cancer in Europe; Recognises that over 150,000 new cases of melanoma every year, accounting for 4% of all new cancer diagnoses in EU-27 countries in 2020, making it the sixth most frequently occurring cancer in Europe; Recommends a phasing out of the use of sunbeds as consumer products for non- medical purposes1a; Urges Commission to take measures to facilitate improved registration of melanoma cases across the EU, allocate EU funds and support research into and the development of skin cancer screening methods, particularly with new technologies; _________________ 1a https://www.epsu.org/sites/default/files/art icle/files/EADV-Joint-Statement-Skin- Cancer-FINAL.pdf
Amendment 27 #
Motion for a resolution Citation 7 a (new) – having regard to the EU Global Health Strategy of 30 November 2022,
Amendment 270 #
Motion for a resolution Paragraph 3 b (new) 3b. Underlines that the ‘One Health’ approach should guide the reduction and use optimisation of antimicrobials, to prevent and fight the Antimicrobial Resistance (AMR) as well as the development of new medicines, including antimicrobial agents;
Amendment 271 #
Motion for a resolution Paragraph 4 4. Acknowledges that tobacco
Amendment 272 #
Motion for a resolution Paragraph 4 4. Acknowledges that tobacco use was responsible for 1.6 million deaths in Europe in 2019 and is a high risk factor for developing NCDs such as cancer, cardiovascular diseases and chronic respiratory diseases; Acknowledges that second hand smoke increases the risk of cancer, particularly of the lung, and may increase the overall risk for all cancers by up to 16% in never smokers. Notes that around 31% of the European population on average is exposed to second-hand tobacco smoke at home, at work, during leisure activities, in educational institutions or in public settings. Underlines that children are particularly vulnerable to it both before and after birth and that about 12% of European children are regularly exposed to SHS at home;
Amendment 273 #
Motion for a resolution Paragraph 4 4. Acknowledges that tobacco use was responsible for 1.6 million deaths in Europe in 2019 and is a high risk factor for developing NCDs such as cancer, cardiovascular diseases and chronic respiratory diseases and calls for an harmonisation in the definitions of tobacco and related products across EU legislation;
Amendment 274 #
Motion for a resolution Paragraph 4 4. Acknowledges that tobacco use was responsible for 1.6 million deaths in Europe in 2019 and is a high risk factor for developing NCDs such as cancer, cardiovascular diseases and chronic respiratory diseases, and that this figure may be even higher since causes of death are not monitored in all cases;
Amendment 275 #
Motion for a resolution Paragraph 4 4. Acknowledges that tobacco use, including second hand smoking, was responsible for 1.6 million deaths in Europe in 2019 and is a high risk factor for developing NCDs such as cancer, cardiovascular diseases and chronic respiratory diseases;
Amendment 276 #
Motion for a resolution Paragraph 4 Amendment 277 #
Motion for a resolution Paragraph 4 4. Acknowledges that harmful tobacco use was responsible for 1.6 million deaths in Europe in 2019 and is a high risk factor for developing NCDs such as cancer, cardiovascular diseases and chronic respiratory diseases;
Amendment 278 #
Motion for a resolution Paragraph 4 a (new) 4a. Strongly believes that comprehensive preventive actions against NCDs, through measures supporting the elimination or reduction of harm caused by modifiable risk factors, should be implemented across all European policies and funding programmes; calls on the Commission and the Member States to integrate public awareness-raising campaigns about NCDs prevention into all relevant policies; strongly believes that preventive actions should be evidence- based; therefore, calls on the Commission and Member States to increase the funding for scientific research into the causes of NCDs and the efficiency and implementation of preventive measures;
Amendment 279 #
Motion for a resolution Paragraph 4 a (new) 4a. Stresses that novel smoking and tobacco products, such as heated tobacco and electronic cigarettes, poses a danger to people's health and are not harmless, with links to many different NCDs such as cancer, cardiovascular and respiratory diseases; recalls that these devices are particularly dangerous towards non- smokers, women and young people such as children and adolescents; asks the Commission to align the restrictions and legislation of these products to the traditional ones in the context of the review of the tobacco legislation, including taxation and the restriction related to smoke-free environments;
Amendment 28 #
Motion for a resolution Citation 9 d (new) – having regard to the Commission Decision of 16 September 2021 establishing the Health Emergency Preparedness and Response Authority,
Amendment 280 #
Motion for a resolution Paragraph 4 b (new) 4b. Recalls that decades of restrictive legislative measures, increased taxation and information campaigns to limit smoking and tobacco consumption have produced concrete results, reduced the number of tobacco consumers and ultimately saved lives; regrets that the results obtained, particularly among the youth and women, are jeopardised by the alarming increase in the use of novel tobacco products and electronic smoking devices; urges the Commission to swiftly update the Tobacco legislation to better include those new products by using the precautionary principle to protect people's health, particularly youth and women as some of the most exposed portions of population;
Amendment 281 #
Motion for a resolution Paragraph 5 – introductory part 5. Supports
Amendment 282 #
Motion for a resolution Paragraph 5 – introductory part 5. Supports the
Amendment 283 #
Motion for a resolution Paragraph 5 – introductory part 5. Supports Europe’s Beating Cancer Plan to achieve a Tobacco-Free Generation and prevent tobacco use by reducing tobacco consumption to 5% by 2040, as well as the Commission’s proposals to review the Tobacco Products Directive11 and the Tobacco Taxation Directive12 and the proposal to update the Council recommendation of 30 November 2009 on smoke-free environments13 and prevent any delays in revisions of the legislation; calls for a full implementation of the WHO Framework Convention on Tobacco Control; calls on the Commission and the Member States to: _________________ 11 Directive 2014/40/EU of the European
Amendment 284 #
5. Supports the
Amendment 285 #
Motion for a resolution Paragraph 5 – introductory part 5. Supports the
Amendment 286 #
Motion for a resolution Paragraph 5 – introductory part 5. Supports the
Amendment 287 #
Motion for a resolution Paragraph 5 – introductory part 5. Supports Europe’s Beating Cancer Plan to achieve a Tobacco-Free Generation and support the Commission’s proposals to review the Tobacco Products Directive11 and the Tobacco Taxation Directive12 and the proposal to update the Council recommendation of 30 November 2009 on smoke-free environments13 ; calls for a full implementation of the WHO Framework Convention on Tobacco Control; calls on the Commission and the Member States to: _________________ 11 Directive 2014/40/EU of the European
Amendment 288 #
Motion for a resolution Paragraph 5 – introductory part 5. Supports the Commission’s proposals to review the Tobacco Products Directive
Amendment 289 #
Motion for a resolution Paragraph 5 – introductory part 5. Strongly supports the
Amendment 29 #
Motion for a resolution Citation 9 e (new) – having regard to the Commission’s proposal for a regulation on the European health data space (COM(2022)0197),
Amendment 290 #
Motion for a resolution Paragraph 5 – point a a. implement
Amendment 291 #
Motion for a resolution Paragraph 5 – point a a.
Amendment 292 #
Motion for a resolution Paragraph 5 – point a a. implement measures to help tobacco users quit in line with WHO FCTC and by following WHO recommendations and scientific advice from public health authorities;
Amendment 293 #
Motion for a resolution Paragraph 5 – point a a. implement measures to help tobacco users quit, including measures supporting the elimination or reduction of harm caused by modifiable risk factors;
Amendment 294 #
Motion for a resolution Paragraph 5 – point a Amendment 295 #
Motion for a resolution Paragraph 5 – point a a. implement measures to help tobacco users quit, reduce the rate of new tobacco users, and prevent tobacco use among minors;
Amendment 296 #
a. implement measures to help tobacco users quit in line with WHO FCTC guidelines for Article 14;
Amendment 297 #
Motion for a resolution Paragraph 5 – point a a. implement measures to help tobacco users quit, in line with WHO FCTC guidelines for Article 14;
Amendment 298 #
Motion for a resolution Paragraph 5 – point a a. implement measures to help tobacco users quit in line with WHO FCTC guidelines for Article 14;
Amendment 299 #
Motion for a resolution Paragraph 5 – point a a.
Amendment 3 #
Motion for a resolution Citation 9 c (new) – having regard to Regulation (EU) 2022/370 of the European Parliament and of the Council of 23 November 2022 amending Regulation (EC) No 851/2004 establishing a European centre for disease prevention and control,
Amendment 30 #
Motion for a resolution Citation 9 f (new) – having regard to the Commission’s proposal for a Regulation laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency and a Directive on the Union code relating to medicinal products for human use,
Amendment 300 #
Motion for a resolution Paragraph 5 – point a a. implement viable measures to help tobacco users quit;
Amendment 301 #
Motion for a resolution Paragraph 5 – point a a. implement measures to help
Amendment 302 #
Motion for a resolution Paragraph 5 – point a a (new) aa. strengthen packaging rules by introducing mandatory plain standardised packaging with graphic health warnings covering 80% of the front and the back of all tobacco products and introducing pack inserts;
Amendment 303 #
Motion for a resolution Paragraph 5 – point a a (new) aa. increase the protection of minors from the negative effects of tobacco use, including the adoption of educational measures aimed at reducing the attractiveness of tobacco use in these age groups;
Amendment 304 #
Motion for a resolution Paragraph 5 – point b b. follow up on the scientific evaluations of the health risks related to electronic cigarettes, heated tobacco products and novel tobacco products including the assessment of the risks of using these products compared to consuming other tobacco products;
Amendment 305 #
Motion for a resolution Paragraph 5 – point b b.
Amendment 306 #
Motion for a resolution Paragraph 5 – point b b. follow up on
Amendment 307 #
Motion for a resolution Paragraph 5 – point b b. follow up on the
Amendment 308 #
Motion for a resolution Paragraph 5 – point b b. follow up on the scientific evaluations of the health risks related to electronic cigarettes, heated tobacco products and novel tobacco products, including the assessment of the risks of using these products compared to consuming other tobacco products, especially taking into account the fact that an ever-increasing number of young people are using electronic cigarettes;
Amendment 309 #
Motion for a resolution Paragraph 5 – point b b. follow up on the scientific evaluations of the health risks related to electronic cigarettes, heated tobacco products and novel tobacco products including the assessment of the risks of using these products compared to consuming other tobacco products
Amendment 31 #
Motion for a resolution Citation 9 h (new) – having regard to the Commission communication of 20 November 2022 entitled ‘EU Global Health Strategy – Better Health for All in a Changing World’ (COM(2022)0675),
Amendment 310 #
Motion for a resolution Paragraph 5 – point b b. follow up on the scientific evaluations of the health risks related to
Amendment 311 #
Motion for a resolution Paragraph 5 – point b b. follow up on the scientific
Amendment 312 #
Motion for a resolution Paragraph 5 – point b a (new) Amendment 313 #
Motion for a resolution Paragraph 5 – point b a (new) ba. Implement the European Ombudsman recommendations ‘a whole- of-Commission approach to complying with the obligations stemming from the FCTC constitutes maladministration’; to keep and make available minutes on all of the Commission’s meetings with tobacco interest representatives constitutes maladministration; ensuring implementation of the guidelines for Article 5.3 of the FCTC that state “Parties should interact with the tobacco industry only when and to the extent strictly necessary to enable them to effectively regulate the tobacco industry and tobacco products”;
Amendment 314 #
Motion for a resolution Paragraph 5 – point b a (new) ba. Implement the European Ombudsman recommendations to keep and make available minutes on all of the Commission’s meetings with tobacco interest representatives constitutes maladministration; Calls for Member State and European Commision to ensure the implementation of the guidelines for Article 5.3 of the FCTC that state “Parties should interact with the tobacco industry only when and to the extent strictly necessary to enable them to effectively regulate the tobacco industry and tobacco products.
Amendment 315 #
Motion for a resolution Paragraph 5 – point b a (new) ba. evaluate, in the framework of the Tobacco Products Directive, which flavours in e-cigarettes are in particular attractive to minors and non-smokers, and to propose a ban on these, and furthermore, to propose a ban on all characteristic flavours in heated tobacco products and novel tobacco products;
Amendment 316 #
Motion for a resolution Paragraph 5 – point b a (new) ba. an increase and an upward convergence in minimum excise duties for all tobacco products and their final market price, which would improve prevention by reducing tobacco uptake and use, notably among current smokers, and prevent young people from starting smoking;
Amendment 317 #
Motion for a resolution Paragraph 5 – point b a (new) ba. an increase and an upward convergence in minimum excise duties for all tobacco products and their final market price, which would improve prevention by reducing tobacco uptake and use, notably among current smokers, and prevent young people from starting smoking;
Amendment 318 #
Motion for a resolution Paragraph 5 – point b a (new) Amendment 319 #
Motion for a resolution Paragraph 5 – point b a (new) ba. publish annual reports on the progress towards achieving a tobacco-free generation by 2040;
Amendment 32 #
Motion for a resolution Citation 9 i (new) – having regard to the 2030 Agenda for Sustainable Development, in particular Sustainable Development Goal (SDG) 3 target 4, to reduce by one third premature mortality from non- communicable diseases through prevention and treatment and promote mental health and well-being, and SDG 3 target 8, to achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all,
Amendment 320 #
Motion for a resolution Paragraph 5 – point b b (new) bb. a requirement for standardised plain packaging and the obligation to include health warnings on 80% of the front and back of tobacco product packaging, including pictorial warnings;
Amendment 321 #
Motion for a resolution Paragraph 5 – point b b (new) Amendment 322 #
Motion for a resolution Paragraph 5 – point b b (new) bb. bringing the taxation of novel smoking products, such as vapes and heated tobacco, into line with cigarettes;
Amendment 323 #
Motion for a resolution Paragraph 5 – point b b (new) bb. bringing the taxation of novel smoking products, such as vapes and heated tobacco, into line with cigarettes;
Amendment 324 #
Motion for a resolution Paragraph 5 – point b c (new) Amendment 325 #
Motion for a resolution Paragraph 5 – point b c (new) bc. the strict enforcement of the ban on characterising flavours in tobacco products to reduce the appeal of these products to smokers, non-smokers, and young people;
Amendment 326 #
Motion for a resolution Paragraph 5 – point b c (new) bc. publish annual reports on the progress towards achieving a tobacco-free generation by 2040;
Amendment 327 #
Motion for a resolution Paragraph 5 – point b c (new) bc. publish annual reports on the progress towards achieving a tobacco-free generation by 2040;
Amendment 328 #
Motion for a resolution Paragraph 5 – point b d (new) bd. in the context of the Evaluation of the legislative framework for tobacco control, recommend the European Commission to work collectively with EU Member States to raise the minimum age for tobacco sales to 21;
Amendment 329 #
Motion for a resolution Paragraph 5 – point b d (new) bd. invite European Commission after consulting Member States to adopt Tobacco 21 policies which raise the minimum age for the sale of tobacco products to 21 years.
Amendment 33 #
Motion for a resolution Citation 9 j (new) – having regard to the European Pillar of Social Rights, in particular its principle 16 (healthcare) and 18 (long- term care),
Amendment 330 #
Motion for a resolution Paragraph 5 – point b d (new) bd. publish annual reports on the progress towards achieving a tobacco-free generation by 2040;
Amendment 331 #
Motion for a resolution Paragraph 5 – point b e (new) be. introduce a requirement for standardised plain packaging and the obligation to include health warnings on 80 % of the front and back of tobacco and smoking products packaging, including pictorial warnings;
Amendment 332 #
Motion for a resolution Paragraph 5 – point b e (new) be. ensure greater protection of EU citizens from second-hand smoke;
Amendment 333 #
Motion for a resolution Paragraph 5 – point b f (new) bf. a strict enforcement of the ban on appealing flavours in tobacco products and the introduction of similar restrictions to novel smoking devices to reduce the appeal of these products to smokers, non-smokers, and young people;
Amendment 334 #
Motion for a resolution Paragraph 5 – point b g (new) bg. to further enhance the protection of consumers from the advertisement of smoking devices, heated tobacco products and electronic cigarettes; is concerned by the fact that the ban on cigarettes and tobacco advertising is often eluded by the advertisement of the device itself; calls on the Commission to propose urgent measures in order to protect consumers from advertisement and promotion of such dangerous and addictive devices and products;
Amendment 335 #
Motion for a resolution Paragraph 5 a (new) 5a. Underlines that alcohol is classified by the International Agency for Research on Cancer as a toxic, psychoactive, and dependence-producing substance and a Group 1 carcinogen that is causally linked to seven types of cancer, including oesophagus, liver, colorectal, and breast cancers; recalls that alcohol consumptions is associated with 740000 new cancer cases each year globally; stresses that in the EU, light to moderate alcohol consumption was associated with almost 23000 new cancer cases in 2017, accounting for 13,3% of all alcohol- attributable cancers and for 2,3% of all cases of the seven alcohol-related cancer types;
Amendment 336 #
Motion for a resolution Paragraph 5 a (new) 5a. Urges the Commission to implement the European Ombudsman recommendations to comply with the obligations stemming from the FCTC, to keep and make available minutes on all of the Commission's meetings with tobacco interest representatives, ensuring the implementation of the guidelines for Article 5.3 of the FCTC that state 'parties should interact with the tobacco industry only when and to the extent strictly necessary to enable them to effectively regulate the tobacco industry and tobacco products';
Amendment 337 #
Motion for a resolution Paragraph 5 a (new) 5a. Calls for the full implementation by Member States of the obligation under the Single Use Plastics Directive 2019/904 as regards filters in tobacco products containing plastics to address environmental and health concerns related to these filters,
Amendment 338 #
Motion for a resolution Paragraph 5 a (new) 5a. Take into account national best practices on reduced smoking related harm through harm reduction strategies, such as in Sweden, the United Kingdom and Japan
Amendment 339 #
Motion for a resolution Paragraph 5 b (new) Amendment 34 #
Motion for a resolution Citation 12 a (new) – having regard to the Commission communication of 20 May 2020 on the Farm to Fork Strategy for a fair, healthy and environmentally-friendly food system (COM(2020)0381);
Amendment 340 #
Motion for a resolution Paragraph 5 c (new) 5c. Supports the Commission’s proposal to update the Council recommendation of 30 November 2009 on smoke-free environments1a to extend its coverage to emerging products, such as e- cigarettes and heated tobacco products, and to extend smoke-free environments to include outdoor spaces; _________________ 1a OJ C 296, 5.12.2009, p. 4.
Amendment 341 #
6.
Amendment 342 #
Motion for a resolution Paragraph 6 6.
Amendment 343 #
Motion for a resolution Paragraph 6 6.
Amendment 344 #
Motion for a resolution Paragraph 6 6. Acknowledges that the harmful use of alcohol is a risk factor for multiple NCDs and underlines that the lower the amount of alcohol consumed, the lower the risk is of developing NCDs14 ; highlights that an estimated 1 million deaths annually are attributable to alcohol consumption in the WHO European Region1a; _________________ 14 Global burden of disease 2016 Alcohol
Amendment 345 #
Motion for a resolution Paragraph 6 6. Highlights that one in ten deaths in the WHO Europe region results from alcohol use, or about 1 million deaths every year; Acknowledges that the harmful use of alcohol is a risk factor for multiple NCDs and underlines that the lower the amount of alcohol consumed, the lower the risk is of developing NCDs14 ;
Amendment 346 #
Motion for a resolution Paragraph 6 6.
Amendment 347 #
Motion for a resolution Paragraph 6 6. Acknowledges that the harmful use of alcohol is a risk factor for multiple NCDs and underlines that the lower the amount of alcohol consumed, the lower the risk is of developing NCDs14; stresses the importance of good-qualitty preventive measures in the Member States, especially for young people; _________________ 14 Global burden of disease 2016 Alcohol
Amendment 348 #
Motion for a resolution Paragraph 6 6. Acknowledges that the harmful use of alcohol is a risk factor for multiple NCD’s and underlines that the lower the amount of alcohol consumed, the lower the risk is of developing certain NCD
Amendment 349 #
Motion for a resolution Paragraph 6 6. Acknowledges that the harmful use of alcohol is a risk factor for multiple NCDs and underlines that the
Amendment 35 #
Motion for a resolution Citation 8 a (new) – having regard to the EEA report Zero pollution monitoring assessment from December 2022,
Amendment 350 #
Motion for a resolution Paragraph 6 6. Acknowledges that the harmful use of alcohol is a risk factor for multiple NCDs and underlines that
Amendment 351 #
Motion for a resolution Paragraph 6 a (new) 6a. Acknowledges that social, economic, cultural, and commercial determinants of health, and health inequities increase the risk of NCDs and underlines the need to create favourable conditions that address these factors; emphasizes the importance of a more robust implementation of the Health in All Policies principle, in dialogue with the public health community, and with thorough consideration of the health impacts of sectoral policies;
Amendment 352 #
Motion for a resolution Paragraph 6 a (new) 6a. Acknowledges the efforts of the European Commission to support Member States in reducing the burden of NCDs with the launch of the ‘Healthier together – EU non-communicable diseases initiative (NCD)’ in December 2021; but calls for more ambitious action at EU level not only to revert the rising number of people living with NCDs but also to improve quality of life and well- being of people affected by NCDs;
Amendment 353 #
Motion for a resolution Paragraph 6 b (new) 6b. Acknowledges the efforts of the European Commission to support Member States in reducing the burden of NCDs with the launch of the ‘Healthier together – EU non-communicable diseases initiative (NCD)’ in December 2021; calls for more ambitious action at EU level not only to revert the rising number of people living with NCDs but also to improve quality of life and well- being of people affected by NCDs;
Amendment 354 #
Motion for a resolution Paragraph 7 – introductory part 7. Welcomes the Commission
Amendment 355 #
Motion for a resolution Paragraph 7 – introductory part 7.
Amendment 356 #
Motion for a resolution Paragraph 7 – introductory part 7. Welcomes the Commission’s objective of achieving a 10 % reduction in
Amendment 357 #
Motion for a resolution Paragraph 7 – point a Amendment 358 #
Motion for a resolution Paragraph 7 – point a a.
Amendment 359 #
Motion for a resolution Paragraph 7 – point a a.
Amendment 36 #
Motion for a resolution Citation 8 b (new) – having regard to the report 'Healthy environment, healthy lives: how the environment influences health and well-being in Europe' by the European Environment Agency, Report No 21/2019,
Amendment 360 #
Motion for a resolution Paragraph 7 – point a a. Enact restrictions on alcohol advertising t
Amendment 361 #
Motion for a resolution Paragraph 7 – point a a.
Amendment 362 #
Motion for a resolution Paragraph 7 – point a a. Enact more comprehensive restrictions on alcohol advertising targeting
Amendment 363 #
Motion for a resolution Paragraph 7 – point a a. Enact restrictions on alcohol advertising t
Amendment 364 #
Motion for a resolution Paragraph 7 – point a a (new) aa. prohibit alcohol advertising and sponsorship at sport events when those events are attended by minors, including alcohol free beverages advertising or sponsorship by companies or brands whose main business is alcoholic beverages;
Amendment 365 #
Motion for a resolution Paragraph 7 – point a a (new) aa. Enhance public awareness about the established connection between alcohol use and non-communicable diseases, in order to facilitate informed decisions regarding alcohol consumption and its potential health consequences
Amendment 366 #
Motion for a resolution Paragraph 7 – point a a (new) aa. increase the protection of minors from the negative effects of alcohol use, including the adoption of educational measures aimed at reducing the attractiveness of alcohol use in these age groups;
Amendment 367 #
Motion for a resolution Paragraph 7 – point b b. Promote evidence-based and proportionate measures aimed at reducing and preventing alcohol-related harm within the revised EU alcohol strategy;
Amendment 368 #
Motion for a resolution Paragraph 7 – point b b. Promote evidence-based, proportionate measures aimed at reducing and preventing alcohol-related harm within the revised EU alcohol strategy;
Amendment 369 #
Motion for a resolution Paragraph 7 – point b b. Promote evidence-based, proportionate measures aimed at reducing and preventing alcohol-related harm within the revised EU alcohol strategy;
Amendment 37 #
Motion for a resolution Citation 8 d (new) – having regard to EFSA scientific opinion regarding Tolerable upper intake level for dietary sugars 2a _________________ 2a https://efsa.onlinelibrary.wiley.com/doi/ep df/10.2903/j.efsa.2022.7074
Amendment 370 #
Motion for a resolution Paragraph 7 – point b b. Promote measures aimed at reducing and preventing alcohol
Amendment 371 #
Motion for a resolution Paragraph 7 – point b a (new) ba. urges the Commission to implement evidence-based alcohol policies -based alcohol policies and put forward a legislative proposal on the introduction of health warnings to alcohol labelling requirements, as Ireland did in Section 12 of the Public Health (Alcohol) Act 2018; including possible interactions with other products - ie. drug, medicines and/or analgesics;
Amendment 372 #
Motion for a resolution Paragraph 7 – point b a (new) ba. Recommends the Commission to submit a proposal to introduce health warnings and strict alcohol labeling requirements, as well as a nutritional declaration on all alcoholic products, as announced in 2021 with the adoption of the Europe Beating Cancer Plan;
Amendment 373 #
Motion for a resolution Paragraph 7 – point b a (new) ba. introduce a requirement for standardised plain packaging and the obligation to include health warnings on of the front and back of all alcohol products packaging, including pictorial warnings;
Amendment 374 #
Motion for a resolution Paragraph 7 – subparagraph 1 (new) c. seek further convergence of excise duty rates on alcohol and alcoholic beverages across Member States; calls, to this end, it for a revision of Council Directive 92/84/EEC.
Amendment 375 #
Motion for a resolution Paragraph 7 – point b a (new) ba. provide better information to consumers including moderate and responsible drinking information, also through digital labelling.
Amendment 376 #
Motion for a resolution Paragraph 7 – point b a (new) ba. promote better information to consumers, including information on moderate and responsible alcohol consumption, through digital labelling;
Amendment 377 #
Motion for a resolution Paragraph 7 – point b a (new) ba. implement evidence-based policies, such as increase prices through taxation or price thresholds, to reduce alcohol consumption;
Amendment 378 #
Motion for a resolution Paragraph 7 – point b b (new) bb. introduce a requirement for standardised labelling of alcohol beverages including name of the beverage (including any additives), allergen information, quantity of certain ingredients, date marking (best before / use by), country of origin, if required for consumer clarity (example: products that display on their packaging country flags or famous landmarks), name and address of the food business operator established in the EU or importer, net quantity, any special storage conditions and/or conditions of use, instructions for use if needed, alcohol level for beverages (if higher than 1.2%), nutrition in line with the on provision of food information to consumers legal framework in the EU;
Amendment 379 #
Motion for a resolution Paragraph 7 – point b b (new) bb. urges the Commission to welcome the introduction of the list of ingredients and the nutrition declaration on all alcoholic products, as announced in 2021, with the adoption of the Europe’s Beating Cancer Plan;
Amendment 38 #
Motion for a resolution Citation 9 a (new) Amendment 380 #
Motion for a resolution Paragraph 7 – point b b (new) bb. elaborate a proposal on the introduction of health warnings to alcohol labelling requirements, as Ireland did in Section 12 of the Public Health (Alcohol) Act 2018;
Amendment 381 #
Motion for a resolution Paragraph 7 – point b c (new) bc. advance the introduction of the list of ingredients and the nutrition declaration on all alcoholic products, as announced in 2021, with the adoption of the Europe’s Beating Cancer Plan1h; _________________ 1h https://health.ec.europa.eu/system/files/20 22-02/eu_cancer-plan_en_0.pdf
Amendment 382 #
7a. Underscores the essential role of a healthy food environment in preventing NCDs and asks the Member State and the Commission to step up their actions to ensure that the most healthy and sustainable food is also the most affordable;
Amendment 383 #
Motion for a resolution Paragraph 7 a (new) 7a. Recalls the Commission and Member States to enhance the provision of better information to consumers including moderate and responsible drinking information through digital labelling;
Amendment 384 #
Motion for a resolution Paragraph 7 a (new) 7a. promote better information to consumers, including information on moderate and responsible alcohol consumption, through digital labelling.
Amendment 385 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that an unhealthy diet is one of the major risk factors for NCDs, including cardiovascular diseases, cancer, diabetes, oral diseases and other conditions linked to obesity
Amendment 386 #
8. Notes that an unhealthy diet is one of the major risk factors for NCDs, including cardiovascular diseases, cancer, diabetes and other conditions linked to obesity15 ; emphasises the role of a healthy diet in preventing and limiting the incidence and the recurrence of non- communicable diseases, and stresses that individual risks can be reduced by an increased consumption of sustainably- produced plants and plant-based foods, such as fresh fruits and vegetables, whole grains and legumes; emphasises, furthermore, the need to address the overconsumption of meat and ultra- processed products, and products high in sugars, salt and fats; acknowledges that obesity is considered a risk factor for several NCDs; calls on the Commission and the Member States to: _________________ 15 World Health Organization Regional
Amendment 387 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that an unhealthy diet, which may be characterised as being high in sugars, saturated and transfats, low fibre foods and high-sugar drinks and the overconsumption of meat and other animal products, is one of the major risk factors for NCDs, including cardiovascular diseases, cancer, diabetes and other conditions linked to obesity15 ; acknowledges that obesity is considered a risk factor for several NCDs and is itself recognized as an NCD1i ; calls on the Commission and the Member
Amendment 388 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that an unhealthy diet, and especially fast food products, whose use has burgeoned in recent years, is one of the major risk factors for NCD
Amendment 389 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that an unhealthy diet is one of the major risk factors for NCDs, including obesity, cardiovascular diseases, cancer, diabetes
Amendment 39 #
Motion for a resolution Citation 9 a (new) – having regard to the World Health Organization 'Health service delivery framework for prevention and management of obesity' (2023),
Amendment 390 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that an unhealthy diet is one of the major risk factors for NCDs, including cardiovascular diseases, cancer, diabetes, oral diseases, and other conditions linked to obesity15 ; acknowledges that obesity is considered a risk factor for several NCDs and is itself recognized as an NCD1a; calls on the Commission and the Member States to: _________________ 1a European Commission classifies obesity as a chronic disease - The Lancet Diabetes & Endocrinology 15 World Health Organization Regional
Amendment 391 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that an unhealthy diet is one of the major risk factors for NCDs, including obesity, cardiovascular diseases, cancer, diabetes
Amendment 392 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that an unhealthy diet is one of the major risk factors for NCDs, including cardiovascular diseases, cancer, diabetes and other conditions linked to obesity15 ; acknowledges that obesity is considered a risk factor for several NCDs and that obesity is in itself recognised as a NCD; calls on the Commission and the Member States to:
Amendment 393 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that an unhealthy diet is one of the major risk factors for NCDs, including obesity, cardiovascular diseases, cancer, diabetes
Amendment 394 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that an unhealthy diet is one of the major risk factors for NCDs, including cardiovascular diseases, cancer, diabetes, oral and dental diseases and other conditions linked to
Amendment 395 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that an unhealthy diet is one of the major risk factors for NCDs, including cardiovascular diseases, cancer, diabetes, oral diseases and other conditions linked to obesity15 ; acknowledges that obesity is considered a risk factor for several NCDs; calls on the Commission and the Member States to: _________________ 15 World Health Organization Regional
Amendment 396 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that an unhealthy diet is one of the major risk factors for NCDs,
Amendment 397 #
Motion for a resolution Paragraph 8 – introductory part 8. Notes that
Amendment 398 #
Motion for a resolution Paragraph 8 – point a a. encourage and help consumers to make informed and healthy choices about food products, for example by adopting a harmonised EU front-of-pack nutritional label based on robust and independent scientific evidence or by implementing fiscal measures at a national level to make healthy food more affordable; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable diets;
Amendment 399 #
Motion for a resolution Paragraph 8 – point a a. encourage and help consumers to make informed and healthy choices about food products; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable diets; notes that the Mediterranean diet is known as a healthy, balanced diet that plays a protective role in the primary and secondary prevention of the main chronic degenerative diseases;
Amendment 4 #
Motion for a resolution Citation 1 a (new) – having regard to its resolution on “Strengthening Europe in the fight against cancer”, adopted on 16 February 2022,
Amendment 40 #
Motion for a resolution Citation 9 b (new) – having regard to the World Health Organization 'Acceleration plan to support Member States in implementing the recommendations for the prevention and management of obesity over the life course' (2022),
Amendment 400 #
Motion for a resolution Paragraph 8 – point a a. encourage and help consumers to make informed and healthy choices about food products; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable diets; implement considerable restrictions on advertising of ultra-processed foods, particularly those aimed at children, and encouraging obligatory front-of-pack food labelling;
Amendment 401 #
Motion for a resolution Paragraph 8 – point a a. encourage and help consumers to make informed and healthy choices about food products; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable diets; implement considerable restrictions on advertising of ultra-processed foods, particularly those aimed at children, and encouraging obligatory front-of-pack food labelling;
Amendment 402 #
Motion for a resolution Paragraph 8 – point a a. encourage and help consumers to make informed and healthy choices about food products; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable diets; mainstream physical activities such as walking, cycling, and the practice of sports in urban planning, and put an increased emphasis on physical activity in schools;
Amendment 403 #
Motion for a resolution Paragraph 8 – point a a. encourage and help consumers to make informed and healthy choices about food products; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable diets; prohibit advertising of ultra- processed food, particularly those aimed at children, and encourage obligatory front-of-pack food labeling;
Amendment 404 #
Motion for a resolution Paragraph 8 – point a a.
Amendment 405 #
Motion for a resolution Paragraph 8 – point a a. encourage and help consumers to make informed and healthy choices about food products, empowering them to follow healthy, varied and balanced diets; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable diets;
Amendment 406 #
Motion for a resolution Paragraph 8 – point a Amendment 407 #
Motion for a resolution Paragraph 8 – point a a. encourage and help consumers to make informed and healthy choices about food products; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy
Amendment 408 #
Motion for a resolution Paragraph 8 – point a a. encourage and help consumers to make informed and healthy choices about food products; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable diets;
Amendment 409 #
Motion for a resolution Paragraph 8 – point a a (new) aa. Reiterates its strong support for the ambitions and goals of the EU Farm to Fork Strategy, in particular for policies stimulating healthy eating and a population-wide shift in consumption patterns towards more healthy foods, diets and lifestyles, including increased consumption of sustainably and regionally produced plants and plant- based foods, such as fresh fruits and vegetables, whole grains and legumes, and to address the overconsumption of meat and ultra-processed products, as well as products high in sugars, salt and fats, which will also benefit the environment and animal welfare and secure a more resilient economy;
Amendment 41 #
Motion for a resolution Citation 9 c (new) – having regard to the Global Monitoring Framework for the prevention and control of non-communicable diseases (NCDs),
Amendment 410 #
Motion for a resolution Paragraph 8 – point a a (new) aa. Place limits on advertising for ultra-processed foods, particularly those intended for children and adolescents, and encourage the compulsory labelling of foodstuffs on the front of packaging, with details of the processing used to make them;
Amendment 411 #
Motion for a resolution Paragraph 8 – point a a (new) aa. implement a comprehensive strategy to combat eating disorders, through allocation of resources, data collection, prevention campaigns as well as support systems and coordination with existing bodies in individual Member States;
Amendment 412 #
Motion for a resolution Paragraph 8 – point a a (new) aa. Calls on the Member States to promote behavioural changes via communication and mass media campaigns based on scientific evidence;
Amendment 413 #
Motion for a resolution Paragraph 8 – point a b (new) ab. Stresses that self-regulation is not effective enough and should be accompanied by binding targets and measures to discourage non-compliance, such as administrative or economic sanctions, as the only means to ensure business operators to improve the formulation of processed food and levels of nutrients;
Amendment 414 #
Motion for a resolution Paragraph 8 – point a b (new) ab. Calls on the Member States to consider applying differentiated VAT, in line with the options of the EU VAT Directive, to encourage the uptake of certain foods;
Amendment 415 #
Motion for a resolution Paragraph 8 – point a c (new) ac. Urges the overhaul of the EU promotion programme for agricultural and food products, including the EU school scheme, to align it fully with the European Green Deal and the Sustainable Development Goals, with view to bringing it into coherence with the objectives of the Green Deal and the Farm to Fork Strategy and to enhancing its contribution to sustainable production and consumption, notably by promoting organic produce, focusing on educational messages about the importance of healthy and sustainable nutrition and promoting greater consumption of fruit and vegetables with the aim of reducing obesity rates, increasing environmental awareness and encouraging a shift towards a more sustainable plant-based diet;
Amendment 416 #
Motion for a resolution Paragraph 8 – point a d (new) ad. Calls for regulatory measures to reduce the burden that highly processed foods with high salt, sugar and fat content place on public health; recalls that nutrient profiles which are long overdue remain pertinent and necessary to meet the objectives of the Regulation (EC)No 1924/2006 on Nutrition and Health Claims; welcomes the announcement of a legislative proposal to establish nutrient profiles; points out that many food products, including some marketed towards children, continue to use health and nutrition claims despite of containing high levels of nutrients of concern; stresses that a robust set of nutrient profiles must be developed to prohibit the use of claims on foods high in fats, sugars and salt;
Amendment 417 #
Motion for a resolution Paragraph 8 – point a e (new) ae. Calls for binding targets for major food producers and retailers to reformulate processed foods; recognises that front-of-pack labels have been identified by international public health bodies such as the World Health Organisation as a key tool to help consumers make more informed and healthier food choices; deeply deplores the delays on the side of the Commission to ensure that the EU mandatory front-of- pack nutritional label is developed based on robust, independent scientific evidence and demonstrated consumer understanding; stresses that a legislative proposal to ensure mandatory harmonised front-of-pack labeling needs to be adopted during the current mandate of the European Parliament;
Amendment 418 #
Motion for a resolution Paragraph 8 – point a f (new) af. Calls for renewed attention to achieve an effective and EU-wide approach to tackle the exposure of children and adolescents to the advertising and marketing of processed foods high in fat, sugar and salt on broadcast and digital media; calls on the Commission to consider taking legislative action to protect the health of this vulnerable group of consumers;
Amendment 419 #
Motion for a resolution Paragraph 8 – point a g (new) ag. Calls on the Member States and Regional Authorities to ban commercial communications in public spaces for unhealthy foods and to take a stand against the promotion of unhealthy choices due to the rapid release of new establishments of fast-food claims;
Amendment 42 #
Motion for a resolution Citation 9 d (new) – having regard to the World Health Assembly resolution of May 2019 on improving the transparency of markets for medicines, vaccines, and other health products (WHA72.8)m
Amendment 420 #
Motion for a resolution Paragraph 8 – point a h (new) ah. Encourages the Commission to set measurable targets to reduce the consumption of meat in the EU, more in line with dietary guidelines and the sustainability challenges; suggests the inclusion of the targets as established in the Netherlands to ensure a level-playing field in the EU, of a reversal of the ratio of animal protein to plant protein consumption from 60/40 to 40/60, and a 10 to 15% reduction in the total protein intake;
Amendment 421 #
Motion for a resolution Paragraph 8 – point a i (new) ai. Reiterates the importance of recognising the role and influence of the food environment in shaping consumption patterns and the need to make it easier for consumers to choose healthy and sustainable diets; regrets the lack of a systematic and evidence-based approach to creating healthy food environments and the continued reliance on self-regulation; calls on the Commission and the Member States to actively participate in creating a healthy food environment that sends the right signals to citizens and in particular to children, instead of seducing them to buy sweet, salty and fatty foods;
Amendment 422 #
Motion for a resolution Paragraph 8 – point a j (new) aj. Reiterates the importance of promoting sustainable diets by changing the food environment, raising consumer awareness of the impact of consumption patterns, and by providing information on diets that are better for human health and have a lower environmental footprint;
Amendment 423 #
Motion for a resolution Paragraph 8 – point b b.
Amendment 424 #
Motion for a resolution Paragraph 8 – point b Amendment 425 #
b. Calls on the Commission to propose a New Action Plan for child obesity, including measures and recommendations for early diagnosis and screening, treatment and long term management, which addresses also the impact of parental obesity and the demand for interdisciplinary treatment and management services;
Amendment 426 #
Motion for a resolution Paragraph 8 – point b b. propose a comprehensive and integrated New Action Plan for child obesity with clear and binding targets, benchmarks, indicators and mechanisms to monitor and guarantee results;
Amendment 427 #
Motion for a resolution Paragraph 8 – point b b. propose a
Amendment 428 #
Motion for a resolution Paragraph 8 – point b b. propose a
Amendment 429 #
Motion for a resolution Paragraph 8 – point b b. propose a
Amendment 43 #
Motion for a resolution Citation 9 e (new) Amendment 430 #
Motion for a resolution Paragraph 8 – point b a (new) ba. counter the availability of nutritionally poor foods by limiting fast- food establishments in proximity of schools, taking into account that encouraging behavioural change is intrinsically linked to an individual's socio-economic status, geographical location and available and affordable opportunities;
Amendment 431 #
Motion for a resolution Paragraph 8 – point b a (new) ba. propose the implementation of taxation on unhealthy foods and sugary beverages, while subsidizing affordable access to minimally processed nutritious foods for socioeconomically disadvantaged populations;
Amendment 432 #
Motion for a resolution Paragraph 8 – point b a (new) ba. propose the implementation of taxation on unhealthy foods and sugary beverages, while subsidizing affordable access to minimally processed nutritious foods for socioeconomically disadvantaged populations;
Amendment 433 #
Motion for a resolution Paragraph 8 – point b a (new) ba. promote behavioural changes via communication, and mass media campaigns for healthy diets and encourage public food procurement and service policies for healthy and sustainable diets;
Amendment 434 #
Motion for a resolution Paragraph 8 – point b a (new) ba. recommends the EU Member States to adopt the WHO guidelines on healthy diet by all European countries, as part of a shared commitment to address the burden of Non-Communicable Disease;
Amendment 435 #
Motion for a resolution Paragraph 8 – point b a (new) Amendment 436 #
Motion for a resolution Paragraph 8 – point b a (new) ba. Calls on the Commission to include obesity as a chronic relapsing disease in future revisions of the EU NCD Initiative;
Amendment 437 #
Motion for a resolution Paragraph 8 – point b b (new) bb. implement restrictions on advertising of ultra-processed food during child-focused TV and digital media, at cinemas and in locations that attract a high proportion of children;
Amendment 438 #
Motion for a resolution Paragraph 8 – point b b (new) Amendment 439 #
Motion for a resolution Paragraph 8 – point b b (new) bb. adopt an evidence-based, harmonised and mandatory front-of-pack nutrition label to help consumers to make informed and healthier choices about food products;
Amendment 44 #
Motion for a resolution Citation 9 f (new) – having regard to Appendix 3 (= set of best buys and other recommended interventions for the prevention and control of NCDs) of the WHO global action plan for the prevention and control of noncommunicable diseases 2013–2030,
Amendment 440 #
Motion for a resolution Paragraph 8 – point b b (new) bb. enhance the availability, affordability, and accessibility of nutritional care provided by dietitians and nutritionists;
Amendment 441 #
Motion for a resolution Paragraph 8 – point b c (new) bc. establish and nurture food environments that seamlessly promote the selection of healthy and sustainable food options, ensuring they become the default choices due to their ease of access and affordability; enable a shift in focus from individual responsibility to enhancing the environments where choices are made; counter industry-driven narratives and foster a broader understanding of the commercial and social determinants of dietary behaviour;
Amendment 442 #
Motion for a resolution Paragraph 8 – point b c (new) bc. promote behavioural changes via communication, and media campaigns for healthy diets and encourage public food procurement and service policies for healthy and sustainable diets;
Amendment 443 #
Motion for a resolution Paragraph 8 – point b c (new) Amendment 444 #
Motion for a resolution Paragraph 8 – point b c (new) bc. enhance the availability, affordability, and accessibility of nutritional care provided by dietitians and nutritionists;
Amendment 445 #
Motion for a resolution Paragraph 8 – point b d (new) bd. establish and nurture food environments that seamlessly promote the selection of healthy and sustainable food options, ensuring they become the default choices due to their ease of access and affordability; enable a shift in focus from individual responsibility to enhancing the environments where choices are made; counter industry-driven narratives and foster a broader understanding of the commercial and social determinants of dietary behaviour;
Amendment 446 #
Motion for a resolution Paragraph 8 – point b d (new) bd. drive transformative shifts in nutritionally poor food availability through limiting the density of fast-food outlets, especially in proximity to schools and underserved areas. acknowledge that encouraging behavioural change is intrinsically linked to an individual's socioeconomic status, geographical location, and available opportunities;
Amendment 447 #
Motion for a resolution Paragraph 8 – point b d (new) bd. implement restrictions on advertising of ultra-processed foods, particularly those aimed at children; propose the implementation of taxation on unhealthy foods and sugary beverages, while subsidizing affordable access to minimally processed nutritious foods for socioeconomically disadvantaged populations;
Amendment 448 #
Motion for a resolution Paragraph 8 – point b d (new) bd. propose the implementation of taxation on unhealthy foods and sugary beverages, while subsidizing affordable access to minimally processed nutritious foods for socioeconomically disadvantaged populations;
Amendment 449 #
Motion for a resolution Paragraph 8 – point b e (new) be. drive transformative shifts in nutritionally poor food availability through limiting the density of fast-food outlets, especially in proximity to schools and underserved areas. Acknowledge that encouraging behavioural change is intrinsically linked to an individual's socioeconomic status, geographical location, and available opportunities;
Amendment 45 #
Motion for a resolution Citation 12 c (new) – having regard to the WHO report "A Health Perspective on the role of the environment in One Health",
Amendment 450 #
Motion for a resolution Paragraph 8 a (new) 8a. Welcomes the recognition in the Farm to Fork Strategy that current consumption patterns in the EU are not sustainable from both health and environmental points of view and moving towards a more plant-based diet with increased intakes of fruit and vegetables as well as less red and processed meats will provide benefits both for the health of consumers and reduced environmental impact of the food system; calls therefore on the Commission to come forward with EU-wide guidelines for healthy and sustainable diets;
Amendment 451 #
Motion for a resolution Paragraph 8 a (new) Amendment 452 #
Motion for a resolution Paragraph 8 a (new) 8a. The increase in drug use has become a public health problem and is a major risk factor for non-communicable diseases, including mental health disorders and hetero-aggression, as well as a major contributory factor in road accidents;
Amendment 453 #
Motion for a resolution Paragraph 8 a (new) 8a. Highlights that the Mediterranean diet is recognized as a healthy, balanced diet that plays a protective role in the primary and secondary prevention of the main chronic degenerative diseases;
Amendment 454 #
Motion for a resolution Paragraph 8 a (new) 8a. Welcomes the Commission’s intention to tackle the presence of carcinogenic contaminants in food; urges the Commission to swiftly come forward with regulatory proposals;
Amendment 455 #
Motion for a resolution Paragraph 8 b (new) 8b. Regrets the delay of the proposal for a revision of the Food Information to Consumers Regulation (1169/2011) as well-evidenced front-of-pack nutrition labels which are independently developed and implemented and backed by significant amounts of scientific research have already been shown to be effective in helping consumers to opt for healthier food and beverage choices. Calls for the inclusion on food labels of information on the environmental footprint of foods and drinks and on the presence of pesticides in order to empower customers to follow healthier and more sustainable diets; Calls for improvement o the Union’s authorisation procedure for pesticides;
Amendment 456 #
Motion for a resolution Paragraph 8 b (new) 8b. Calls on the Commission to heed Parliament’s various calls in its resolution of 16 January 2019 to improve the Union’s authorisation procedure for pesticides;
Amendment 457 #
Motion for a resolution Paragraph 8 c (new) 8c. Calls for a revision of Food Information to Consumers regulation 1169/2011 to empower the consumer and allow for healthy lifestyle choices such as improving the sugar labelling on the back of pack in order correctly inform consumers of the amount free and added sugars as a proportion of total sugars as well as the use of non-sugar sweeteners;
Amendment 458 #
Motion for a resolution Paragraph 9 9. Highlights the role of physical activity in NCD prevention and welcomes the Commission’s HealthLifestyle4All initiative; calls on the Commission and Member States to promote physical activity and awareness campaigns to prevent NCDs; recognizes that improving population lifestyle choices is not enough to tackle the burden of NCDs, and while primary prevention plays a crucial role in reducing the incidence of many types of NCDs, secondary prevention is key for the optimal management of chronic diseases and contributes to reduce the risk of complications, comorbidities and death; stresses that a holistic approach to NCDs care pathways should be reflected in national NCDs plans and strategies, which include clear implementation roadmaps;
Amendment 459 #
Motion for a resolution Paragraph 9 9. Highlights the role of physical activity in NCD prevention and welcomes Commission’s HealthLifestyle4All initiative; calls on the Commission and Member States to promote physical activity and awareness campaigns to prevent NCDs; recognizes that improving population lifestyle choices is not enough to tackle the burden of NCDs, and while primary prevention plays a crucial role in reducing the incidence of many types of NCDs, secondary prevention is key for the optimal management of chronic diseases and contributes to reduce the risk of complications, comorbidities and death; stresses that a holistic approach to NCDs care pathways should be reflected in national NCDs plans and strategies, which include clear implementation roadmaps;
Amendment 46 #
Motion for a resolution Citation 9 b (new) – having regard to the OECD/European Union (2022), Health at a Glance: Europe 2022: State of Health in the EU Cycle, OECD Publishing, Paris,
Amendment 460 #
Motion for a resolution Paragraph 9 9. Highlights the role of physical
Amendment 461 #
Motion for a resolution Paragraph 9 9. Highlights the role of physical activity in NCD prevention in health promotion at population level for all major chronic diseases and welcomes Commission’s HealthLifestyle4All initiative; calls on the Commission and Member States to promote physical activity and awareness campaigns to prevent NCDs;
Amendment 462 #
Motion for a resolution Paragraph 9 a (new) 9a. Notes that a large part of NCDs- related deaths are preventable; notes that, in addition to health promotion and primary prevention, screening and early detection, especially for at-risk individuals, are critically important to reduce premature deaths from NCDs such as cardiovascular diseases, diabetes and obesity; stresses that secondary prevention strategies targeted toward known common metabolic risk factors are crucial to best support patients and improve the quality of life of people living with these diseases;
Amendment 463 #
Motion for a resolution Paragraph 9 a (new) 9a. Calls on the European Commission to develop a holistic action plan on cardiovascular health, including rare cardiovascular diseases and setting forth targets and recommendations to improve the prevention and management of cardiovascular disease and encompassing all different aspects and stages of the disease;
Amendment 464 #
Motion for a resolution Paragraph 9 a (new) 9a. Calls on the Member States to improve physical and sporting activities in schools in order to reduce the risk of NCDs; stresses that physical tests (in respect of sport) should be carried out to detect various risk factors in children;
Amendment 465 #
Motion for a resolution Paragraph 9 a (new) 9a. Stresses the role of health education in the prevention of non- communicable diseases and calls on the Commission and the Member States to promote health education and to introduce health education as a compulsory subject for study in all educational establishments.
Amendment 466 #
Motion for a resolution Paragraph 9 b (new) 9b. Calls on Member States to develop tailored national plans to address the specificities of different subcategories of NCDs, including specific plans for highly prevalent diseases, with high mortality and morbidity rates, such as cardiovascular diseases, diabetes and obesity.
Amendment 467 #
Motion for a resolution Paragraph 9 b (new) 9b. Calls on the European Commission to develop a holistic action plan on diabetes;
Amendment 468 #
Motion for a resolution Paragraph 10 10.
Amendment 469 #
Motion for a resolution Paragraph 10 10. Acknowledges environmental factors contribute significantly to the burden of death and disease in Europe and, therefore, improving environmental conditions will improve the health and well-being of European citizens; Considers the European Green Deal to be instrumental in preventing NCDs in the EU by reducing air, food, water and soil pollution and chemical exposure; highlights that prevention of chronic respiratory diseases besides tobacco cessation also includes the prevention of exposure to dust and other indoor pollutants; Highlights the increased vulnerability of people living with NCDs to extreme weather events and other impacts of climate change and therefore calls for targeted measures in climate change mitigation and adaptation policies;
Amendment 47 #
Motion for a resolution Citation 9 a (new) – having regard to the report from the European Society of Cardiology titled “European Society of Cardiology: cardiovascular disease statistics 2021,
Amendment 470 #
Motion for a resolution Paragraph 10 10. Considers the European Green Deal
Amendment 471 #
Motion for a resolution Paragraph 10 10. Considers the European Green Deal to be instrumental in preventing NCDs in the EU by reducing air, food, water and soil pollution and chemical exposure; highlights that prevention of chronic respiratory diseases besides tobacco cessation also includes the prevention of exposure to dust
Amendment 472 #
Motion for a resolution Paragraph 10 10. Considers the European Green Deal and other environmental strategies, such as the EU Biodiversity Strategy 2030 and the new EU Forest Strategy 2030, to be instrumental in preventing and treating NCDs in the EU
Amendment 473 #
Motion for a resolution Paragraph 10 10. Considers the European Green Deal to be instrumental in preventing NCDs in the EU by reducing air, food, water and soil pollution and chemical exposure; highlights that preventi
Amendment 474 #
Motion for a resolution Paragraph 10 10. Considers the European Green Deal to be instrumental in preventing NCDs in the EU by reducing air, food, water and soil pollution and chemical exposure; highlights that prevention of chronic respiratory diseases besides tobacco cessation also includes the prevention of exposure to dust and other indoor pollutants; stresses that alignment of the EU quality standards to the WHO guidelines is essential;
Amendment 475 #
Motion for a resolution Paragraph 10 10. Considers the European Green Deal to be instrumental in preventing NCDs in the EU by reducing air, food, water and soil pollution and chemical exposure; highlights that prevention of chronic respiratory diseases besides
Amendment 476 #
Motion for a resolution Paragraph 10 10. Considers that the European Green Deal
Amendment 477 #
Motion for a resolution Paragraph 10 a (new) 10a. Notes with regret that the revised EU Ambient Air Quality Directive (AAQD) proposals of the Commission failed to include a clear path to reducing annual mean concentrations to below 5 µg/m3 for PM2.5 and 10 µg/m3 for NO2, in line with the latest WHO health-based Air Quality Guidelines and therefore calls for EP and Council to set ambitious targets and to strengthen the proposed limit values to allign to current WHO guidelines; Calls for a continued improvement in air quality down to, or below, the WHO’s air quality guidelines that would maximize health benefits to European citizens;
Amendment 478 #
Motion for a resolution Paragraph 10 a (new) 10a. Reiterates the importance of the European Green Deal as a significant contributing factor to disease prevention in Europe, by means of reducing air, soil, water and food pollution and chemical exposure, and by ensuring access to and information about healthy foods; calls for an evaluation of the impact of policies on NCD incidence to be integrated into the Farm to Fork Strategy, the Chemicals Strategy for Sustainability, the Zero Pollution and Non-Toxic Environment Strategies;
Amendment 479 #
Motion for a resolution Paragraph 10 a (new) 10a. Acknowledges that air pollution has a negative impact on human health and exposure to it affects 100% of the population, from unborn babies to the elderly, that 400,000 premature deaths every year are caused by outdoor air pollution in Europe, and that as many as 15% of all lung cancer deaths are linked to air pollution; calls therefore the Commission and member states to further improve air quality provisions in order to protect public health;
Amendment 48 #
Motion for a resolution Recital A A. whereas non-communicable diseases (NCDs) are diseases that are not passed from person to person; whereas
Amendment 480 #
Motion for a resolution Paragraph 10 a (new) 10a. Acknowledges the impact that some NCD treatments, such as kidney dialysis, can have on the environment and highlights that early prevention and detection of NCDs can significanlty reduce that impact; Calls on the European Commission and the Member States to implement measures to lower the environmental footprint of treatments and to accelerate the transition to sustainable healthcare without compromising the efficiency of the treatment for the patient;
Amendment 481 #
Motion for a resolution Paragraph 10 a (new) 10a. Highlights the importance of NCD prevention and early intervention; acknowledges that many NCDs have their origins in early childhood and the importance of investing in strategies and programmes that promote children’s healthy growth and development, from infancy and early years;
Amendment 482 #
10b. Underlines that the work of the Green Deal is not done and calls on the Commission to step up its efforts to adopt the legislative proposals which were announced in the various elements of the Green Deal;
Amendment 483 #
Motion for a resolution Paragraph 10 c (new) 10c. Stresses that the WHO report "Health perspective on the role of the environment in One Health" highlights that anthropogenic stressors - including land use change, biodiversity loss, climate change and pollution - afflict the role played by the environment in the human- animal health interface;
Amendment 484 #
Motion for a resolution Paragraph 10 d (new) Amendment 485 #
Motion for a resolution Paragraph 10 e (new) 10e. Underlines that AMR may be the next global health crisis and that there is consequently a need for accelerated action by implementating the required action plans, specific global mechanisms for AMR surveillance, research, and antimicrobial stewardship to ensure their availability and affordability;
Amendment 486 #
Motion for a resolution Paragraph 11 11. Calls on the Commission and the Member States to accelerate the transition to sustainable energy and transport sectors and to ensure a shift towards sustainable food systems, with a greater emphasis on increasing the consumption of plant- based proteins and reducing the over- consumption of animal products;
Amendment 487 #
Motion for a resolution Paragraph 11 11. Calls on the Commission and the Member States to accelerate the transition to sustainable energy and transport sectors and to ensure a shift towards sustainable food systems through an ambitious proposal for the Framework for Sustainable Food Systems (FSFS);
Amendment 488 #
Motion for a resolution Paragraph 11 11. Calls on the Commission and the Member States to accelerate the transition to sustainable energy and transport sectors and to ensure a shift towards sustainable food systems through an ambitious proposal for the Framework for Sustainable Food Systems (FSFS);
Amendment 489 #
Motion for a resolution Paragraph 11 11. Calls on the Commission and the Member States to accelerate the transition to sustainable energy and transport sectors and to ensure a shift towards sustainable food systems, while taking into account the differences between EU Member States;
Amendment 49 #
Motion for a resolution Recital A A. whereas non-communicable diseases (NCDs) are diseases that are not passed from person to person; whereas non-communicable diseases (NCD’s) cause 90 % of all deaths in the EU4
Amendment 490 #
Motion for a resolution Paragraph 11 11. Calls on the Commission and the Member States to accelerate the transition to sustainable energy and transport sectors and to ensure a shift towards sustainable food systems through an ambitious proposal for the Framework for Sustainable Food Systems;
Amendment 491 #
Motion for a resolution Paragraph 11 11. Calls on the Commission and the
Amendment 492 #
Motion for a resolution Paragraph 11 11. Calls on the Commission and the Member States to accelerate the transition to sustainable energy
Amendment 493 #
Motion for a resolution Paragraph 11 a (new) 11a. Highlights the importance of NCD prevention and early intervention; acknowledges that many NCDs have their origins in early childhood and the importance of investing in strategies and programmes that promote children’s healthy growth and development, from infancy and early years;
Amendment 494 #
Motion for a resolution Paragraph 11 a (new) 11a. Calls on the Commission and the Member States to limit the expansion of globalisation which is pushing maritime freight cargo towards seas and oceans; calls, therefore, on the Commission to call into question the many free trade agreements;
Amendment 495 #
Motion for a resolution Paragraph 11 b (new) 11b. Regrets the delay in the publication of the revision of the Food Information to Consumers Regulation (1169/2011), foreseen under the Farm to Fork Strategy for the fourth quarter of 2022;
Amendment 496 #
Motion for a resolution Paragraph 12 12. Stresses that per- and polyfluorinated alkyl substances (PFAS) can lead to health problems such as obesity and cancer16 ; calls on the Commission to swiftly implement the PFAS restriction proposal
Amendment 497 #
Motion for a resolution Paragraph 12 12. Stresses that certain per- and polyfluorinated alkyl substances (PFAS) can lead to health problems such as obesity and cancer16 ; calls on the Commission to implement the PFAS restriction proposal submitted to European Chemicals Agency on 13 January 202317 according to a risk- based approach with sufficient exemptions for essential use taking into account the whole supply chain ; _________________ 16 European Environment Agency, ‘What
Amendment 498 #
Motion for a resolution Paragraph 12 12. Stresses that some per- and polyfluorinated alkyl substances (PFAS) can lead to health problems such as obesity, diabetes 1a and cancer16 ; calls on the Commission to implement the PFAS restriction proposal submitted to European Chemicals Agency on 13 January 202317 ; _________________ 1a https://www.clinicaltrialsarena.com/comm ent/high-exposure-pfas-diabetes-women/ 16 European Environment Agency, ‘What
Amendment 499 #
Motion for a resolution Paragraph 12 12. Stresses that per- and polyfluorinated alkyl substances (PFAS) can lead to health problems such as diabetes1a, obesity and cancer16 ; calls on the Commission to implement the PFAS restriction proposal submitted to European Chemicals Agency
Amendment 5 #
Motion for a resolution Citation 1 b (new) – having regard to its resolution of 12 July 2023 on the COVID-19 pandemic: lessons learned and recommendations for the future’ (2022/2076(INI)),
Amendment 50 #
Motion for a resolution Recital A A. whereas non-communicable diseases (NCDs) are diseases that are not passed from person to person; whereas
Amendment 500 #
Motion for a resolution Paragraph 12 12. Stresses that per- and polyfluorinated alkyl substances (PFAS) can lead to health problems such as diabetes1a, obesity and cancer16 ; calls on the Commission to implement the PFAS restriction proposal submitted to European Chemicals Agency on 13 January 202317 ; _________________ 1a GlobalData Healthcare, 'High exposure to PFAS more than doubles risk of developing diabetes in women'. Clinical Trials Arena 16 European Environment Agency, ‘What
Amendment 501 #
Motion for a resolution Paragraph 12 12. Stresses that per- and polyfluorinated alkyl substances (PFAS) can lead to
Amendment 502 #
Motion for a resolution Paragraph 12 12. Stresses that per- and polyfluorinated alkyl substances (PFAS) can lead to health problems such as diabetes, obesity and cancer16 ; calls on the Commission to implement the PFAS restriction proposal submitted to European Chemicals Agency on 13 January 202317 ;
Amendment 503 #
Motion for a resolution Paragraph 12 12. Stresses that per- and polyfluorinated alkyl substances (PFAS) can lead to health problems such as diabetes, obesity and cancer16 ; calls on the Commission to implement the PFAS restriction proposal submitted to European Chemicals Agency on 13 January 202317 ; _________________ 16 European Environment Agency, ‘What
Amendment 504 #
Motion for a resolution Paragraph 12 12. Stresses that per- and
Amendment 505 #
Motion for a resolution Paragraph 12 12. Stresses that per- and polyfluorinated alkyl substances (PFAS) can lead to health problems such as diabetes, obesity and cancer
Amendment 506 #
Motion for a resolution Paragraph 12 a (new) 12a. Acknowledges pesticides use can cause neuro--degenerative diseases and cancers, which farmers are the most exposed to, in particular the non- -Hodgkin’s lymphoma, a cancer widespread among regular pesticide users1i; Calls for the adoption of an ambitious proposal on the sustainable use of pesticides with a a high reduction target of the most hazardous pesticides by 2030. Underlines that those pesticides pose a serious threat to health (they are, for example, neurotoxic, carcinogenic, toxic for reproduction or have endocrine disrupting properties) and should have been gradually phased out since 2015. _________________ 1i Zhang et al., Exposure to glyphosate- based herbicides and risk for non- Hodgkin lymphoma: A meta-analysis and supporting evidence, 2019
Amendment 507 #
Motion for a resolution Paragraph 12 a (new) 12a. Recall that endocrine-disrupting chemicals, pervasive in our environment—in foods, packaging materials, cosmetics, drinking water, and consumer products—have been linked to a myriad of non-communicable diseases such as obesity, type 2 diabetes, thyroid disorders, neurodevelopmental disease, hormone-dependent cancers, and reproductive disorders.
Amendment 508 #
Motion for a resolution Paragraph 13 13.
Amendment 509 #
Motion for a resolution Paragraph 13 13.
Amendment 51 #
Motion for a resolution Recital A A. whereas non-communicable diseases (NCDs) are diseases that are not passed from person to person; whereas non-communicable diseases (NCD
Amendment 510 #
Motion for a resolution Paragraph 13 13. Regrets the slow implementation of the Chemicals Strategy for Sustainability, and, in particular, expects the REACH Regulation18 to be revised in order to be able to identify all substances of concern manufactured or imported in the EU; including endocrine disruptors; calls for the need for more comprehensive identification and regulation of these substances that can interfere with the hormonal system and have been associated with adverse health effects; _________________ 18 Regulation (EC) No 1907/2006 of the
Amendment 511 #
Motion for a resolution Paragraph 13 13.
Amendment 512 #
Motion for a resolution Paragraph 13 13. Regrets the slow implementation of the Chemicals Strategy for Sustainability, and, in particular, expects the REACH Regulation18 to be revised in order to be able to identify all substances of concern manufactured or imported in the EU and to ban their use in the EU if necessary; _________________ 18 Regulation (EC) No 1907/2006 of the
Amendment 513 #
Motion for a resolution Paragraph 13 13.
Amendment 514 #
Motion for a resolution Paragraph 13 a (new) Amendment 515 #
Motion for a resolution Paragraph 13 a (new) 13a. Reiterates that chemical exposure is linked to several NCDs; therefore, supports the measures planned in the Chemicals Strategy for Sustainability and the Zero-Pollution Action Plan to reduce citizens’ exposure to harmful chemical products such as carcinogenic, reprotoxic, mutagenic and endocrine-disrupting substances through all different exposure pathways; stresses the need to ensure occupational health for all workers in the EU; calls on the European Commission to propose a revision of all relevant consumer product legislation to ensure these products do not contain chemicals that have any adverse effect on citizens’ health;
Amendment 516 #
Motion for a resolution Paragraph 13 a (new) 13a. Recalls that the Commission’s Communication ‘Chemicals strategy for sustainability towards a toxic-free environment’ highlighted the need to protect workers from those substances; calls therefore on the Commission to consider extending the scope of Directive 2004/37/EC to endocrine disruptors;
Amendment 517 #
Motion for a resolution Paragraph 13 a (new) 13a. Reminds the Commission of its promise to ensure that endocrine disruptors will be banned in consumer products as soon as they have been identified; calls on the Commission to urgently live up to the promise;
Amendment 518 #
Motion for a resolution Paragraph 13 a (new) Amendment 519 #
Motion for a resolution Paragraph 13 a (new) 13a. Acknowledges, however, that many NCDs could not be attributed, or could only partially be attributed to behavioural and environmental factors;
Amendment 52 #
Motion for a resolution Recital A A. whereas non-communicable diseases (NCDs) are diseases that are not passed from person to person; whereas non-communicable diseases (NCD’s) cause 90 % of all deaths in the EU4
Amendment 520 #
Motion for a resolution Paragraph 13 a (new) 13a. Calls on Member States to consider the uptake of HPV vaccination in adolescents in the fight against HPV transmission;
Amendment 521 #
Motion for a resolution Paragraph 13 b (new) Amendment 522 #
Motion for a resolution Paragraph 13 b (new) 13b. Calls on the European Environmental Agency (EEA) to produce a report, together with the European Chemicals Agency (ECHA), on chemicals in the environment in Europe. The report should assess the systemic nature of harmful chemicals to the environment and human health, focusing on carcinogenic and endocrine disrupting chemicals within Europe’s production and consumption systems, their use in products, occurrence in Europe’s environment and the harm caused to human health, especially concerning NCDs;
Amendment 523 #
Motion for a resolution Paragraph 13 b (new) 13b. Regrets the lack of sufficient public funding and incentives for private investment for scientific research on the interconnection between communicable and non-communicable diseases, the failure to ensure the systematization of scientific data on these interconnections and promote early diagnostics, vaccination and/or treatment of communicable diseases, leading to NCDs;
Amendment 524 #
Motion for a resolution Paragraph 13 b (new) 13b. Deeply regrets the slow implementation of the Farm to Fork Strategy, and expect particularly an ambitious legislative framework for sustainable food systems, a proposal for harmonised front-of-pack labeling and nutrient profiles, and stresses that the delay of the revision of the Food Contact Materlials legislation until 2025 is unacceptable;
Amendment 525 #
Motion for a resolution Paragraph 13 b (new) 13b. Supports the ambition of the Farm to Fork Strategy in reducing the use and risk of chemical pesticides by 50% in 2030; calls on the Commission to ensure that the common agricultural policy helps farmers to reduce the use of pesticides and to substitute harmful active substances;
Amendment 526 #
Motion for a resolution Paragraph 13 c (new) 13c. Considers that the next edition of the European Code Against Cancer (ECAC) will have to take into account the latest knowledge on environmental carcinogens; calls on the Commission to propose without delay a revision of REACH Article 68(2), the regulation on food contact materials, the regulation on cosmetic products, the directive on toys safety and other relevant consumer product legislation to ensure that consumer products do not contain chemicals that cause cancer or affect the endocrine system in line with the Chemicals Strategy for Sustainability;
Amendment 527 #
Motion for a resolution Paragraph 13 c (new) 13c. Acknowledges the efforts of the European Commission to support Member States in reducing the burden of NCDs with the launch of the "Healthier Together - EU non-communicable diseases initiative (NCD)" in December 2021; calls nevertheless for more ambitious action to revert the rising number of people afflicted with NCDs but also to improve the quality of life and mental wellbeing of those suffering from NCDs;
Amendment 528 #
Motion for a resolution Paragraph 13 c (new) 13c. Reiterates the need for further study of the impact of communicable diseases on patients with NCDs and of the various so-called post-viral conditions and possible links between such chronic conditions as ME/CFS and previous communicable infections;
Amendment 529 #
Motion for a resolution Paragraph 13 d (new) Amendment 53 #
Motion for a resolution Recital A A. whereas non-communicable diseases (NCDs) are diseases that are not passed from person to person; whereas non-communicable diseases (NCD’s) cause 90 % of all deaths in the EU4 and their prevalence continues to grow across the EU; _________________ 4 World Health Organization, ‘Monitoring
Amendment 530 #
Motion for a resolution Paragraph 13 e (new) 13e. Reiterates its recommendation to the Commission and the Member States to revise the residential and public exposure limits for the public and the environment in order to reduce RF exposures from cell towers, Small-Area Wireless Access Points (SAWAPs) and Near-Field Communication, i.e. to around 6 V/m globally, which is an exposure level at which no cancer effects in experimental animals have been observed; supports measures to incentivise the reduction of RF-EMF exposures (including fiber-optic cables, Li-Fi, etc.);
Amendment 531 #
Motion for a resolution Paragraph 13 f (new) 13f. Calls for the implementation of novel technology for mobile phones that enables RF exposures to be reduced whatever the frequencies, from 1G to 5G and any future standards; calls for multidisciplinary scientific research to assess the long-term health effects of 5G and to find an adequate method of monitoring exposure to 5G; encourages the Commission and the Members States to carry out information campaigns, including at schools, to inform on potential health risks of mobile phone use and safety measures taken by the EU and Member States;
Amendment 532 #
Motion for a resolution Paragraph 14 14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes in this regard such as in the fight against human papillomavirus transmission;
Amendment 533 #
Motion for a resolution Paragraph 14 14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes in this regard such as in the fight against human papillomavirus transmission; calls on Member States to consider the uptake of gender-neutral HPV vaccination in adolescents in the fight against HPV transmission;
Amendment 534 #
Motion for a resolution Paragraph 14 14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes
Amendment 535 #
Motion for a resolution Paragraph 14 14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes in this regard such as in the fight against human papillomavirus transmission, including the adoption of gender-neutral HPV vaccinations for adolescents;
Amendment 536 #
Motion for a resolution Paragraph 14 14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes in th
Amendment 537 #
Motion for a resolution Paragraph 14 14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes in this regard such as in the fight against human papillomavirus transmission, Identification of high-risk populations and early diagnosis of NCDs;
Amendment 538 #
Motion for a resolution Paragraph 14 14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes in this regard such as in the fight against human papillomavirus transmission
Amendment 539 #
Motion for a resolution Paragraph 14 14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes in
Amendment 54 #
Motion for a resolution Recital A A. whereas non-communicable diseases (NCDs) are diseases that are not passed from person to person; whereas non-communicable diseases (NCD’s) cause 90 % of all deaths in the EU4
Amendment 540 #
Motion for a resolution Paragraph 14 14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes, in
Amendment 541 #
Motion for a resolution Paragraph 14 14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes in this regard such as in the fight against human papillomavirus transmission, hepatitis and bacterial infections leading to stomach cancer;
Amendment 542 #
Motion for a resolution Paragraph 14 14. Encourages the Commission and the Member States to work together in order to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes in this regard such as in the fight against human papillomavirus transmission;
Amendment 543 #
Motion for a resolution Paragraph 14 a (new) 14a. Stresses the importance of preventing non-communicable diseases and of early intervention by medical services; recognises that many non- communicable diseases set in from a very young age and that it is important to invest in strategies and programmes to foster children's healthy development and growth, from infancy and their first years of life; calls, therefore, on the Member States to revise their health systems to take better account of early interventions;
Amendment 544 #
Motion for a resolution Paragraph 14 a (new) 14a. Acknowledges that social, economic, cultural, and commercial determinants of health, and health inequities increase the risk of NCDs and underlines the need to create favourable conditions that address these factors; emphasizes the importance of a more robust implementation of the Health in All Policies principle, in dialogue with the public health community, and with thorough consideration of the health impacts of sectoral policies;
Amendment 545 #
Motion for a resolution Paragraph 14 a (new) 14a. Recognises the impact that the permacrisis, including the COVID-19 pandemic, Russia’s war of aggression against Ukraine, climate change, and the energy crisis, have on the insufficient actions taken on NCDs; calls on the Commission and Member States to prioritise NCD prevention and management as this would strengthen the resilience of healthcare systems and prepare for future shocks;
Amendment 546 #
Motion for a resolution Paragraph 14 a (new) 14a. Recognises the impact that the permacrisis, including the COVID-19 pandemic, war, climate change, and the energy crisis, have on the insufficient actions taken on NCDs; calls on the Commission and Member States to prioritise NCD prevention and management as this would strengthen the resilience of healthcare systems and prepare for future shocks;
Amendment 547 #
Motion for a resolution Paragraph 14 a (new) 14a. Highlights the importance of NCD prevention and early intervention; acknowledges that many NCDs have their origins in early childhood and stresses the importance of investing in strategies and programmes that promote children's healthy growth and development from infancy onwards;
Amendment 548 #
Motion for a resolution Paragraph 14 a (new) 14a. Calls on Member States to develop tailored national plans to address the specificities of different subcategories of NCDs, including specific plans for highly prevalent diseases, with high mortality and morbidity rates, such as cardiovascular diseases, diabetes and obesity;
Amendment 549 #
Motion for a resolution Paragraph 14 a (new) 14a. Stresses that primary prevention is crucial for reducing the occurrence of many types of NCDs; notes that secondary prevention is key for the optimal management of NCDs and contributes to reduce the risk of complications, comorbidities and death;
Amendment 55 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe; whereas other NCDs include mental and neurological disorders, kidney diseases, oral diseases, osteoporosis, osteoarthritis and endometriosis among other conditions, whereas they are also increasing in prevalence and require urgent action; whereas existing data gaps in certain disease areas can result in a misevaluation of the prevalence of these diseases and their burden;
Amendment 550 #
Motion for a resolution Paragraph 14 a (new) 14a. Calls for the implementation of prevention programmes to be inclusive by involving regions and municipalities, citizens, the social partners, civil society and patient organisations at all steps of the decision-making process,
Amendment 551 #
Motion for a resolution Paragraph 14 a (new) 14a. Acknowledges that many NCDs have their origins in early childhood and stresses the importance of investing in strategies and programmes that promote children’s healthy growth and development, from infancy and early years;
Amendment 552 #
Motion for a resolution Paragraph 14 b (new) 14b. Encourages the Commission and the Member States to further promote health literacy on NCDs’ risks and determinants as well as digital literacy that is linked to it, to develop educational tools for prevention, and to support the creation of e-learning platforms and applications; calls for particular attention be paid to disadvantaged, vulnerable, socially excluded and marginalised people, and underlines that specific awareness-raising campaigns for groups with particular health literacy needs are essential;
Amendment 553 #
Motion for a resolution Paragraph 14 b (new) 14b. Regrets the delay in the publication of the revision of the Food Information to Consumers Regulation (1169/2011) as foreseen under the Farm to Fork Strategy for the fourth quarter of 2022;
Amendment 554 #
14b. Welcome the approval of the 2022 Council Recommendations on Cancer Screening Recommendations in Europe which include comprehensive strategies for earlier detection of breast, cervical, colorectal cancer and extend recommended screenings in Europe for lung, prostate and gastric cancers;
Amendment 555 #
Motion for a resolution Paragraph 15 a (new) 15a. Points out that many people with NCDs (including diabetes in particular) in Europe are undiagnosed and unaware of their illness, and thus fail to get proper, timely treatment;
Amendment 556 #
Motion for a resolution Paragraph 15 15. Highlights the importance of identifying people with a high risk of developing NCDs and diagnosing people as early as possible to improve disease management, prevent complications and save downstream costs for healthcare
Amendment 557 #
Motion for a resolution Paragraph 15 15. Highlights the importance of identifying people with a high risk of developing NCDs and diagnosing people as early as possible to improve disease management, prevent life-altering complications and save downstream costs for healthcare systems; calls for the implementation of accessible and equitable self-management tools, including peer support networks, collaborative care platforms, and mental health services, considering factors like technology access;
Amendment 558 #
Motion for a resolution Paragraph 15 15. Highlights the importance of identifying people with a high risk of developing NCDs and diagnosing people
Amendment 559 #
Motion for a resolution Paragraph 15 15. Highlights the importance of identifying people with
Amendment 56 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs),
Amendment 560 #
Motion for a resolution Paragraph 15 15. Highlights the importance of identifying people with a high risk of developing NCDs and diagnosing people
Amendment 561 #
Motion for a resolution Paragraph 15 15. Highlights the importance of identifying people with a high risk of developing NCDs and diagnosing people as early as possible to improve disease management, prevent complications and save downstream costs for healthcare systems; points out, therefore, that people with NCDs are also more likely to suffer from other diseases;
Amendment 562 #
Motion for a resolution Paragraph 15 15. Highlights the importance of identifying people with a high risk of developing NCDs and diagnosing people as early as possible for example through the implementation of health checks and early detection programmes in order to improve disease management, prevent complications and save downstream costs for healthcare systems;
Amendment 563 #
15. Highlights the importance of identifying people with a high risk of developing NCDs and diagnosing people as early as possible to improve disease management, prevent complications and save downstream costs for healthcare systems; stresses, in this context, the importance of caring for children and adolescents, including with regard to their mental health;
Amendment 564 #
Motion for a resolution Paragraph 15 15. Highlights the importance of identifying people with a high risk of developing NCDs and diagnosing people as early as possible to improve disease management, prevent complications and save downstream costs for healthcare systems and calls for fair, accessible self- management tools to be set up;
Amendment 565 #
Motion for a resolution Paragraph 15 15. Highlights the importance of identifying people with a high risk of
Amendment 566 #
Motion for a resolution Paragraph 15 15. Highlights the importance of identifying people with a high risk of developing NCDs, such as the elderly population, and diagnosing people as early as possible to improve disease management, prevent complications and save downstream costs for healthcare systems;
Amendment 567 #
Motion for a resolution Paragraph 15 15. Highlights the importance of identifying as early as possible people with a high risk of developing NCDs and diagnosing people as early as possible to improve disease management, prevent complications and save downstream costs for healthcare systems;
Amendment 568 #
Motion for a resolution Paragraph 15 a (new) 15a. Welcomes the European Beating Cancer Plan; stresses the importance of early detection and that 25 Member States had introduced population-based screening programmes for breast cancer, 22 for cervical cancer and 20 for colorectal cancer in their National Cancer Control Plans in 2020; welcomes the 2022 Council Recommendation on strengthening prevention through early detection: A new EU approach on cancer screening which include strategies for earlier detection of breast, cervical, colorectal cancer and extend recommended screenings in Europe for lung, prostate and gastric cancers; 1a _________________ 1a https://health.ec.europa.eu/system/files/20 22-02/eu_cancer-plan_en_0.pdf: page 14
Amendment 569 #
Motion for a resolution Paragraph 15 a (new) Amendment 57 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in people aged 30-69 in Europe; whereas other NCDs include mental and neurological disorders (including depression, dementia and schizophrenia), kidney diseases, oral diseases, osteoporosis, osteoarthritis, Parkinson’s, multiple sclerosis and endometriosis, among other conditions;
Amendment 570 #
Motion for a resolution Paragraph 15 a (new) 15a. Welcomes the approval of the 2022 Council Recommendations on Cancer Screening Recommendations in Europe, which include comprehensive strategies for earlier detection of breast, cervical, colorectal cancer and extend recommended screenings in Europe for lung, prostate and gastric cancers;
Amendment 571 #
Motion for a resolution Paragraph 15 a (new) 15a. Welcomes the approval of the 2022 Council Recommendations on Cancer Screening Recommendations in Europe which include comprehensive strategies for earlier detection of breast, cervical, colorectal cancer and extend recommended screenings in Europe for lung, prostate and gastric cancers;
Amendment 572 #
Motion for a resolution Paragraph 15 a (new) 15a. Recommends EU funding support for pan-European public health literacy initiatives, such as the suggestion of creating a European Atlas of Early Warning Signs for Cancer, building on the model for cancer prevention created by the European Code Against Cancer;
Amendment 573 #
Motion for a resolution Paragraph 15 a (new) 15a. Recommends EU funding support for pan-European public health literacy initiatives, such as the suggestion of creating a European Atlas of Early Warning Signs for Cancer, building on the model for cancer prevention created by the European Code Against Cancer;
Amendment 574 #
Motion for a resolution Paragraph 15 a (new) Amendment 575 #
Motion for a resolution Paragraph 15 b (new) 15b. Recognising that NCDs operate within a broader context, calls for a systemic perspective that acknowledges the interconnected challenges faced by high-risk populations, such as limited access to education, green spaces, healthy foods, physical activity opportunities, healthcare systems, proper air quality, and suitable housing;
Amendment 576 #
Motion for a resolution Paragraph 15 b (new) 15b. Emphasises that NCD prevention and management, i.a. through improved therapeutic adherence and personalised care, can help lighten the burden of NCDs on healthcare systems and strengthen their resilience in the face of health crises and unexpected shocks;
Amendment 577 #
Motion for a resolution Paragraph 16 16. Calls on Member States to improve the access to social and healthcare services for vulnerable population, such as racial or ethnic minorities, children, elderly, socioeconomically disadvantaged, refugees, migrants, underinsured or those with certain medical conditions, that is marked by variability and disparities. Urges Member States to include in their health strategies the needs of vulnerable and high risk populations and tackle the health disparities rooted in legal barriers, economic limitations, language and cultural challenges, and discriminatory practices. Encourages Member States to reduce undiagnosed NCDs by introducing targeted health checks for high-risk individuals addressing the main shared metabolic risk factors, ensuring quality care and support NCD patients’ self- management;
Amendment 578 #
Motion for a resolution Paragraph 16 16. Encourages Member States to reduce undiagnosed NCDs by: fostering tailored approaches for the identification and continuous monitoring of patients at (high) risk of NCDs and/or co- morbidities, introducing targeted health checks for high-risk individuals addressing the main shared metabolic risk factors, ensuring quality care and support NCD patients’ self-
Amendment 579 #
Motion for a resolution Paragraph 16 16. Encourages the Member States to reduce undiagnosed NCDs by introducing targeted health checks for high-risk individuals, addressing the main shared metabolic risk factors, ensuring timely access to high-quality care and supporting NCD patients’ self-
Amendment 58 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe; whereas other NCDs include mental and neurological disorders, liver diseases , kidney diseases, oral diseases, Rheumatic and Musculoskeletal Diseases (RMDs), including osteoporosis, osteoarthritis and endometriosis among other conditions;
Amendment 580 #
Motion for a resolution Paragraph 16 16. Encourages Member States to reduce undiagnosed NCDs by introducing joint targeted health checks for high-risk individuals addressing the main shared metabolic risk factors
Amendment 581 #
Motion for a resolution Paragraph 16 16. Encourages Member States to reduce undiagnosed NCDs by introducing targeted health checks of
Amendment 582 #
Motion for a resolution Paragraph 16 16. Encourages Member States to reduce undiagnosed NCDs by introducing targeted health checks for high-risk individuals addressing the main shared metabolic risk factors, ensuring timely access to high quality care and support NCD patients’ self-
Amendment 583 #
Motion for a resolution Paragraph 16 16. Encourages Member States to reduce undiagnosed NCDs by introducing targeted health checks for high-risk individuals and individuals belonging to vulnerable and marginalised groups, addressing the main shared metabolic risk factors, ensuring quality care and support NCD patients’ self-
Amendment 584 #
Motion for a resolution Paragraph 16 16. Encourages Member States to
Amendment 585 #
Motion for a resolution Paragraph 16 16. Encourages Member States to reduce undiagnosed NCDs by introducing targeted health checks for high-risk individuals, also by promoting self-tests where appropriate and recommended by public health authorities, addressing the main shared metabolic risk factors, ensuring quality care and support NCD patients’ self-
Amendment 586 #
Motion for a resolution Paragraph 16 16. Encourages Member States to reduce undiagnosed NCDs by organising screening, introducing targeted health checks for high-risk individuals addressing the main shared metabolic risk factors, ensuring quality care and support NCD patients’ self-
Amendment 587 #
Motion for a resolution Paragraph 16 16. Encourages Member States to reduce undiagnosed NCDs by introducing targeted health checks for high-risk individuals addressing the main shared metabolic risk factors, ensuring timely access to high-quality care and support NCD patients’ self-
Amendment 588 #
Motion for a resolution Paragraph 16 16. Encourages Member States to reduce undiagnosed NCDs by introducing regular targeted health checks for high-risk individuals addressing the main shared metabolic risk factors, ensuring quality care and support NCD patients’ self- management;
Amendment 589 #
Motion for a resolution Paragraph 16 a (new) 16a. stresses the complexity of diagnosis in certain non-communicable diseases in childhood, such as Multiple Sclerosis, whose onset may be similar to that found in other inflammatory diseases of the central nervous system, stresses that diagnosis is crucial for the delivery of targeted and effective therapies;
Amendment 59 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe; whereas other NCDs include mental and neurological disorders, kidney diseases,
Amendment 590 #
Motion for a resolution Paragraph 16 a (new) 16a. Highlights the importance of early intervention in the case of mental health problems; stresses that daycares, schools and workplaces can play an important role in recognising mental health problems at early stages and that timely support can be provided; 1a _________________ 1a https://health.ec.europa.eu/system/files/20 23-06/com_2023_298_1_act_en.pdf
Amendment 591 #
Motion for a resolution Paragraph 17 17. Notes that some NCDs are closely
Amendment 592 #
Motion for a resolution Paragraph 17 17. Notes that some NCDs
Amendment 593 #
17. Notes that some NCDs are closely linked such as diabetes and cardiovascular diseases and that the interlinks between these conditions exacerbate their respective morbidity and mortality; further notes that important synergies can be achieved by improving diagnosis and integrated care19 ; _________________ 19 European Commission, ‘Healthier
Amendment 594 #
Motion for a resolution Paragraph 17 17. Notes that some NCDs are closely linked such as diabetes, chronic kidney diseases and cardiovascular diseases and that important synergies can be achieved by improving diagnosis, early detection, screening and integrated care19 ; _________________ 19 European Commission, ‘Healthier
Amendment 595 #
17. Notes that some NCDs are closely linked such as diabetes and cardiovascular diseases and cancer and depression and that important synergies can be achieved by improving diagnosis and integrated care19 ; 1a _________________ 1a https://www.ejcancer.com/article/S0959- 8049(16)32595-3/fulltext 19 European Commission, ‘Healthier
Amendment 596 #
Motion for a resolution Paragraph 17 17. Notes that some NCDs are closely linked such as
Amendment 597 #
Motion for a resolution Paragraph 17 17. Notes that some NCDs are closely linked such as diabetes, oral diseases and cardiovascular diseases or cancer and depression, and that important synergies can be achieved by improving diagnosis and integrated care
Amendment 598 #
Motion for a resolution Paragraph 17 17. Notes that some NCDs are closely linked such as diabetes, oral diseases and cardiovascular diseases and that important synergies can be achieved by improving diagnosis and integrated care19 ; _________________ 19 European Commission, ‘Healthier
Amendment 599 #
Motion for a resolution Paragraph 17 17. Notes that some NCDs are closely linked such as diabetes, oral diseases and cardiovascular diseases and that important synergies can be achieved by improving diagnosis and integrated care19 ; _________________ 19 European Commission, ‘Healthier
Amendment 6 #
Motion for a resolution Citation 3 a (new) Amendment 60 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory
Amendment 600 #
Motion for a resolution Paragraph 17 a (new) 17a. Calls on the Member States to pay enhanced attention to addressing the physical and psychological impacts of NCD and its treatment, including pain management, patient and carers access to psychological support, palliative and supportive care in their national health plans;
Amendment 601 #
Motion for a resolution Paragraph 17 a (new) Amendment 602 #
Motion for a resolution Paragraph 17 a (new) 17a. Recommends EU funding support for pan-European public health literacy initiatives, such as the suggestion of creating a European Atlas of Early Warning Signs for Cancer, building on the model for cancer prevention created by the European Code Against Cancer;
Amendment 603 #
Motion for a resolution Paragraph 17 a (new) 17a. Highlights the link between oral health, including pariodental disease and caries, and some NCDs, such as diabetes and cardiovascular diseases, and the potential positive effects on NCDs of improved oral health;
Amendment 604 #
Motion for a resolution Paragraph 17 a (new) 17a. Calls on Member States to develop, implement and monitor national NCD prevention plans that include risk reduction and secondary screening programmes for at-risk populations;
Amendment 605 #
Motion for a resolution Paragraph 17 b (new) 17b. Recognizing that NCDs operate within a broader context, calls for a systemic perspective that acknowledges the interconnected challenges faced by high-risk populations, such as limited access to education, green spaces, healthy foods, physical activity opportunities, healthcare systems, proper air quality, and decent, sustainable, affordable and adequately air-conditioned housing;
Amendment 606 #
Motion for a resolution Paragraph 18 b (new) 18b. Calls for inclusion of holistic treatment methods for NCD with the combination of conventional and complementary therapies, also known as integrative medicine, including fostering the development of a high quality multidisciplinary workforce to improve patients’ quality of life and well-being, including mental, psychosocial and nutritional support; calls for increased research investment to assess the validity of the integrative approach of NCD care and treatments; emphasises the importance of specific EU recommendations to improve the quality of life of patients, including via supportive care (pain relief, psychological services, adapted physical activity, nutritional support, integrative medicine, social assistance, access to reproductive health and restoration of aesthetic integrity); asks Member States for recognition of sequelae (physical or mental disabilities), as well as social discrimination;
Amendment 607 #
Motion for a resolution Paragraph 18 b (new) 18b. Regrets the disparities in terms of access to high-quality healthcare services among Member States, and also among different regions within Member States, and asks the Commission to address those disparities through the appropriate legislative measures in order to ensure equal rights in the EU;
Amendment 608 #
Motion for a resolution Paragraph 17 a (new) 17a. Expresses support for the creation of an EU Network of Comprehensive Cancer Centres, as a good case study for pan European action to improve access to high quality care and to deliver next level cooperation across borders in combating inequalities in access and improved research cooperation;
Amendment 609 #
Motion for a resolution Paragraph 17 b (new) 17b. Stresses that functioning, efficient and accessible public healthcare systems in all member states, with appropriate funding and support, are vital in the fight against NCDs; underlines the need to ensure equal access to primary care and healthcare services for all in the EU; is concerned about the widespread discrimination faced by EU citizens in the access to basic healthcare services, prevention services, screening programs and continuous care and treatments, for example for chronic diseases patients; calls on the Commission to propose legislative and regulatory measures to introduce minimum standards for healthcare services all across the EU in order to protect and promote people's health;
Amendment 61 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe; whereas other NCDs include mental and neurological disorders, liver and gastrointestinal diseases, kidney diseases, oral diseases, osteoporosis, osteoarthritis and endometriosis among other conditions;
Amendment 610 #
Motion for a resolution Paragraph 18 c (new) 18c. Emphasises the need to deploy person-centred, continued, and fully integrated care across the entire chronic diseases care pathway and to strengthen community and priority care, with a focus on chronic diseases requiring access to care across specialties and care levels; calls on the Member States to review and as appropriate advance their national models of care to this end, with the support of the Commission through the Recovery and Resilience Facility, guided by the European Semester process;
Amendment 611 #
Motion for a resolution Paragraph 18 d (new) 18d. Believes that the high interconnection between some NCDs, such as diabetes, cardiovascular diseases, renal diseases, obesity and mental health can exacerbate their respective morbidity and mortality, and therefore requires a holistic and integrated approach, complemented by disease specific priorities for action; notes the potential benefits of a comprehensive strategy, taking into account disease progression over the life course; calls on the Commission to develop an NCD prevention and management blueprint, complemented by disease-specific programmes including clear targets, benchmark indicators and a monitoring framework;
Amendment 612 #
Motion for a resolution Paragraph 18 a (new) 18a. Recalls that notwithstanding the lifting of most of the COVID-19 related restrictions, NCDs patients are still at higher risk in case of any coronavirus infection; stresses that these patients must be protected in their day-to-day lives and particularly during the access to public health services for their treatment and care; underlines the need to mantain an high level of surveillance on the new variants and the potential trends of COVID-19 and any other communicable diseases that could affect NCDs patients;
Amendment 613 #
Motion for a resolution Paragraph 18 18. Stresses that
Amendment 614 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners
Amendment 615 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners and other primary and proximity care professionals as well as patient organisations and the third sector at large have a significant role in referring patients for diagnostic tests and treating NCDs;
Amendment 616 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners
Amendment 617 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners, dental health professionals as well as patient organizations and other primary care professionals have a significant role in referring patients for diagnostic tests and treating NCDs; encourages the Member States to offer competency-based, inter- proffesional training to healthcare professionals to better identify high-risk individuals, prevent and treat NCDs according to the latest evidence- based studies;
Amendment 618 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners, oral health professionals, pharmacists, dieticians and other
Amendment 619 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners, dental practitioners and other primary care professionals have a significant role in referring patients for diagnostic tests and treating NCDs; encourages the Member States to offer inter-professional training to healthcare professionals to better identify high-risk individuals
Amendment 62 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe; whereas other NCDs include mental and neurological disorders, kidney diseases, liver and gastrointestinal diseases, oral diseases, osteoporosis, osteoarthritis and
Amendment 620 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners. dental health professionals, dietitians and nutritionists and other
Amendment 621 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners and other primary care professionals have a significant role in referring patients for diagnostic tests and treating NCDs; encourages the Member States to empower workforce with appropriate diagnostic tools and to offer training to healthcare professionals to better identify high-risk individuals and treat NCDs;
Amendment 622 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners
Amendment 623 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners, dental health professionals and other primary care professionals have a significant role in referring patients for diagnostic tests and treating NCDs; encourages the Member States to offer training to healthcare professionals to better identify high-risk individuals and treat NCDs;
Amendment 624 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners and other primary care professionals , as well as pharmacists, have a significant role in referring patients for diagnostic tests and treating NCDs; encourages the Member States to offer training to healthcare professionals to better identify high-risk individuals and treat NCDs;
Amendment 625 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners and other primary care professionals have a significant role in
Amendment 626 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners and other primary care professionals have a significant role in referring patients for early diagnostic tests and treating NCDs; encourages the Member States to offer training to healthcare professionals to better identify high-risk individuals and treat NCDs;
Amendment 627 #
Motion for a resolution Paragraph 18 18. Stresses that nurses, doctors, general practitioners and other primary care professionals have a significant role in referring patients for diagnostic tests and treating NCDs; encourages the Member States to offer training to healthcare professionals to better identify
Amendment 628 #
Motion for a resolution Paragraph 18 a (new) 18a. Is concerned about the lack of progress to support health and care workers on the ground in response to the unprecedented healthcare staff shortages in the EU.Call to the Commission and Member States to: a) reinforce social dialogue and promote collective bargaining as provided for in Directive (EU) 2022/2041, in particular with a view to improving wage-setting and working conditions for healthcare staff; b) Close the underinvestment gap in public healthcare systems, making full use of all available EU funds, such as EU4Health, Digital Europe Programme, Horizon Europe, the RRF, Cohesion Funds and Regional Development Funds; c) Ensure rural and deprived areas benefit from specific attention when investing EU funds in order to improve access to care for all; d) Take stronger action, including by leveraging the use of digital services, to support work-life balance measures for health and care staff in the EU; e) Define coordinated retention policies for health and care professionals in the EU, also in view of avoiding intra-EU competition; f) Call for and support the proposal of a Directive on psychosocial risk at work by the European Commission to better integrate the health impacts of work for health and care workers and improve prevention throughout Europe; g)Improve access to employment opportunities in the healthcare workforce for Migrants, Refugees and Asylum- Applicants residing in the EU via faster recognition of their degrees in health and care and facilitated access to education and language training; h) Address burn out in European hospitals and beyond;
Amendment 629 #
Motion for a resolution Paragraph 18 a (new) 18a. Stresses the importance of providing multidisciplinary holistic care, both preventive and curative, in which patients' lifestyle and dietary habits are improved and which allows for the personalisation of a patient's lifestyle and treatment system that facilitates maximum sustainability and health options, as offered by Integrative Medicine, scientifically recognised, approved by public health authorities and practiced by healthcare professionals; urges the Commission and Member States to prioritise the regulation, research, teaching and implementation of science- based Integrative Medicine in all the EU national healthcare systems;
Amendment 63 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe; whereas other NCDs include mental and neurological disorders, kidney, liver and gastrointestinal diseases, oral diseases, osteoporosis, osteoarthritis and endometriosis among other conditions
Amendment 630 #
Motion for a resolution Paragraph 18 a (new) 18a. recognises the critical impact of conflict of interest between public health objectives and the interests of industries producing alcohol, tobacco, and poorly nutritious and ultra-processed foods, acknowledges that the undue influence of these industries on health policies and strategies can hinder effective NCD prevention efforts and that just as transparency is vital in maintaining the integrity of public health, it is equally essential to implement stringent measures to mitigate conflicts of interest;
Amendment 631 #
Motion for a resolution Paragraph 18 a (new) 18a. Expresses support for the creation of an EU Network of Comprehensive Cancer Centres, as a good case study for pan European action to improve access to high quality care and to deliver next level cooperation across borders in combating inequalities in access and improved research cooperation;
Amendment 632 #
Motion for a resolution Paragraph 18 a (new) 18a. Calls on the Commission to develop a strategy for reversing the rising trend in numbers of Europeans living with diabetes; Encourages the Commission and the Member States to set up a working group that is capable of collecting data at national level and sharing of best practices;
Amendment 633 #
Motion for a resolution Paragraph 18 a (new) 18a. Encourages the Commission and Member States to embed engagement with patient organisations and people living with NCDs into all activities and initiatives related to the design and implementation of prevention and care activities;
Amendment 634 #
Motion for a resolution Paragraph 18 a (new) 18a. Stresses the importance of cost- effective healthcare, so that limited resources are put to the best use and to the use of patients in most need;
Amendment 635 #
Motion for a resolution Paragraph 18 a (new) 18a. Highlights that the pandemic exacerbated existing structural issues in the public health and care sectors, in particular workforce shortages;
Amendment 636 #
Motion for a resolution Paragraph 18 a (new) 18a. Calls for measures to address the shortage of health workers, which is essential to ensure access to care;
Amendment 637 #
Motion for a resolution Paragraph 18 b (new) Amendment 638 #
Motion for a resolution Paragraph 18 b (new) 18b. Recommends urgent actions, including a Commission level study on the current status and impacts of the EU’s health workforce shortage and increased investment in its availability measuring and mapping exercises at the EU level; supports the proposed actions by the European Commission to address the pan-European problem of medicines shortages, encourage re-shoring of production; recognises that health workforce shortage can be a worsening factor in the response to future health emergencies and therefore recommends that the European Health Emergency Response Authority (HERA) be provided with explicit mandate to map and propose remedial measures to combat health workforce shortage;
Amendment 639 #
Motion for a resolution Paragraph 18 b (new) 18b. Believes that the high interconnection between some NCDs, such as diabetes, cardiovascular diseases, renal diseases, obesity and mental health requires a holistic and integrated approach, complemented by disease specific priorities for action; notes the potential benefits of a comprehensive strategy, taking into account disease progression over the life course; calls on the Commission to develop an NCD prevention and management blueprint, complemented by disease-specific programmes including clear targets, benchmark indicators and a monitoring framework;
Amendment 64 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe; whereas other NCDs include mental and neurological disorders, kidney diseases, liver diseases, oral diseases, osteoporosis, osteoarthritis and endometriosis among other conditions;
Amendment 640 #
Motion for a resolution Paragraph 18 b (new) 18b. Urges the Commission to speed up the procedures to adopt a code of conduct for financial intermediaries, which recognises the right to be forgotten, cancer patients as a fundamental right for all European citizens, allowing former cancer patients access to financial services throughout Europe without discrimination;
Amendment 641 #
Motion for a resolution Paragraph 18 c (new) 18c. In line with a (mental) health in all policies approach, acknowledges that providing integrated care and support, in collaboration with local social and community services, is essential, as health and social needs are often intertwined;
Amendment 642 #
Motion for a resolution Paragraph 18 c (new) 18c. Encourages the Commission and Member States to embed engagement with patient organisations and people living with NCDs into all activities and initiatives related to the design and implementation of prevention and care activities;
Amendment 643 #
Motion for a resolution Paragraph 18 c (new) Amendment 644 #
Motion for a resolution Paragraph 18 d (new) 18d. Recognises that health workforce shortage was a pertinent element of the Covid-19 pandemic crisis and therefore recommends that that the European Health Emergency Response Authority (HERA) be provided with explicit mandate to map and propose remedial measures to combat health workforce shortage;
Amendment 645 #
Motion for a resolution Paragraph 18 d (new) 18d. Emphasises the need to deploy person-centred and fully integrated care across the entire chronic diseases care pathway and to strengthen community and priority care, with a focus on chronic diseases requiring access to care across specialties and care levels such as diabetes;
Amendment 646 #
Motion for a resolution Paragraph 18 d (new) 18d. Emphasises the need to deploy person-centred and fully integrated care across the entire chronic diseases care pathway and to strengthen community and priority care, with a focus on chronic diseases requiring access to care across specialties and care levels such as diabetes;
Amendment 647 #
Motion for a resolution Paragraph 18 e (new) 18e. Highlights the valuable role of community pharmacies and recognises their valuable contribution in continuously providing an essential and quality service to support the treatment of NCDs and keep the general public informed; stresses that pharmacists are an independent, reliable and trustworthy source of information; suggests that pharmacists play a more active role in pharmacovigilance activities to assess and monitor the effectiveness of medicines and invites Member States to include them in their health, care and research programmes; calls for greater recognition of pharmacies in rural areas, which enable such areas to retain their populations and ensure the well-being of citizens;
Amendment 648 #
Motion for a resolution Paragraph 18 e (new) 18e. Encourages the Commission and Member States to embed engagement with patient organisations and people living with NCDs into all activities and initiatives related to the design and implementation of prevention and care activities; emphasises the need to deploy person-centred and fully integrated care across the entire chronic diseases care pathway and to strengthen community and priority care, with a focus on chronic diseases requiring access to care across specialties and care levels such as diabetes;
Amendment 649 #
Motion for a resolution Paragraph 18 f (new) 18f. Calls to provide free and quality diagnostic services and checks and drugs for patients attending the NCD clinics for all NCD patients and give as a priority to the healthcare facility that provided the oncological and/or surgical treatment;
Amendment 65 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe; whereas other NCDs include mental and neurological disorders, kidney diseases, liver diseases, oral diseases, osteoporosis, osteoarthritis and endometriosis among other conditions;
Amendment 650 #
Motion for a resolution Paragraph 19 19. Believes that every patient is different and no NCD is the same; notes that for some NCDs, such as obesity, stigma in healthcare settings remains one of the biggest barriers to diagnose early and provide timely care and management services; calls for NCDs to be prevented and treated as effectively as possible, with a personalised and evidence-based approach tailored to the patient and the disease;
Amendment 651 #
Motion for a resolution Paragraph 19 19. Believes that every patient is different and no NCD is the same; calls for NCDs to be prevented and treated as effectively as possible, with a personalised approach tailored to the patient and the disease; calls on Member States to prioritize also training of health care professionals which enable them to support patients in engaging in their own treatment and in improving therapeutic adherence;
Amendment 652 #
19. Believes that every patient is different and no NCD is the same; calls for NCDs to be prevented and treated as effectively as possible, with a personalised and integrated approach tailored to the patient and the disease and in compliance with human rights obligations, which include meaningful engagement of users in every decision that impacts on them;
Amendment 653 #
Motion for a resolution Paragraph 19 19.
Amendment 654 #
Motion for a resolution Paragraph 19 19. Believes that every patient is
Amendment 655 #
Motion for a resolution Paragraph 19 19. Believes that every patient is different and no NCD is the same; calls for NCDs to be prevented and treated as effectively as possible, with a personalised approach tailored to the patient and the disease, while taking Member States' need for an efficient organisation of healthcare into account;
Amendment 656 #
Motion for a resolution Paragraph 19 19. Believes that every patient is different and no NCD is the same; calls for NCDs to be prevented and treated as effectively as possible, with a personalised approach tailored to the patient and the disease, and in compliance with human rights obligations;
Amendment 657 #
Motion for a resolution Paragraph 19 19. Believes that every patient is different and that no NCD is the same; calls for NCDs to be prevented and treated as effectively as possible, with a personalised, integrated and evidence- based approach tailored to the patient and the disease;
Amendment 658 #
Motion for a resolution Paragraph 19 19. Believes that every patient is different and no NCD is the same; calls for NCDs to be prevented and treated as effectively as possible, with a personalised and integrated approach tailored to the patient and the disease;
Amendment 659 #
Motion for a resolution Paragraph 19 19. Believes that every patient is
Amendment 66 #
Motion for a resolution Recital B B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe; whereas other NCDs include mental and neurological disorders, kidney diseases, liver diseases, oral diseases, osteoporosis, osteoarthritis and endometriosis among other conditions;
Amendment 660 #
Motion for a resolution Paragraph 19 a (new) 19a. Notes that the Covid-19 pandemic has highlighted how serious health threats can put severe pressure on the capacities of healthcare systems, with a negative impact on the provision of healthcare for patients with non- communicable diseases, such as the continuity of healthcare, delay of or interruption to treatment for patients and people with mental health issues1a; underlines that the impact of serious cross-border threats to health may thus pose further challenges in ensuring a high level of human health protection; stresses the need for Member States to anticipate and to monitor the impact of public health emergencies on the provision of healthcare services for other diseases and conditions, while respecting the responsibilities of Member States for the definition of their health policy and for the organisation and delivery of health services and medical care; _________________ 1a Invisible numbers: the true extent of NCDs and what to do about them. Geneva: World Health Organization; 2022.
Amendment 661 #
Motion for a resolution Paragraph 19 a (new) 19a. Underlines the impact of antimicrobial resistance on NCDs care and call for the accelerated implementation of the current action plans and specific global mechanisms for AMR surveillance, research and innovation and antimicrobial stewardship; highlights the need to support the development of novel antimicrobial agents, as well as to ensure their availability and affordability;
Amendment 662 #
Motion for a resolution Paragraph 19 a (new) 19a. Notes that NCDs can have a significant negative effect on mental health, and stresses the need for integrated healthcare for concerned patients; stresses that negative stereotypes related to certain NCDs, notably obesity, can be counterproductive in healthcare and prevention while recalling individual responsibility for certain risk factors;
Amendment 663 #
Motion for a resolution Paragraph 19 a (new) 19a. Acknowledges the urgency of ensuring a sufficient number of specialised health professionals in NCD care; recommends urgent actions, including a Commission level study on the current status and impacts of the EU’s health workforce shortages and increased investment in its availability measures and mapping exercises at EU level;
Amendment 664 #
Motion for a resolution Paragraph 19 a (new) 19a. Recommends funding support for pan-European public health literacy initiatives, such as the suggestion of creating a European Atlas of Early Warning Signs for Cancer, building on the model for cancer prevention created by the European Code Against Cancer;
Amendment 665 #
Motion for a resolution Paragraph 19 a (new) Amendment 666 #
Motion for a resolution Paragraph 19 a (new) 19a. Urges Member States to provide training to healthcare professionals on the social and environmental determinants of health, including racism and mental health, as well as on intersectoral collaboration, integrated service provision, and human rights;
Amendment 667 #
Motion for a resolution Paragraph 19 a (new) 19a. Considers that each patient faces different obstacles in keeping to their treatment for NCDs; calls on the Member States to offer a range of training courses for health-care professionals in providing patients with therapeutic education;
Amendment 668 #
Motion for a resolution Paragraph 19 a (new) 19a. Calls on the European Commission and the Member States to promote targeted initiatives to reduce healthcare disparities and ensure equitable access to NCDs prevention and treatment services for individuals coming from marginalised backgrounds;
Amendment 669 #
Motion for a resolution Paragraph 19 a (new) 19a. Recommends urgent actions, including a Commission level study on the current status and impacts of the EU’s health workforce shortage and increased investment in its availability measuring and mapping exercises at the EU level;
Amendment 67 #
Motion for a resolution Recital B Amendment 670 #
Motion for a resolution Paragraph 19 a (new) 19a. Recommends urgent actions, including a Commission level study on the current status and impacts of the EU’s health workforce shortage and increased investment in its availability measuring and mapping exercises at the EU level;
Amendment 671 #
Motion for a resolution Paragraph 19 a (new) 19a. Invites the Commission and Member States to promote basic and clinical research on the use and potential beneficial effects of medical ozone for its complementary use in prevention and treatment of different NCDs;
Amendment 672 #
Motion for a resolution Paragraph 19 a (new) 19a. Encourages the Member States to provide regular information to the public on the risk of these diseases and the need for regular checks and examinations to be conducted to detect them as early as possible;
Amendment 673 #
Motion for a resolution Paragraph 19 a (new) 19a. Recommends formulating comprehensive guidelines to enhance NCD management within primary care settings, with an emphasis on advocating for consistent and efficient treatment approaches;
Amendment 674 #
Motion for a resolution Paragraph 19 a (new) 19a. Highlights the importance of addressing social determinants, health literacy, and digital literacy to reduce the overall burden of NCDs;
Amendment 675 #
Motion for a resolution Paragraph 19 a (new) 19a. Invites the Commission to publish a study on the current state of affairs in respect of and the impact of the shortage of health-care workers in the European Union;
Amendment 676 #
Motion for a resolution Paragraph 19 b (new) 19b. Believes that the high interconnection between some NCDs, such as diabetes, cardiovascular diseases, renal diseases, obesity and mental health requires a holistic and integrated approach, complemented by disease specific priorities for action; notes the potential benefits of a comprehensive strategy, taking into account disease progression over the life course; calls on the Commission to develop an NCD prevention and management blueprint, complemented by disease-specific programmes including clear targets, benchmark indicators and a monitoring framework;
Amendment 677 #
Motion for a resolution Paragraph 19 b (new) 19b. Calls for the adoption of an EU strategy to anticipate and monitor the impacts of serious health threats on people affected by communicable and non-communicable diseases/other diseases or conditions; proposes to constitute a European NCD specialists emergency reserve composed of voluntary NCDs experts trained and ready to be deployed to ensure care to people living with NCDs in any Member State or neighboring country in crisis time;
Amendment 678 #
Motion for a resolution Paragraph 19 b (new) 19b. Calls on the Commission to support Member States in reviewing national models of care with a focus on prevention-oriented primary care systems and the upskilling of primary care professionals, even through the Recovery and Resilience Facility, guided by the European Semester process, to reduce inequities across Member States, and improve the resilience of national health systems;
Amendment 679 #
Motion for a resolution Paragraph 19 b (new) 19b. Calls on the Commission to support Member States in reviewing national models of care with a focus on prevention-oriented primary care systems and the upskilling of primary care professionals, through the Recovery and Resilience Facility, to reduce inequities across Member States, and improve the resilience of national health systems;
Amendment 68 #
Motion for a resolution Recital B a (new) Ba. whereas antimicrobial resistance (AMR) significantly disrupts medical procedures like surgeries, dental implants, cancer treatments, and organ transplants; AMR also complicates the management of prevalent NCDs, including cardiovascular diseases, dementias, and tumours1a; whereas the repercussions of AMR on disease incidence, mortality rates, hospital stays, and healthcare expenses; _________________ 1a https://www.europarl.europa.eu/RegData/ etudes/BRIE/2023/740238/EPRS_BRI(20 23)740238_EN.pdf
Amendment 680 #
Motion for a resolution Paragraph 19 b (new) 19b. Emphasizes that the results of NCDs treatment can be hampered by malnutrition, therefore optimal nutritional care is an essential part of NCDs care; calls on the Commission and Member States to develop recommendations for incorporating clinical nutrition into all aspects of NCDs care, including treatment, support and research;
Amendment 681 #
Motion for a resolution Paragraph 19 b (new) 19b. Strongly welcomes digital health solutions such as telemedicine, which can enable better accesses to healthcare in rural areas as well protect immunosuppressed NCD patients from exposure to infectious diseases;
Amendment 682 #
Motion for a resolution Paragraph 19 b (new) 19b. Notes that improving disease management, notably through therapeutic adherence, and reducing complications of NCDs plays a key role in improving health systems’ resilience and preparing for future health crises;
Amendment 683 #
Motion for a resolution Paragraph 19 b (new) 19b. Notes that improving disease management, notably through therapeutic adherence, and reducing complications of NCDs plays a key role in improving health systems’ resilience and preparing for future health crises;
Amendment 684 #
Motion for a resolution Paragraph 19 b (new) 19a. Considers that health-care systems need to focus research on the early detection of NCDs, as well as overall improvements in the management of these various diseases;
Amendment 685 #
Motion for a resolution Paragraph 19 b (new) 19a. Notes the growing labour shortages in the health-care sector in Europe, which are jeopardising access to good-quality, integrated care for NCDs;
Amendment 686 #
Motion for a resolution Paragraph 19 c (new) 19c. Urges Member States to provide training to healthcare professionals on the social and environmental determinants of health and on patient therapeutic education, and ensure they have the necessary resources to provide appropriate guidance to their patients; underlines the importance of constant training for health professionals to keep them updated on new treatment options;
Amendment 687 #
Motion for a resolution Paragraph 19 c (new) Amendment 688 #
Motion for a resolution Paragraph 19 c (new) 19c. Calls on Member States to continue investing in innovation in NCDs care, in order to reduce overall morbidity, mortality and the quality of life of patients; calls on the European Union to support more these investments through EU funding mechanisms, such as the EU4Health and Horizon Europe programmes;
Amendment 689 #
Motion for a resolution Paragraph 19 c (new) 19c. Urges Member States to provide training to healthcare professionals on the social and environmental determinants of health, including racism and mental health, as well as on intersectoral collaboration, integrated service provision, and human rights;
Amendment 69 #
Ba. whereas cardiovascular diseases are the leading cause of death in the European Union, accounting for 37% of annual deaths, there is a significant gap between Eastern and Northern countries compared to the rest, and they affect women and people with poorer socioeconomic conditions more;
Amendment 690 #
Motion for a resolution Paragraph 19 c (new) 19c. Urges Member States to provide training to healthcare professionals on the social and environmental determinants of health, including racism, as well as on inter-sectoral collaboration, integrated service provision, and human rights;
Amendment 691 #
Motion for a resolution Paragraph 19 c (new) 19c. Stresses the urgent need to tackle regional disparities in healthcare access, striving for equitable availability of quality NCD management across diverse geographical areas within Member States;
Amendment 692 #
Motion for a resolution Paragraph 19 d (new) 19d. Believes that the high interconnection between some NCDs, such as diabetes, cardiovascular diseases, renal diseases, obesity and mental health requires a holistic and integrated approach, complemented by disease specific priorities for action; notes the potential benefits of a comprehensive strategy, taking into account disease progression over the life course; calls on the Commission to develop an NCD prevention and management blueprint, complemented by disease-specific programmes including clear targets, benchmark indicators and a monitoring framework;
Amendment 693 #
Motion for a resolution Paragraph 19 d (new) 19d. Asks for enhanced communication between health professionals, patients, survivors, caregivers, parents and public authorities regarding the effectiveness and safety of health interventions, in particular NCDs’ diagnosis and treatment, and for increased awareness campaigns for prevention in times of crisis;
Amendment 694 #
Motion for a resolution Paragraph 19 d (new) 19d. Takes note of Europe’s increasing healthcare workforce shortages and inadequate skill mix as a threat to the provision of good quality integrated care for NCDs; calls on the Commission and Member States to address the imbalance between the demand and supply of specialised NCD health professionals;
Amendment 695 #
Motion for a resolution Paragraph 19 d (new) 19d. Highlights the increased vulnerability of people living with NCDs effected by extreme weather events and other impacts of climate change and therefore calls for targeted measures in climate change mitigation and adaptation policies;
Amendment 696 #
Motion for a resolution Paragraph 19 d (new) 19d. Highlights the increased vulnerability of people living with NCDs to extreme weather events and other impacts of climate change and therefore calls for targeted measures in climate change mitigation and adaptation policies;
Amendment 697 #
Motion for a resolution Paragraph 19 e (new) 19e. Calls on the Member States and relevant authorities to recognise the pivotal role of informal carers, integrate them into health and care teams and empower them with the possibility of making informed choices regarding available supportive measures with the support of healthcare professionals; recognises that the COVID-19 pandemic has exacerbated the crucial role of informal carers, who provide most of the daily care for NCDs patients and who face a clear lack of practical and policy support, including as regards social rights, training, psychological help, information and recognition; points to the high percentage of informal carers among the EU population and to the disparities regarding the way in which they are supported and how their rights are recognised across Member States; calls on the Commission to consider the formalisation of informal care, which would ensure the recognition of a certain minimum standard of rights, especially for those who are providing long-term care;
Amendment 698 #
Motion for a resolution Paragraph 19 e (new) 19e. Calls on the Commission to support Member States in reviewing national models of care with a focus on prevention-oriented primary care systems and the upskilling of primary care professionals, through the Recovery and Resilience Facility, guided by the European Semester process, to reduce inequities across Member States, and improve the resilience of national health systems;
Amendment 699 #
Motion for a resolution Paragraph 19 e (new) 19e. Expresses support for the creation of an EU Network of Comprehensive Cancer Centres, as a good case study for pan European action to improve access to high quality care and to deliver next level cooperation across borders in combating inequalities in access and improved research cooperation;
Amendment 7 #
Motion for a resolution Citation 3 a (new) – having regard to to its resolution of 15 January 2020 on the European Green Deal (2019/2956(RSP))and the Commission communication of 11 December 2019 on the European Green Deal (COM(2019)0640),
Amendment 70 #
Motion for a resolution Recital B a (new) Ba. whereas obesity is the fourth largest cause of premature deaths globally with an estimated 4.7 million deaths1a; whereas there are over 200 medical complications of obesity; _________________ 1a GBD 2017 Risk Factor Collaborators – “Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017”
Amendment 700 #
Motion for a resolution Paragraph 19 e (new) 19e. Stresses the urgent need to tackle regional disparities in healthcare access, striving for equitable availability of quality NCD management across diverse geographical areas within Member States;
Amendment 701 #
Motion for a resolution Paragraph 19 f (new) 19f. Calls on Member States to continue investing in innovation in NCDs care, in order to reduce overall morbidity, mortality and the quality of life of patients; calls on the European Union to support these investments through EU funding mechanisms, such as the EU4Health and Horizon Europe programmes;
Amendment 702 #
Motion for a resolution Paragraph 19 g (new) 19g. Calls on Member States to modernise diabetes care, through early diagnosis and timely treatment intensification as per the latest treatment guidelines, avoiding therapeutic inertia and contributing to achieve better health outcome targets, and reducing the risk of costly complications;
Amendment 703 #
Motion for a resolution Paragraph 19 h (new) 19h. Welcomes the "patient-centricity" approach of the Europe's Beating Cancer Plan, and in particular the flagship initiative under the EU4Health 2021-2027 programme to develop a smart card for cancer survivors - in the form of a mobile app - to improve the health and well-being of cancer survivors across Europe;
Amendment 704 #
Motion for a resolution Paragraph 20 20. Recalls that patient empowerment
Amendment 705 #
Motion for a resolution Paragraph 20 20. Recalls that patient empowerment and health literacy
Amendment 706 #
Motion for a resolution Paragraph 20 20. Recalls that patient empowerment and health literacy are crucial for an EU NCD strategy and that prevention, reduction of behavioral risk factors, treatment and care should be patient- centred; encourages the promotion of services resulting in well-informed patients who are actively involved in their own prevention, reduction of behavioral risk factors and treatment and calls for the therapeutic training of caregivers and patients, and their empowerment in the care programmes, including those focusing on reduction of risk;
Amendment 707 #
Motion for a resolution Paragraph 20 20. Recalls that patient empowerment
Amendment 708 #
Motion for a resolution Paragraph 20 20. Recalls that patient empowerment and health literacy are crucial for an EU NCD strategy and that treatment, treatment adherence and care should be patient- centred; encourages the promotion of well- informed patients who are actively involved in their own treatment and calls for the therapeutic training of caregivers and patients and their empowerment in the care programmes;
Amendment 709 #
Motion for a resolution Paragraph 20 20. Recalls that patient empowerment and health literacy are crucial for an EU NCD strategy and that early detection, treatment and care should be patient- centred; encourages the promotion of well- informed patients who are actively involved in their own treatment and calls for the therapeutic training of caregivers and patients and their empowerment in the care programmes;
Amendment 71 #
Ba. whereas the ‘Health in All Policies’ and ‘One Health’ approaches should be promoted further, and efforts to fight non-communicable diseases should be integrated into all EU policies;
Amendment 710 #
Motion for a resolution Paragraph 20 a (new) 20a. Highlights that patient stigma should be counteracted and mitigated at the national level;
Amendment 711 #
Motion for a resolution Paragraph 21 21. Notes the need to focus on the quality of life of NCD patients whose illnesses cannot be cured but may be stabilised for a number of years; emphasises the importance of specific EU recommendations to improve the quality of life of patients including by integrating comprehensive supportive care into care, starting with the diagnosis and continuing over the course of the disease and by granting access to specialised support centres, by helping Member States to set up comprehensive cancer centres with multidisciplinary professional teams for example;
Amendment 712 #
Motion for a resolution Paragraph 21 21. Notes the need to focus on the quality of life of NCD patients whose illnesses cannot be cured but may be stabilised for a number of years; emphasises the importance of specific EU recommendations to improve the quality of life of patients including by integrating comprehensive supportive
Amendment 713 #
Motion for a resolution Paragraph 21 21. Notes the need to focus on the quality of life of NCD patients whose illnesses cannot be cured but may be stabilised
Amendment 714 #
Motion for a resolution Paragraph 21 21. Notes the need to focus on the quality of life of NCD patients whose illnesses cannot be cured but may be stabilised for a number of years; emphasises the importance of specific EU recommendations to improve the quality of life of patients, including by integrating comprehensive supportive and psychological care into care
Amendment 715 #
Motion for a resolution Paragraph 21 21. Notes the need to focus on the quality of life of NCD patients whose illnesses cannot be cured but may be stabilised for a number of years; emphasises the importance of specific
Amendment 716 #
Motion for a resolution Paragraph 21 21. Notes the need to focus on the quality of life of NCD patients whose illnesses cannot be cured but may be stabilised
Amendment 717 #
Motion for a resolution Paragraph 21 a (new) 21a. Supports modern solutions, including digital ones, aimed at patients with NCDs; emphasises that such solutions – such as helplines or mobile applications that are available to patients and their families to help them obtain the necessary information on procedures, what to do when disease is detected, treatment and dates of examinations – are extremely useful tools that simplify the treatment process and make life easier for patients; points out that the existence of such solutions supports patients and helps them find answers to any questions or concerns they may have;
Amendment 718 #
Motion for a resolution Paragraph 21 a (new) 21a. Address the urgent need to tackle regional disparities in healthcare access, striving for equitable availability of quality NCD management across diverse geographical areas within Member States. Explore innovative methods to enhance access to NCD healthcare, such as mobile clinics, trauma-informed teams, and peer advocates. This strategy aims to not only bridge gaps in healthcare access but also to foster a patient-centred and personalized approach to NCD prevention and treatment
Amendment 719 #
Motion for a resolution Paragraph 21 a (new) 21a. Considers that regional disparities in access to health care must be addressed as a matter of urgency stresses the need to look into innovative methods of improving access to health care, such as mobile clinics, with a view to fostering a personalised, patient-centred approach to the prevention and treatment of NCDs;
Amendment 72 #
Motion for a resolution Recital B b (new) Bb. whereas there are about 20 million people who have survived cancer in Europe1a and only seven EU countries recognise the 'right to be forgotten' for former cancer patients therefore continue to experience difficulties in accessing financial services like insurance or mortgages, years after successfully completing treatment; _________________ 1a https://ecpc.org/policy/the-right-to-be- forgotten/
Amendment 720 #
Motion for a resolution Paragraph 21 a (new) 21a. Highlights that patient- centredness and participatory decision- making must be at the heart of treatment and care development processes; encourages the promotion of well- informed patients who are actively involved in their own treatment and calls for the therapeutic education of caregivers and patients and their empowerment in the care programmes;
Amendment 721 #
Motion for a resolution Paragraph 21 a (new) 21a. Stresses that NCDs’ patients should not suffer a ‘double punishment’ in their daily lives; calls for the adoption of an anti-discrimination directive, as well as for the fair and equal implementation of directives on financial services, such as the Consumer Credit Directive, without any discrimination against NCDs’ patients and survivors;
Amendment 722 #
Motion for a resolution Paragraph 21 a (new) 21a. Stresses the urgent need to combat regional disparities in access to health care by striving to ensure availability of quality NCD management on an equitable basis in different geographical areas within Member States with a view to eradicating medical deserts;
Amendment 723 #
Motion for a resolution Paragraph 21 a (new) Amendment 724 #
Motion for a resolution Paragraph 21 b (new) 21b. Encourages the Member States to take into account the frequent exhaustion of the families and relatives of NCDs patients and to provide them with psychological and socioeconomic assistance, especially to the most vulnerable, and rest periods in the workplace, throughout the course of the disease, as well as with bereavement support; encourages, furthermore, the development of integrated, adequate and accessible support schemes for NCDs’ patients and their families, that take health, community and social services into account;
Amendment 725 #
Motion for a resolution Paragraph 21 b (new) 21b. Stresses the pivotal role of informal care-givers, who provide patients with NCDs with the majority of their day- to-day care and who are lacking in support (in terms of social rights, training, psychological help, information and recognition); calls on the Commission and the Members States to set up online training platforms as well as therapeutic care programmes granting qualifications and recognising their skills;
Amendment 726 #
Motion for a resolution Paragraph 21 c (new) 21c. Acknowledges the central role of independent patients’ and carers’ associations in relation to patient advocacy and accompaniment, services provided to NCDs’ patients and caregivers, dissemination of health literacy, awareness raising and ongoing support both at EU and national level; calls on the Commission and the Member States to take into account the formal participation of these associations, as well as their requests and recommendations, when formulating NCDs’ policies and legislation, and to provide them with public support in the form of both operating grants and project-related grants in order to guarantee their independence from private funding; calls on the Commission to set clear criteria according to which public financial support can be awarded.
Amendment 727 #
Motion for a resolution Paragraph 22 22.
Amendment 728 #
Motion for a resolution Paragraph 22 22. Welcomes the pharmaceutical package and calls for the strengthening of the European medicines market to ensure access to medicines and alleviate medicine shortages
Amendment 729 #
Motion for a resolution Paragraph 22 22. Welcomes the pharmaceutical package and calls for the strengthening of the European medicines market to ensure a
Amendment 73 #
Motion for a resolution Recital C C. whereas NCDs account for the largest
Amendment 730 #
Motion for a resolution Paragraph 22 22. Welcomes the pharmaceutical package of April 26 2023, and calls for the strengthening of the European medicines market to ensure access to medicines and alleviate medicine shortages, reduce barriers to cross-border
Amendment 731 #
Motion for a resolution Paragraph 22 22. Welcomes the pharmaceutical package and calls for
Amendment 732 #
Motion for a resolution Paragraph 22 22. Welcomes the pharmaceutical package and calls for the strengthening of the European medicines market to ensure access to medicines and alleviate medicine shortages, reduce barriers to cross-border business, while strengthening incentives for investment in innovation; underlines that in many cases the immediate availability of precise and appropriate medicines can hinder the irreversible degeneration of certain diseases; underlines that data protection and intellectual property rights are crucial to ensure competitiveness in the EU by incentivising innovators to develop new products and further ongoing research efforts;
Amendment 733 #
Motion for a resolution Paragraph 22 22. Welcomes the pharmaceutical package and calls for the strengthening of the European medicines market to ensure access to medicines and alleviate medicine shortages
Amendment 734 #
Motion for a resolution Paragraph 22 22. Welcomes the pharmaceutical package and calls for the strengthening of the European medicines market to ensure access to medicines and alleviate medicine shortages, reduce barriers to cross-border business, while strengthening incentives for investment in innovation; underlines that data protection and intellectual property rights are crucial to ensure competitiveness in the EU by incentivising innovators to develop new products and further ongoing research efforts; notes that a narrow definition of unmet medical need can harm development of important therapies for people living with NCDs;
Amendment 735 #
Motion for a resolution Paragraph 22 22. Welcomes the pharmaceutical package and calls for the strengthening of the European medicines market to ensure access to medicines and innovative treatments such as Advanced Therapy Medicinal Products (ATMPs) and alleviate medicine shortages, reduce barriers to cross-border business, while strengthening incentives for investment in innovation; underlines that data protection and intellectual property rights are crucial to ensure competitiveness in the EU by incentivising innovators to develop new products and
Amendment 736 #
Motion for a resolution Paragraph 22 22. Welcomes the pharmaceutical package and calls for the strengthening of the European medicines market to ensure access to medicines and alleviate medicine shortages, reduce barriers to cross-border business, while strengthening incentives for investment in innovation; underlines that upheld regulatory data protection and intellectual property rights are crucial to ensure competitiveness in the EU by incentivising innovators to develop new products and further ongoing research efforts;
Amendment 737 #
Motion for a resolution Paragraph 22 22. Welcomes the pharmaceutical package and calls for the strengthening of the European medicines market to ensure access to affordable medicines and alleviate medicine shortages, reduce barriers to cross-border business, while strengthening incentives for investment in innovation; underlines
Amendment 738 #
Motion for a resolution Paragraph 22 a (new) 22a. Stresses the need for the publication of concrete and legally binding shortage management and prevention plans as part of the medicine supply obligations of marketing authorisation holders based on an analysis of the manufacturing and distribution risks, including minimum stock levels, measures allowing for the diversification of raw materials supply sources, and the development of other manufacturing sites when necessary;
Amendment 739 #
Motion for a resolution Paragraph 22 a (new) 22a. Welcomes the creation of the IPCEI on Health to support innovation and to improve quality and access to care for European patients; considers the Health IPCEI should facilitate the development of innovative and greener technologies and production processes for drug manufacturing, of gene and cell therapies and innovation in strategic treatments;
Amendment 74 #
Motion for a resolution Recital C C. whereas NCDs account for the largest share of countries’ healthcare expenditures,
Amendment 740 #
Motion for a resolution Paragraph 22 a (new) 22a. Calls for the incorporation of an equitable approach for digital healthcare strategies: quality and safety of technology should be ensured and inequities in access be addressed, technology as an option should be discussed and agreed upon by the main healthcare professional and the patient in a process of shared decision-making;
Amendment 741 #
Motion for a resolution Paragraph 22 a (new) 22a. Stresses that public production, through democratic public undertakings, with an active role for health system users and trade unions, should be part of an effective public health strategy; urges that public production of this kind should cover all health products;
Amendment 742 #
Motion for a resolution Paragraph 22 a (new) 22a. Calls on Member States to identify and remove policy barriers to optimal NCDs care, improving adherence to clinical guidelines and reducing the risk of complications;
Amendment 743 #
Motion for a resolution Paragraph 22 b (new) 22b. Calls on the Commission and Member States to map out and address barriers to both human and analogue insulin, and to ensure affordability for both users and national health systems;
Amendment 744 #
Motion for a resolution Paragraph 22 b (new) 22b. calls for the creation of a European Medicines Infrastructure for pharmaceutical R&D in the public interest, with a public-driven R&D agenda and laboratory capacity;
Amendment 745 #
Motion for a resolution Paragraph 22 b (new) 22b. Considers that the future European Sovereignty Fund could help restore EU's strategic autonomy on medical products;
Amendment 746 #
Motion for a resolution Paragraph 22 c (new) 22c. recalls resolution WHO 72.8 on “improving the transparency of markets for medicines, vaccines and other health products” which explicitly urges member states, through their national legislative framework, to take steps to enhance dissemination and access to the cost of clinical trials; calls on the EMA and the European Commission to take steps in this regards;
Amendment 747 #
22c. Calls for the adoption of a Critical Medicines Act to support the European green, digital manufacturing of critical medicines, APIs and intermediate ingredients to diversify the EU pharmaceutical supply chains and to secure the strategic autonomy of critical medicines, in parallel of the review of the European pharmaceutical legislation;
Amendment 748 #
Motion for a resolution Paragraph 22 d (new) 22d. Notes that NCDs’ patients are frequently affected by medicine shortages and that severe disruptions in the supply of their treatments are highly detrimental to them, their carers and their families; calls on the Commission and the Member States to work together to prevent and manage shortages of all medicines and medical products and of NCDs medicines in particular, including shortages of inexpensive essential NCDs medicines; supports the development of a common basket of NCDs’ drugs of which there may be shortages to ensure that patients have continuous access to appropriate treatment, based on transparently and appropriately defined patient needs;
Amendment 749 #
Motion for a resolution Paragraph 22 e (new) 22e. Calls for the reinforcement and diversification of the supply chain of medicines within the EU, close monitoring of supply tensions and shortages, and the creation of a strategic stockpile of critical medicines, active ingredients and raw materials, particularly where the number of suppliers is limited; stresses the importance of the role of sustainable procurement practices in preventing medicine shortages;
Amendment 75 #
Motion for a resolution Recital C C. whereas NCDs account for the largest share of countries’ healthcare expenditures
Amendment 750 #
Motion for a resolution Paragraph 22 f (new) 22f. Urges the Commission to submit a proposal for the revision of Council Directive 89/105/EEC on the transparency of measures regulating the prices of medicinal products in order to ensure effective scrutiny and greater transparency of the procedures used to determine the price of and reimbursement amount for medicines, particularly cancer medicines, in all Member States;
Amendment 751 #
22g. Insists on the need to ensure equal access to affordable drugs to every European citizen; calls for collective negotiation on the price of medicines with pharmaceutical industries, as per the Beneluxa Initiative on Pharmaceutical Policy and the Valetta Declaration;
Amendment 752 #
Motion for a resolution Paragraph 22 h (new) 22h. Strongly advocates the extension of joint procurement procedures for NCDs medicines to counter shortages and improve affordability and access to those treatments at EU level; recalls that Joint Procurement Agreements should be carried out in a transparent, timely and effective way; underlines, in this respect, that clear and transparent stages for the process, scope, tender, specifications, timelines and formalities should be defined;
Amendment 753 #
Motion for a resolution Paragraph 22 i (new) Amendment 754 #
Motion for a resolution Paragraph 23 Amendment 755 #
Motion for a resolution Paragraph 23 23. Welcomes public-private partnerships as a way of strengthening innovation in healthcare; highlights the European Health Innovation Collaborative, which promotes entrepreneurship and innovation in the healthcare sector and
Amendment 756 #
Motion for a resolution Paragraph 23 23. Highlights the potential of the private sector with respect to disease control and healthcare; Welcomes public- private partnerships as a way of strengthening innovation in healthcare; highlights the European Health Innovation Collaborative, which promotes entrepreneurship and innovation in the healthcare sector and brings together academia, research, and industry to foster collaboration and investment in health technologies; encourages the Commission and the Member States to foster and accelerate public-private partnerships;
Amendment 757 #
Motion for a resolution Paragraph 23 23. Welcomes public-private partnerships as a way of strengthening innovation in healthcare; highlights the European Health Innovation Collaborative, which promotes entrepreneurship and innovation in the healthcare sector and brings together academia, research, and industry to foster collaboration and investment in health technologies; encourages the Commission and the Member States to foster and accelerate public-private partnerships only if they have strong leadership of the public health sector ;
Amendment 758 #
Motion for a resolution Paragraph 23 23. Welcomes public-private partnerships as a way of strengthening innovation in healthcare; highlights the European Health Innovation Collaborative, which promotes entrepreneurship and innovation in the healthcare sector and brings together academia, research, and industry to foster collaboration and investment in health technologies; encourages the Commission and the Member States to foster and accelerate public-private partnerships with the caveat of measures to protect public interest;
Amendment 759 #
Motion for a resolution Paragraph 23 a (new) 23a. Stresses the importance of innovations to improve the detection, diagnosis, management and treatment of NCDs; for instance, the development of high-quality medical technologies has improved clinical and procedural outcomes and quality of life of people living with cardiovascular diseases;
Amendment 76 #
Motion for a resolution Recital C C. whereas NCDs account for the largest share of countries’ healthcare expenditures, costing EU economies EUR
Amendment 760 #
Motion for a resolution Paragraph 23 a (new) 23a. Calls on the Commission and the Member States to create European Medicine R&D infrastructure Hub that would work based on priorities set by the scientific communities and public health- policy authorities with a focus on improving NCDs treatments and care;
Amendment 761 #
Motion for a resolution Paragraph 23 a (new) Amendment 762 #
Motion for a resolution Paragraph 23 a (new) 23a. Highlights that publicly funded research should prioritise promising products and methods characterised by limited commercial interest, non- patentability, and low benefits in scaleability;
Amendment 763 #
Motion for a resolution Paragraph 23 b (new) 23b. Calls on the Commission and the Member States to establish a network of European non-profit pharmaceutical undertakings which operate in the public interest to manufacture priority medicinal products for health care with a focus on improving NCDs treatments accessibility, guarantees supplies and avoid medicine shortages;
Amendment 764 #
Motion for a resolution Paragraph 24 Amendment 765 #
Motion for a resolution Paragraph 24 24. Calls on the Commission to strengthen support and investment in the development of new innovative medical devices; believes that new technologies can lead to new and better treatments for NCDs; notes the slow uptake of medical devices under the current Medical Devices Regulation and In Vitro Diagnostic Devices Regulation, and welcomes the postponement of application of certain provisions; calls on the Commission to evaluate the specific needs for the pediatric and orphan medical devices sectors, and propose any legislative amendments necessary to ensure the continuous supply for these patient groups;
Amendment 766 #
Motion for a resolution Paragraph 24 24. Calls on the Commission to ensuring access to existing medical devices and strengthen support and investment in the development of, and access to, new innovative medical devices, and to support the digitalisation of health services; believes that new technologies and digitalisation can lead to new and better
Amendment 767 #
Motion for a resolution Paragraph 24 24. Calls on the Commission to strengthen support and investment in the development of new innovative medical devices and medicinal products; believes that new technologies can lead to new and better treatments for NCDs; calls on the Member States to continually invest in innovation for addressing NCDs; underlines the importance in this regard of EU funding such as the EU4Health and Horizon Europe programmes;
Amendment 768 #
Motion for a resolution Paragraph 24 24. Calls on the Commission to strengthen support and investment in unmet medical needs and the development of
Amendment 769 #
Motion for a resolution Paragraph 24 24. Calls on the Commission to strengthen support and investment in the development of, and access to, new innovative medical devices, and to support the digitalisation of national health services; believes that new technologies and digitalisation can lead to new and better
Amendment 77 #
Motion for a resolution Recital C C. whereas NCDs account for the largest share of countries’ healthcare expenditures
Amendment 770 #
Motion for a resolution Paragraph 24 24. Calls on the Commission to strengthen support and investment in the development of, and access to, new innovative medical devices, and to support the digitalisation of national health services; believes that new technologies and digitalisation can lead to new and better
Amendment 771 #
Motion for a resolution Paragraph 24 24. Calls on the Commission to strengthen support and investment in the development and uptake of new innovative
Amendment 772 #
Motion for a resolution Paragraph 24 24. Calls on the Commission to strengthen support and investment in the
Amendment 773 #
Motion for a resolution Paragraph 24 24. Calls on the Commission to strengthen support and investment in the development of new innovative medical devices and making them available to the public as soon as possible; believes that new technologies can lead to new and better treatments for NCDs;
Amendment 774 #
Motion for a resolution Paragraph 24 24. Calls on the Commission to strengthen support and investment in the development of new innovative medical devices, diagnostics and treatment solutions; believes that new technologies can lead to new and better treatments for NCDs;
Amendment 775 #
Motion for a resolution Paragraph 24 a (new) 24a. Acknowledges that organ failure can affect patients suffering from chronic diseases and that transplantation can be the best treatment; notes that the EU Action Plan on Organ Donation and Transplantation (2009-2015) contributed to increase organ donation and transplantation over Europe; acknowledges the potential benefits of organoids and xenotransplantation to address the current shortage of organs available for transplantation; calls on the European Commission to present a new action plan on organ donation and transplantation and to foster research and development on organoids and xenotransplantation;
Amendment 776 #
Motion for a resolution Paragraph 24 a (new) 24a. Considers the significant potential of the use of artificial intelligence, ‘big data’ algorithmic analysis and other modern technologies in diagnosis and decision-making for NCDs in the coming years; underlines that the combination of real-world data, mathematical modelling, artificial intelligence and digital tools will significantly help to develop innovative treatments in a more cost-efficient way; urges all implementation partners to be ever mindful of the principles of data privacy and security, trust, transparency, patient centricity and patient involvement at all times;
Amendment 777 #
Motion for a resolution Paragraph 24 a (new) 24a. Stresses that its resolution on the shortage of medicines (2020/2071(INI)) calls on the Commission and the Member States to assess the possibility of creating one or more European non-profit pharmaceutical undertakings which operate in the public interest to manufacture medicinal products in order to guarantee security of supply and to prevent possible shortages of medicines in cases of emergency;
Amendment 778 #
Motion for a resolution Paragraph 24 a (new) 24a. Believes that good quality data and evidence are important and that correlating health data with social, economic, and environmental data, and strengthening the equity elements of existing health monitoring systems, such as European Health Data Space, will support development of evidence-based and targeted policies and interventions for improved health equity;
Amendment 779 #
Motion for a resolution Paragraph 24 a (new) 24a. Stresses that the COVID-19 pandemic has shown the limits of dependence on third countries for medicines; proposes redoubling EU efforts to solve the problem of medicine shortages, encouraging the relocation of production facilities and specifically examining shortages of generic medicines;
Amendment 78 #
Motion for a resolution Recital C C. whereas NCDs account for the largest share of countries’ healthcare expenditures
Amendment 780 #
Motion for a resolution Paragraph 24 a (new) 24a. Notes that patients with NCDs are frequently affected by shortages of medicines and that interruptions in treatment can harm patients, care-givers and families;
Amendment 781 #
Motion for a resolution Paragraph 24 a (new) 24a. Calls on Member States to take actions to improve adherence to treatment in order to secure greater health benefits from investments into treatments of NCDs;
Amendment 782 #
Motion for a resolution Paragraph 24 b (new) 24b. Takes note of the scoping study made by the European Commission on evidence to tackle high-burden under- researched medical conditions; regrets that some chronic diseases including chronic kidney diseases and mental health are still underfunded compared to the burden they pose to patients, national healthcare systems and the society at large; calls on the European Commission and Member States to dedicate appropriate funding through Horizon Europe and national research programmes to stimulate the development of new diagnoses and treatments;
Amendment 783 #
Motion for a resolution Paragraph 24 b (new) 24b. Calls for improved coordination to avoid the stockpiling of medicines within Member States and to build up a European emergency reserve of essential medicines at high risk of shortages;
Amendment 784 #
Motion for a resolution Paragraph 24 c (new) 24c. Calls on the Commission and the Member States to look into the possibility of creating one or more European non- profit pharmaceutical undertakings which operate in the public interest to manufacture medicines of health and strategic importance for health care, in the absence of existing industrial production, in order to complete and guarantee security of supply and prevent possible shortages of medicines in emergency situation;
Amendment 785 #
Motion for a resolution Paragraph 24 d (new) 24d. Stresses the need to establish arrangements for EU-level monitoring of the risks of shortages and to ensure greater transparency of stocks of medicines in order to better anticipate shortages;
Amendment 786 #
Motion for a resolution Paragraph 24 e (new) 24e. Stresses that public health sovereignty must be a priority for the EU in order to ensure European citizens have access to treatment and that ‘Made in Europe’ would make it possible to achieve this goal; invites the Commission to consider establishing a European sovereignty fund that would be responsible for financing strategic projects in the health-care sector;
Amendment 787 #
Motion for a resolution Paragraph 25 25. Believes that improving knowledge and sharing of evidence-based best practices among Member States is needed to accelerate effective prevention measures and innovative practices, including digital solutions; recalls that the implementation of the European Health Data Space should contribute to strengthening the underlying data for evidence-based public health policy;
Amendment 788 #
Motion for a resolution Paragraph 25 25. Believes that improving knowledge and sharing of evidence-based best practices among Member States is needed to accelerate effective prevention measures and innovative practices; underlines the crucial importance of protecting the privacy of the public and underlines that data protection and informed and active consent before their data is shared is essential;
Amendment 789 #
Motion for a resolution Paragraph 25 25. Believes that
Amendment 79 #
Motion for a resolution Recital C C. whereas NCDs account for the largest share of
Amendment 790 #
Motion for a resolution Paragraph 25 25. Believes that improving knowledge and sharing of evidence-based best practices among Member States is needed to accelerate effective prevention measures and innovative practices, and improve management of NCDs, quality of care and health outcomes;
Amendment 791 #
Motion for a resolution Paragraph 25 25. Believes that improving knowledge and sharing of evidence-based best practices among Member States is needed to accelerate effective prevention measures, such as supporting treatment adherence, and innovative practices;
Amendment 792 #
Motion for a resolution Paragraph 25 25. Believes that improving knowledge, systematization of scientific data and sharing of evidence-based best practices among Member States is needed to accelerate effective prevention measures and innovative practices;
Amendment 793 #
Motion for a resolution Paragraph 25 25. Believes that improving knowledge and sharing of evidence-based best practices among Member States is needed to accelerate effective prevention measures and innovative, cost effective, accesible practices;
Amendment 794 #
Motion for a resolution Paragraph 25 a (new) 25a. Believes that good quality data and evidence are crucial and that correlating health data with social, economic, and environmental data, and strengthening the equity elements of existing health monitoring systems, such as European Health Data Space, will support the development of evidence-based and targeted policies and interventions for improved health equity;
Amendment 795 #
Motion for a resolution Paragraph 25 a (new) 25a. Invites the European Union to support the Member States in implementing the Europe’s Beating Cancer Plan and to ensure that all Member States have national cancer action plans to improve knowledge and information sharing arrangements;
Amendment 796 #
Motion for a resolution Paragraph 25 a (new) 25a. Believes that further economic data collection at national level is needed in order to achieve a better understanding of the associated costs and burden in the Member States;
Amendment 797 #
Motion for a resolution Paragraph 25 a (new) 25a. Believes that further economic data collection at national level is needed in order to achieve a better understanding of the associated costs and burden in the Member States;
Amendment 798 #
Motion for a resolution Paragraph 25 b (new) 25b. Acknowledges the great disparity in the level of funding between different NCDs and the need to evaluate funding priorities to ensure that those diseases which are underfunded despite their high burden, especially among disadvantaged groups, (such as alcohol-related liver disease, pancreatitis, and irritable bowel syndrome) attract more funding;
Amendment 799 #
Motion for a resolution Paragraph 25 b (new) 25b. Calls on the Commission to support treatment adherence and to recognise innovation in the form and dosage of medications, such as fixed- dose-combinations, as an innovative solution that can support patients adhere to their treatments in the long-term;
Amendment 8 #
Motion for a resolution Citation 4 – having regard to its resolution of 10 July 2020 on the Chemicals Strategy for Sustainability and the Commission communication of 14 October 2020 entitled ‘Chemicals Strategy for Sustainability – Towards a Toxic-Free Environment’ (COM(2020)0667),
Amendment 80 #
Motion for a resolution Recital C a (new) Ca. whereas air pollution increases the health cost for EU citizens; whereas, in 2018, average every inhabitant of a European city suffered a welfare loss of over € 1,250 a year owing to direct and indirect health losses associated with poor air quality with amounts varying from the Romanian capital Bucharest total welfare loss amounts to over € 3,000 per capita/year to Santa Cruz de Tenerife in Spain where it is under € 400/cap/yr; whereas most of these costs relate to premature mortality: for the 432 cities investigated in the report, the average contribution of mortality to total social costs is 76.1% while, the average contribution of morbidity (diseases) is 23.9%.1b _________________ 1b report Health costs of air pollution in European cities and the linkage with transport published by CE Delft,
Amendment 800 #
Motion for a resolution Paragraph 25 c (new) 25c. Calls on the Member States to implement or improve e-health technologies, telemedicine and telecare services to ensure the continuity of inpatient and outpatient cancer care as well as community care; urges the Commission to deploy Horizon Europe research funding to support the use of telemedicine and to assist with the establishment of evidence-based guidelines; calls for actions to ensure equal access to telemedicine services across the Member States, and for EU4Health and Digital Europe funding to support an increase in digital literacy for patients and healthcare professionals;
Amendment 801 #
Motion for a resolution Paragraph 26 Amendment 802 #
Amendment 803 #
Motion for a resolution Paragraph 26 Amendment 804 #
Motion for a resolution Paragraph 26 Amendment 805 #
Motion for a resolution Paragraph 26 26.
Amendment 806 #
Motion for a resolution Paragraph 26 26. Calls on the Commission to
Amendment 807 #
Motion for a resolution Paragraph 26 a (new) 26a. Acknowledges that many chronic diseases can lead to organ failure for which transplantation is the best therapy; notes that the EU action plan on organ donation and transplantation (2009-2015) resulted in a considerable increase in organ donation and transplantation in the EU over its period of implementation; calls on the Commission to establish a 2nd EU action plan on organ donation and transplantation during the 2024-2027 mandate;
Amendment 808 #
Motion for a resolution Paragraph 26 a (new) 26a. Acknowledges that many chronic diseases can lead to organ failure for which transplantation is the best therapy; notes that the EU action plan on organ donation and transplantation (2009-2015) resulted in a considerable increase in organ donation and transplantation in the EU over its period of implementation; calls on the Commission to establish a second EU action plan on organ donation and transplantation during the 2024-2029 mandate;
Amendment 809 #
Motion for a resolution Paragraph 26 a (new) 26a. Express support for EU level exercises and projects such as the European Cancer Inequities Registry and recommend its expansion into further areas of attention such as inequities related to race-ethnicity, age, gender, LGBTIQ+, vulnerable groups, such as people living with a disability, impairment or (multiple) chronic conditions, and concerns about medical deserts;
Amendment 81 #
Motion for a resolution Recital C a (new) Ca. whereas investment in health promotion, chronic disease prevention and management remains limited, despite the learnings from the COVID-19 pandemic;
Amendment 810 #
Motion for a resolution Paragraph 26 a (new) 26a. Stress the importance of the principle of open science to foster greater transparency and trust for the benefit of scientific research and for the benefit of EU citizens;
Amendment 811 #
Motion for a resolution Paragraph 26 b (new) 26b. calls on the European Commission to encourage, including with targeted funding, research into autoimmune diseases, which afflict 5 to 10 per cent of the global population;
Amendment 812 #
Motion for a resolution Paragraph 27 Amendment 813 #
Motion for a resolution Paragraph 27 27. Calls on the Commission to create a European NCD Health Knowledge Centre to improve data collection and research on NCDs;
Amendment 814 #
Motion for a resolution Paragraph 27 27. Calls on the Commission to create a European NCD Health Knowledge Centre to improve data collection and research on NCDs; stresses the need for further research in NCD co-morbidities and management, and the need for open and FAIR (findable, accessible, interoperable, and reusable) data, as well as the promotion and implementation of existing initiatives, including the European Open Science Cloud, to foster research;
Amendment 815 #
Motion for a resolution Paragraph 27 27. Calls
Amendment 816 #
Motion for a resolution Paragraph 27 27. Calls
Amendment 817 #
Motion for a resolution Paragraph 27 27. Calls on the Commission to create a European NCD Health Knowledge Centre to improve data collection and research on NCDs; encourages Member States to exchange best practices on prevention, management and care of NCDs in relevant forums; stresses the need for further research in NCD co-morbidities and management;
Amendment 818 #
Motion for a resolution Paragraph 27 27. Calls on the Commission to
Amendment 819 #
Motion for a resolution Paragraph 27 27. Calls on the Commission to
Amendment 82 #
Motion for a resolution Recital D D. whereas the increasing burden of NCDs on individuals and societies and the health needs of ageing populations 40% of which live with multimorbidity represent challenges to the healthcare systems of the Member States, and require the development of specific NCD prevention, detection and treatment policies contributing to healthy ageing;
Amendment 820 #
Motion for a resolution Paragraph 27 27. Calls on the Commission to create a European NCD Health Knowledge Centre and European reference centres to specific NCDs to improve data collection and research on NCDs; stresses the need for further research in NCD co-morbidities and management;
Amendment 821 #
Motion for a resolution Paragraph 27 27. Calls on the Commission to create a European NCD Health Knowledge Centre to improve data collection and research on
Amendment 822 #
Motion for a resolution Paragraph 27 a (new) 27a. Reminds the Commission of the independent external evaluation of the European centre for disease prevention and control examine the feasibility of extending the mandate of the Centre to address the impact of cross-border threats to health on non-communicable diseases on the Review. Calls on the European Commission to provide the ECDC a sustainable and future-proof mandate that advances health promotion and recognises interconnections between communicable and non-communicable diseases;
Amendment 823 #
Motion for a resolution Paragraph 27 a (new) 27a. Believes that good quality data and evidence are crucial and that correlating health data with social, economic, and environmental data, and strengthening the equity elements of existing health monitoring systems, such as European Health Data Space, will support the development of evidence-based and targeted policies and interventions for improved health equity;
Amendment 824 #
Motion for a resolution Paragraph 27 a (new) 27a. Stresses that good quality data are important to support development of evidence-based and targeted policies for improved health; notes that correlating health data with environmental, social and economic data and strengthening elements of existing health monitoring systems such as European Health Data Space is important in this regard;
Amendment 825 #
Motion for a resolution Paragraph 27 a (new) 27a. Believes that good quality data and evidence are important and that strengthening the equity elements of existing health monitoring systems, such as European Health Data Space, will support development of evidence-based and targeted policies and interventions for improved health equity;
Amendment 826 #
Motion for a resolution Paragraph 27 a (new) 27a. Believes that good quality data and evidence are important and that correlating health data with social and environmental data will support the development of evidence-based and targeted policies improving health equity;
Amendment 827 #
Motion for a resolution Paragraph 27 a (new) 27a. recognises the potential of interoperable and flexible diabetes data registries in improving quality of care and health outcomes; calls on Member States to put in place NCD-specific data registries;
Amendment 828 #
Motion for a resolution Paragraph 28 Amendment 829 #
Motion for a resolution Paragraph 28 28. Welcomes the Commission Expert Group on Public Health and the sub-group on NCDs; calls on the Commission to extend the group to patient experts; calls on the Commission to establish a European expert network for prevention and control of NCD co-
Amendment 83 #
Motion for a resolution Recital D D. whereas the increasing burden of NCDs on individuals and societies and the health needs of ageing
Amendment 830 #
Motion for a resolution Paragraph 28 28. Welcomes
Amendment 831 #
Motion for a resolution Paragraph 28 28. Welcomes the Commission Expert Group on Public Health and the sub-group on NCDs; calls on the Commission to establish a European expert network including patient's representatives for prevention and control of NCD co- morbidities and complications;
Amendment 832 #
Motion for a resolution Paragraph 28 28. Welcomes the Commission Expert Group on Public Health and the sub-group on NCDs; calls on the Commission to establish a European expert network for the prevention and control of NCD
Amendment 833 #
Motion for a resolution Paragraph 28 a (new) 28a. Recognises that the EU has a role in supporting global health, including in respect to the international rise of NCDs; urges that the EU’s global health strategy therefore include objectives such as supporting the WHO goal of global elimination of cervical cancer, in line with the EU goal of eliminating HPV cancers; additionally recommends that there be a health component to EU Neighbourhood policy, including supporting the inclusion of partner countries within the framework of EU health policy, such as Europe’s Beating Cancer Plan;
Amendment 834 #
Motion for a resolution Paragraph 28 a (new) 28a. Address the urgent need to tackle regional disparities in healthcare access, striving for equitable availability of quality NCD management across diverse geographical areas within Member States. Explore innovative methods to enhance access to NCD healthcare, such as mobile clinics, trauma-informed teams, and peer advocates. This strategy aims to not only bridge gaps in healthcare access but also to foster a patient-centred and personalized approach to NCD prevention and treatment;
Amendment 835 #
Motion for a resolution Paragraph 28 a (new) 28a. Belives that the EU has a role in supporting global health, including in respect to the international rise of NCDs;
Amendment 836 #
Motion for a resolution Paragraph 28 a (new) 28a. Importance of Improving Cardiovascular Health Cardiovascular diseases are the main cause of death in the European Union, and also worldwide, and consequently, they are the group of non-communicable diseases with the greatest burden on health systems.Unlike risk factors, cardiovascular diseases require a comprehensive, integrated, and specific approach to reduce their impact on the health of the European Union population;We therefore call on the European Commission and the Member States to: a.Drive a cardiovascular health action plan in the European Union to reduce the impact of these conditions, based on the approach of this document. b. Promote best practices in the Member States of the European Union to improve cardiovascular health.
Amendment 84 #
Motion for a resolution Recital D D. whereas
Amendment 85 #
Motion for a resolution Recital D D. whereas the increasing burden of NCDs and the health needs of ageing populations represent challenges to the health systems of the Member States, which require the development of specific NCD prevention, detection and treatment policies contributing to healthy ageing;
Amendment 86 #
Motion for a resolution Recital D D. whereas the increasing burden of NCDs on individuals and societies and the health needs of ageing populations, 40% of which live with multimorbidity1a, represent challenges to the healthcare systems of the Member States; _________________ 1a Chowdhury S.R., Chandra Das D., Sunna T.C., Beyene J., Hossain A. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta- analysis (2023) eClinicalMedicine, 57, art. no. 101860
Amendment 87 #
Motion for a resolution Recital D D. whereas the increasing burden of NCDs on individuals and societies and the health needs of ageing populations, 40% of which live with multimorbidity, represent challenges to the healthcare systems of the Member States;
Amendment 88 #
Motion for a resolution Recital D D. whereas the increasing burden of NCDs on individuals and societies, and the health needs of ageing populations, 40% of which live with multimorbidity, represent challenges to the health systems of the Member States;
Amendment 89 #
Motion for a resolution Recital D D. whereas the increasing burden of NCDs affecting individuals and societies and the health needs of ageing populations represent challenges to the health systems of the Member States;
Amendment 9 #
Motion for a resolution Citation 5 – having regard to its resolution of 24 November 2021 on a pharmaceutical strategy for Europe (2021/2013(INI)) and the Commission communication of 25 November 2020 entitled ‘Pharmaceutical Strategy for Europe’ (COM(2020)0761),
Amendment 90 #
Motion for a resolution Recital D D. whereas the increasing burden of NCDs on individuals and societies and the health needs of an ageing populations represent challenges to the health systems of the Member States;
Amendment 91 #
Motion for a resolution Recital D D. whereas the increasing burden of NCDs on individuals and societies and the health needs of ageing populations represent challenges to the health systems of the Member States;
Amendment 92 #
Motion for a resolution Recital D D. whereas the increasing burden of NCDs on individuals and societies and the health needs of ageing populations represent challenges to the health systems of the Member States;
Amendment 93 #
Motion for a resolution Recital D D. whereas the increasing burden of NCDs on individuals and societies and the health needs of ageing populations represent challenges to the
Amendment 94 #
Motion for a resolution Recital D a (new) Da. Da. whereas a number of Member States are experiencing a shortage of specialists in certain areas of medical care, such as mental health care in children and adolescents, which is leading to delays in the provision of necessary health care, which can have serious individual and societal impacts;
Amendment 95 #
Motion for a resolution Recital D a (new) Da. whereas the repercussions of NCDs go beyond individual health to affect the whole economy and social fabric; whereas it is imperative to take global measures on the various issues pertaining to NCDs;
Amendment 96 #
Motion for a resolution Recital D a (new) Da. whereas NCDs such as type 2 diabetes increasingly affect children; whereas many people living with NCDs such as diabetes are often diagnosed too late and many people already show signs of complications; 1a _________________ 1a https://link.springer.com/article/10.1007/s 11892-014-0508-y Diabetes Research and Clinical Practice, Volume 183, 2022, 109118, ISSN 0168-8227 https://doi.org/10.1016/j.diabres.2021.109 118.
Amendment 97 #
Motion for a resolution Recital D a (new) Da. whereas, according to Article 168 TFEU, the European Union can play primarily a cooperative and complimentary role with regard to healthcare, while health at its core constitutes a national competence;
Amendment 98 #
Motion for a resolution Recital D a (new) Da. whereas, according to Article 168 TFEU, the European Union can play a cooperative and complimentary role with regard to healthcare, while health at its core constitutes a national competence;
Amendment 99 #
Motion for a resolution Recital D a (new) Da. whereas NCDs, such as obesity, diabetes and endocrine disorders, also increasingly affect children1, which requires a dedicated approach to prevention and management;
source: 752.881
2023/09/18
DEVE
8 amendments...
Amendment 1 #
Draft opinion Recital A A. whereas
Amendment 2 #
Draft opinion Recital A a (new) Amendment 3 #
Draft opinion Recital A b (new) A b. whereas non-communicable diseases are linked to poverty, as they impede poverty reduction initiatives by increasing the share of household costs for health care; whereas treatments of non-communicable diseases tend to involve long-term treatment that can be hard to access to and have a significant impact on household economy; whereas NCDs are not only linked to excess mortality, but also to suffering from morbidity, chronic illness-related disability and increased socio-economic burdens on individuals and families, including poverty from long-term treatment and care costs, loss of productivity that considerably threatens household income and impairs national economies, making non-communicable diseases a contributing factor to poverty and hunger; whereas providing adequate care, prevention and treatment for patients with non-communicable diseases means that many challenges have to be addressed, such as inadequate access to medical care, healthcare facilities and healthcare professionals, as well as deficits in the healthcare structure, particularly in developing countries; whereas the COVID-19 pandemic has exposed insufficient investment in the Health Care Workforce and shown how unprepared health systems were to respond to a global health crisis; whereas low- and middle- income countries’ health systems focus on acute illness because of their weaknesses; whereas, as a result, the patient's journey is often characterised by gaps, whether at the diagnostic phase, treatment or lack of adherence to therapy; whereas prevention aspects are often missing in those systems; whereas the COVID-19 pandemic placed an increasing strain on mental health, especially among young people and those already suffering from mental illness;
Amendment 4 #
Draft opinion Recital A c (new) A c. whereas the Global Goals for Sustainable Development comprise combatting poverty, including the access to basic human needs of health, zero hunger, including establishing sustainable food production and good health and wellbeing, including better and more accessible health systems to increase life-expectancy; whereas food security and education have a significant impact on health in the area of non- communicable diseases; whereas in general, next to infections and behavioural risk factors interlinked with socio-economic factors and according to the World Health Organisation, climate change, air pollution and non- communicable diseases represent some of the most serious threats to global health; which is why One Health needs to become a central determinant in the prevention of health risks and in combatting them;
Amendment 5 #
Draft opinion Paragraph -1 (new) Amendment 6 #
Draft opinion Paragraph 1 1.
Amendment 7 #
Draft opinion Paragraph 2 a (new) Amendment 8 #
Draft opinion Paragraph 2 b (new) 2 b. Highlights the importance of preventing non-communicable diseases, stresses the need to support developing countries in educating communities about the risk factors and prevention strategies for NCDs by disseminating information through various credible channels; Reminds the scale of the problem of health misinformation and the potential danger to human lives that has become apparent with the COVID-19 pandemic; calls on the Commission to support projects, tools and policies that seeks to fight the health misinformation topic; and calls on the WHO to promote further awareness and information in the fight against non-communicable diseases such as cancer or diabetes, as well as further prevention of substance abuse; Underlines the impact of the living environment on health and on the prevention of non-communicable diseases; recalls that 'One Health' lies at the interface between ecological, animal and human health; calls on the EU to commit to a feasible design and implementation of the 'One Health' approach at European and international level through the WHO, regional organisations and States, in particular in negotiations relating to the planned Pandemic Treaty and the Global Health Strategy; urges Team Europe to recall in this regard the principle of policy coherence for development (PCD) as enshrined in Article 208 TFEU and to take the One Health approach in health programming and action into account, including in intersectional fields such as biodiversity, agriculture and a healthy living environment; Stresses that the delivering of “horizontal health” through an holistic and rights- based approach entails i.a. to fully address the multidimensional nature of health along the line of “One Health” approach; Notes with deep concern that pollutants in the environment have a massive impact on global health, especially for low- and middle-income countries (LMICs); calls on the EU to assist developing countries, notably the LMICs and LDCs, to prioritize disease prevention, through investment in the management of pollution, including through strategies on access to clean energies, clean and efficient transport, control of industrial emissions, the sound use of chemicals, as it is a highly cost- effective strategy for enhancing population health, reducing the burden on limited health resources and advancing national development;
source: 752.956
|
History
(these mark the time of scraping, not the official date of the change)
2023-12-15Show (3) Changes | Timetravel
| docs/5 |
|
| events/3 |
|
| procedure/stage_reached |
Old
Awaiting Parliament's voteNew
Procedure completed |
2023-12-14Show (1) Changes | Timetravel
| forecasts |
|
2023-12-14Show (1) Changes | Timetravel
| forecasts/0/title |
Old
Vote in plenary scheduledNew
Vote scheduled |
2023-12-09Show (4) Changes | Timetravel
| docs/5 |
|
| events/2/summary |
|
| forecasts/0 |
|
| forecasts/0 |
|
2023-12-08Show (2) Changes | Timetravel
| docs/5 |
|
| events/2/docs |
|
2023-11-18Show (2) Changes | Timetravel
| events/2 |
|
| procedure/stage_reached |
Old
Awaiting committee decisionNew
Awaiting Parliament's vote |
2023-11-15Show (1) Changes | Timetravel
| commission |
|
2023-11-09Show (2) Changes | Timetravel
| events/1 |
|
| procedure/Other legal basis |
Rules of Procedure EP 159
|
2023-11-08Show (1) Changes | Timetravel
| forecasts/0 |
|
2023-10-28Show (3) Changes | Timetravel
| docs/0 |
|
| docs/4 |
|
| docs/4/date |
Old
2023-08-22T00:00:00New
2023-10-27T00:00:00 |
2023-10-14Show (1) Changes | Timetravel
| forecasts/0/date |
Old
2023-10-24T00:00:00New
2023-11-07T00:00:00 |
2023-10-07Show (1) Changes | Timetravel
| docs/4/date |
Old
2023-09-22T00:00:00New
2023-10-06T00:00:00 |
2023-10-05Show (1) Changes | Timetravel
| forecasts/1 |
|
2023-09-28Show (1) Changes | Timetravel
| docs/4 |
|
2023-09-26Show (1) Changes | Timetravel
| forecasts |
|
2023-09-19Show (3) Changes | Timetravel
| docs/1 |
|
| docs/2 |
|
| docs/3 |
|
2023-09-07Show (1) Changes | Timetravel
| committees/0/shadows |
|
2023-08-23Show (1) Changes | Timetravel
| docs/0/date |
Old
2023-07-19T00:00:00New
2023-08-22T00:00:00 |
2023-07-26Show (1) Changes | Timetravel
| docs |
|
2023-07-22Show (1) Changes | Timetravel
| committees/0/rapporteur |
|
2023-06-17Show (5) Changes
| committees |
|
| events |
|
| procedure/dossier_of_the_committee |
|
| procedure/legal_basis |
|
| procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting committee decision |